SUPPLEMENTARY DOCUMENTATION FOR THE NMES CD-ROM
This file provides additional supporting documentation for this CD-ROM.
These
documents were originally provided as hard-copy attachments to individual
public use tape releases. For the convenience of the user, they are now
provided on this file.
Additionally, the following documents are of relevance to the user.
National Medical Expenditure Survey, Questionnaires
and Data Collection Methods for the Household Survey
and the Survey of American Indians and Alaska Natives,
Methods 2, by W.S.Edwards and M. Berlin, DHHS Publications No. (PHS)89-3450
National Medical Expenditure Survey, Questionnaires
and Data Collection Methods for the Medical Provider
Survey, Methods 4, by K. Tourangeau and E.P. Ward,
AHCPR Pub No. 92-0042
These documents are available from the Agency for Health Care Policy and
Research's Publications Clearinghouse at 1-800-358-9295 or from your
university's Official Representative to the ICPSR.
For reasons of space, the Household Survey Methods 2 does not reproduce
every
question for every round in full. Information on frequency of provider
contacts, type of provider, conditions associated with each contact, and
charges and sources of payment was obtained at each round of the
Household
Survey in separate event booklets. A representative example is provided
in
Methods 2 for dental visits. Booklets for other provider types are
contained
in Methods 2 but excluding questions on charges and sources of payment,
which
were essential identical to those asked for dental visits.
The Medical Provider Survey questionnaire is reproduced in full
in the Methods 4 document, except for repeat series.
A listing of supporting documentation on this file follows.
NMES Data Items for the Civilian Noninstitutionalized
Population
Information on Previously Released NMES Public Use Tapes
Variance Estimation Programs for Use with Complex Survey
Data
National Health Interview Survey Procedure Codes for Use
with the NMES Household Survey Data
X-Codes for Special Impairments (X00-X99) by Type, Site
and Etiology
Medicine Names and Codes (Koch, 1980)
Generic Drug Names and Codes (Koch, 1980)
T Questions from Round 1 of the Household Survey
Technical Specifications for Utilization and Expenditure
Variables
Comparison of Estimates of NMES Health Care Utilization
Using NMES Public Use Tapes 13, 14, and 18
Comparison of Estimates of NMES Health Care Expenditures
Using NMES Public Use Tapes 13, 14, and 18
The remainder of this file contains these supplementary documents in the
order
shown above. Users can use the DOS FIND command with the /n/i options to
locate specific documents.
NMES DATA ITEMS FOR THE CIVILIAN NONINSTITUTIONALIZED POPULATION
DATA ITEM
RECORD IDENTIFIERS AND LINK VARIABLES
Person level
Family level by round
Family level (annual)
ODU level
RU level by Rd
Event level
Medical provider identifiers
Insurance provider identifiers
Policyholder-level identifiers
Links to HIPS private insurance
benefit database
Minor's parent/guardian identifiers
Health insurance eligibility unit
NMES TAPE(S) ON WHICH DATA
IS AVAILABLE:
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
13, 18
18
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
13, 18
14.1-14.5
9, 14.2, 14.4, 14.5
15*, 16*
15*, 16*
16*
18
by round, annual
18
SURVEY ADMINISTRATION AND ELIGIBILITY STATUS
Eligibility status for HS by Rd
13, 18
Interview dates for health status
questionnaire and access data
9
Interview dates for core questionnaire by Rd
13
Reference period dates by Rd
13
Respondent identifiers by Rd
13
Round of data collection
14.1-14.5
Response disposition code in HIPS
15*, 16*
Interview conducted in English
18
Memory aids used in survey recall
18
SAMPLING WEIGHTS AND VARIANCE ESTIMATION
Health status questionnaire/access
supplement weight (HSQACCWT)
9
Preliminary Round 1 weight
(INCR1PER)
10
Final Round 1 Person-level weight
(WGTR1PER)
13, 18
Preliminary Round 4 weight
(INCR4PER)
10
Final Round 4 Person-level weight
(WGTR4PER)
13, 18
Full-year weight (INCALPER)
10, 13, 14.1-14.5, 18
Policyholder weight (POSTJO2)
15*, 16*
Round 1 family-level weight
(FAMID1WT)
Round 4 family-level weight
(FAMID4WT)
Full-year family-level weight
(ANFMIWT)
Full-year annualization factor
(ANFACTOR)
Round 1 Health Insurance Unit
Level weight (HIEU1WT)
Round 4 Health Insurance Unit
Level weight (HIEU4WT)
Full-year Health Insurance Unit
Level weight (ANHIEUWT)
Strata
Primary sampling unit
DEMOGRAPHICS
Census region - R1
Census region - R4
Census division
SMSA status (SMSA/Non-SMSA)
18
18
18
18
18
18
18
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
15*, 16*, 18
13
13
SMSA/density (SMSA core county/
SMSA non-core/non-SMSA)
Age (First age and Last age)
Age by RD
Race
Race/Hispanic ethnicity
Hispanic ancestry group
Sex
Education
Native Language
Veterans status - R1
Current/past military service
Service related disability
Veterans status - R4
Vietnam veteran
Branch of the armed services
FAMILY RELATIONSHIPS
Marital status by Rd
Parent identifiers
Spouse identifiers by Rd
Relationship to family
reference person by Rd
Family reference person
identifiers
Family size
Vital status of parents not
in household
Age of parents not in household
Childcare arrangements for
youngest child
Minor's parent/guardian
identifiers
Parents with mental/physical
difficulties
HEALTH STATUS AND ATTITUDES
Height and weight
Health practices
Health status
Check lists of health conditions
Check lists of symptoms
Immunizations for children 17
and younger
Vision and hearing
Dental care
Health perceptions
Social activities
ADL/IADL difficulties
Continence
18
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
13
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
9, 10, 13, 14.1-14.5,
15*, 16*, 18
13
9, 10, 13, 14.1-14.5, &
15*, 16*, 18
13
9
13
13, 18
13
18
18
18
13
13, 18
13
13
13
13
18
18
18
18
18
9
9
9
9
9
9
9
9
9
9
10
10
Use of special equipment
Use of special transportation,
etc. for those with at least one
ADL/IADL
Prior nursing home stays for
those with at least one ADL/IADL
1987 admission to a institutional
facility
Loss of a close friend or relative
Close friend or relative
institutionalized
Persons with developmental
disabilities
Pregnancy in 1987
Prenatal care
ACCESS TO CARE
Usual source of care
Characteristics of the usual source
of care and regular medical
providers
Reasons for no usual source of care
Usual source of dental care
Travel and waiting times
Barriers to care
Medical provider identifier for
the usual source of care
INCOME AND POVERTY STATUS
Total family income
Total person income
Poverty status
Amount of income from 26 sources
(e.g., from business, wages, etc)
EMPLOYMENT
Employment status in week prior
to interview by Rd
Employment status during the Rd
Details about workers laid off or
without work by Rd
Items for main/last job(s):
Wage rate
Usual hours worked per week
Job start/end dates
Size of employer
Union membership
Industry and occupation codes
Other job characteristics
Annual weeks worked
Employment status as of 12/31/87
Type of employer
Link to last main job
10
10
10
18
18
18
18
18
18
9
9
9
9
9, 14.5
9
9, 14.2, 14.4, 14.5
13
13
13
18
13
13, 18
13
13
13
13
13
13
13
13
13
13
13, 18
18
15*, 18
Changed job during 1987
13
HOUSEHOLD SURVEY REPORTED INSURANCE COVERAGE
Medicare coverage as of the
interview date (as of Dec 31,1987
13
for last round)
CHAMPUS/CHAMPVA as of the
interview date
13
Medicaid as of the interview date
13
Other public medical assistance
as of the interview date
13
Private health insurance as of
the interview date
13
Uninsured as of the interview date
13
Sources of private insurance
plans by Rd
13
Policy holders of priv. insurance
plans by Rd
13
Medicare coverage by month
18
CHAMPUS/CHAMPVA by month
18
Medicaid by month
18
Other public medical assistance
by month
18
Private health insurance by month
18
Uninsured by month
18
Difficulty in purchasing insurance
18
HMO coverage as of the interview
date by round
18
HMO coverage at anytime during RD
18
ANNUAL
Number
Number
Number
Number
PERSON-LEVEL DISABILITY MEASURES
of bed disability days
13
of work-loss days
13
of school-loss days
13
of cutdown days
13
HOUSING DATA
Type of housing unit
Mortgage and tax data
Purchase price of home
Profit or loss from selling home
Home located in a retirement
community
Services available in a retirement
community
Modifications made to home for
handicapped persons
TAX DATA
Tax filing status
Number and relationship of
dependents to taxpayer
Itemized medical expenses
Tax deduction for medical expenses
18
18
18
18
18
18
18
18
18
18
18
ANNUAL PERSON-LEVEL UTILIZATION MEASURES
Number of medical provider visits:
To a physician
13,
To a non-physician provider
13,
Telephone calls to physician
13,
Telephone calls to a non-physician medical provider
13,
Number of hospital outpatient visits:
To a physician
13,
To a non-physician medical
provider
13,
Number of emergency room visits
13,
Number of emergency room visits
resulting in a hospitalization
13,
Number of hospital inpatient
stays
13,
Number of nights spent in a
hospital
13,
Number of home health services:
Provided by physicians
13,
Provided by non-physician
medical providers
13,
Number of prescribed medicine
purchases
13,
Number of dental visits
13,
Number of dental visits involving
orthodontia
13,
14.5, 18
14.5, 18
14.5, 18
14.5, 18
14.5, 18
14.5, 18
14.5, 18
14.5, 18
14.4, 18
14.4, 18
14.2, 18
14.2, 18
14.1, 18
14.3, 18
14.3, 18
ANNUAL PERSON-LEVEL EXPENDITURE AND SOURCES OF
PAYMENT (SOP) MEASURES
Expenditure and SOP for medical provider visits:
To a physician
18, 14.5
To a non-physician provider
18, 14.5
Telephone calls to physician
18, 14.5
Telephone calls to a non-physician medical provider
18, 14.5
Expenditure and SOP for hospital
outpatient visits:
To a physician
18, 14.5
To a non-physician medical
provider
18, 14.5
Expenditure and SOP for emergency
room visits
18, 14.5
Expenditure and SOP for emergency
room visits resulting in a
hospitalization
18, 14.5
Expenditure and SOP for hospital
inpatient stays
18, 14.4
Expenditure and SOP for nights spent
in a hospital
18, 14.4
Expenditure and SOP for home health
services:
Provided by physicians
Provided by non-physician
medical providers
Expenditure and SOP for prescribed
medicine purchases
Expenditure and SOP for dental visits
Expenditure and SOP for dental visits
involving orthodontia
Expenditure and SOP for eye glasses/
contact lenses
Expenditure and SOP for durable goods
(excluding vision wear)
Expenditure and SOP for purchases or
rental of non durable goods (e.g.,
bandages, ambulance service,
catheters)
18, 14.2
18, 14.2
18, 14.1
18, 14.3
18, 14.3
18, 14.2
18, 14.2
18, 14.2
1987 PRESCRIBED MEDICINE USE AND EXPENDITURE
EVENT-LEVEL DATA
Types of prescribed medicines
14.1
Household respondent reported
medical conditions associated
with prescribed medicines obtained 14.1
Types of generic equivalents
14.1
Federal controlled substance status
14.1
Composition status
14.1
Dates first and last taken
14.1
Number of purchases
13, 14.1, 18
Total expense
14.1, 18
Sources of payment from nine
sources
1987 HOME HEALTH VISIT AND EXPENDITURE
Beginning and ending dates of
HH care
Type of provider performing HH care
Provider's place of work
Time of day of visits
Length of visits
Household respondent reported
medical conditions associated
with home health care
Number of visits by provider type
Medical or nursing treatments
performed
ADL or IADL assistance performed
Total expense for visit
Nine sources of payment for last
visit
1987 OTHER MEDICAL EXPENSES USE
AND EXPENDITURE EVENT-LEVEL DATA
14.1, 18
EVENT-LEVEL DATA
14.2
14.2
14.2
14.2
14.2
14.2
13, 14.2, 18
14.2
14.2
14.2, 18
14.2, 18
Type of medical item bought/rented/
used
Date medical item first obtained
Medical conditions associated
with item bought
Total expense
Sources of payment from nine
sources
14.2, 18
14.2
14.2
14.2, 18
14.2, 18
1987 DENTAL VISIT AND EXPENDITURE EVENT-LEVEL DATA
Type of dental services provided
14.3
Number of dental visits
13, 14.3, 18
Dental visits due to accidents
or injury
14.3
Household respondent reported
medical conditions associated
with the dental visit
14.3
Total expense
14.3, 18
Sources of payment from nine
sources
VA facility indicator
14.3, 18
14.3
1987 HOSPITAL INPATIENT STAY AND EXPENDITURE EVENT-LEVEL DATA
Dates entered and left hospital
14.4
Number of hospital stays
13, 14.4, 18
Number of nights in hospitals
13, 14.4, 18
Reason for hospital stay
14.4
Household respondent reported medical
conditions associated with the
hospital stay
14.4
Operations performed
14.4
Procedures performed
14.4
Facility expense and nine
associated sources of
payment
14.4, 18
Doctor expense and nine
associated sources of
payment
14.4, 18
Private duty nurse expense
14.4
VA facility indicator
14.4
1987 MEDICAL PROVIDER VISIT AND EXPENDITURE EVENT-LEVEL DATA
Date of medical visit
14.5
Number of medical provider visits
13, 14.5
Location of service
14.5
Physician/non-physician provider
14.5, 18
Type of medical provider
14.5
In person/telephone visit
14.5, 18
Medical visits by site
14.5
Reason for the visit
14.5
Household respondent reported medical
condition associated with the
medical provider visit
14.5
Type of specialist seen during
visit
Surgical procedures performed during
visit
Types of tests administered during
visit
Total expense for visit
Source of payment from nine sources
14.5
14.5
14.5
14.5, 18
14.5, 18
1987 HOSPITAL OUTPATIENT DEPARTMENT VISIT AND EXPENDITURE EVENT-LEVEL
DATA
Date of medical visits
14.5
Number of medical visits
13, 14.5
Type of provider
14.5
Number of zero night hospital stays
during 1987
14.5
Reason for the visit
14.5
Household respondent reported medical
conditions associated with the
OPD visit
14.5
Surgical procedures performed
during visit
14.5
Types of tests administered during
visit
14.5
Types of physician specialist
seen
14.5
Facility expense and nine associated
sources of payment items
14.5, 18
Doctor expense and nine associated
sources of payment items
14.5, 18
VA facility indicator
14.5
1987 EMERGENCY ROOM VISIT AND EXPENDITURE EVENT - LEVEL DATA
Date of medical visit
14.5
Number of emergency room visits
13, 14.5, 18
Visit results in inpatient hospital
stay
14.5
Household respondent reported medical
condition associated with visit
14.5
Type of physician specialist seen
during visit
14.5
Surgical procedures performed during
visits
14.5
Types of tests administered during
visit
14.5
Travel and waiting times
9, 14.5
Mode of transportation to the
facility
14.5
VA facility indicator
14.5
Facility expense and nine associated
sources of payment items
14.5, 18
Doctor expense and nine associated
sources of payment items
14.5, 18
PRIVATE HEALTH INSURANCE CHARACTERISTICS FROM THE HEALTH INSURANCE PLANS
SURVEY QUESTIONNAIRES (HELD COVERAGE ONLY)
Total health insurance premiums
15*
Employer contributions to health
insurance premiums
15*
Out-of Pocket premium expenses
15*
Other contributions toward health
insurance premiums
15*
Level of health insurance coverage
(single, family, etc.)
15*
Summary variables of health insurance
coverage (including indicators of
coverage for basic medical, basic
hospitalization, major medical,
dental vision and prescription
drugs)
15*
Indicator of whether employment-related
coverage included an HMO or
traditional fee-for-service plan
15*
Indicator of whether coverage that was
not employment-related was an HMO,
traditional fee-for-service, or
Medigap plan
15*
Indicator of group coverage
15*
Indicator of self-insurance status of
employment-related health-insurance
coverage
15*
Characteristics of employers and
unions providing insurance
coverage
15*
HIPS: PRIVATE INSURANCE BENEFIT DATABASE
Basic and major medical benefits for
inpatient hospital, skilled nursing
facilities, surgery, physician visits,
routine physical exams, well child,
psychiatric services, preg-related
care, home health and hospice
16*
Dental, prescription drugs, vision,
or hearing care coverage
characteristics and limitations
16*
Medicare supplementary coverage
(Medigap) including benefits
designed to cover Part A and
Part B deductibles, Part B
coinsurance and outpatient
mental health care, restrictions
to Medicare reasonable and
customary charges, fee schedule
allowances and limits on
pre-existing conditions
16*
HMO characteristics including HMO
model type, locations, etc.
16*
Cost containment provisions including
concurrent and pre admission review,
preferred provider organizations,
and second surgical opinions
16*
Footnote:
* Data from NMES Tapes 15 & 16 is not provided on this CD-ROM. These
data
(Tapes 15 & 16) are from the NMES Health Insurance Plans Survey, which
can be
linked to the data on this CD-ROM at the insurance policyholder level.
INFORMATION ON PREVIOUSLY RELEASED NMES PUBLIC USE TAPES
I.
Introduction
The Agency for Health Care Policy and Research (AHCPR) provides data from
the
1987 National Medical Expenditure Survey (NMES-2) for analysis in several
different ways. NMES public use tapes represent the principal source of
data
from NMES-2.
These tapes undergo stringent quality control review and
are
accompanied by full documentation. NMES public use tapes are made
available
to the public through the National Technical Information Service (NTIS),
the
Inter-university Consortium for Political and Social Research (ICPSR) and
the
National Archives Reference Section of the National Archives. Additional
information about these NMES tapes is provided in Section II; NTIS
ordering
information including prices can be found in Section V.
In addition to releasing public use tapes, the AHCPR also provides a
limited
amount of NMES-2 data (not originally planned for public use) on a
special
request basis. This form of release is constrained to some extent by the
availability of funds and programming support. What can be released is
also
determined by the degree to which confidentiality of persons and
institutions
might be compromised. Special requests fall into two categories:
Research files. Users may request raw files from the NMES-2 data.
These
data are intended for sophisticated analysts. The files have not
been
subjected to the same level of editing as the NMES public use tapes.
The documentation provided is minimal.
Once a research file has
been
produced for one user, it is available to the public through NTIS
and
ICPSR.
See Section III for details.
Merging of NMES-2 data with outside data.
Users may request a tape
that
involves merging of NMES-2 data with other data. The analyst who
requests such a tape pays for the data processing costs involved.
Such
tapes are not distributed to others.
information.
II.
See Section IV for
NMES-2 Public Use Tapes
NMES-2 public use tapes are available through the National Technical
Information Service (NTIS), 5285 Port Royal Road, Springfield, VA 22161,
(703)
487-4650. The tapes can also be ordered through the Inter-university
Consortium for Political and Social Research (ICPSR) or the National
Archives
Reference Section. To order through the National Archives, please
contact the
Reference Section at (202) 501-5579. To order through the Consortium
please
contact your ICPSR Official Representative or call User Support and
Services
at (313) 763-5010. NTIS ordering information including prices is
provided
in Section V.
The data for NMES Public Use Tapes 1 through 6 are available on magnetic
tape
as SAS and EBCDIC files. Beginning with Public Use Tape 8, NMES tapes
have
been released as EBCDIC files only; however, these tapes also include an
EBCDIC file containing the programming statements required to create a
SAS
data file and a SAS format library. Documentation provided with each
NMES
tape consists of a description of NMES and the data file, codebooks,
technical
and programming information, copies of data collection instruments, and
information on weights and variance estimation.
All files from the NMES Household Survey and Health Insurance Plans
Survey
(HIPS) can be linked to each other. Similarly, all files from the
Institutional Population Component (IPC) and files from the Survey of
American
Indians and Alaska Natives (SAIAN) can be linked to other files in the
same
series.
AHCPR holds periodic 3-day workshops on the NMES public use tapes. These
are
generally held in the Washington, DC, metropolitan area. The workshops
are
free to users, but space is limited.
For additional information on NMES public use tapes, including a catalog
of
data items released on specific tapes, call the Agency for Health Care
Policy
and Research, Center for General Health Services Intramural Research, at
(301)
594-1400/1406.
A.
NMES Public Use Tapes Released to Date
NMES Public Use Tape 1, The 1986 Inventory of Long-Term Care Places
(ILTCP).
This tape provides a comprehensive listing of nursing and personal care
homes
and facilities for the mentally retarded in the 50 states and the
District of
Columbia and constitutes the unedited sampling frame for the
Institutional
Population Component of NMES.
NMES Public Use Tape 2, Institutional Population Component, Phase 1.
This
tape provides data obtained from a nationally representative sample of
nursing
homes and facilities for the mentally retarded and their residents on
facility
and patient characteristics as of 1 January 1987. The facility-level
data on
this tape have since been replaced by the data on NMES Public Use Tape 6,
and
the person-level data have been replaced with the data on NMES Public Use
Tape
8.
NMES Public Use Tape 3, Round 1 Household Survey Population
Characteristics
and Home Health Provider Data. This tape provides two data sets on a
nationally representative sample of the civilian noninstitutionalized
population. File 1 contains data on household and individual
characteristics
of the household sample participants for the first months of 1987,
including
demographic, insurance, and employment information and indicators of
functional status related to the need for and provision of long-term
care.
File 2 provides data on characteristics and services of home health care
providers linked to the household sample population for Round 1 of the
Household Survey. File 1 (exclusive of the functional status data) has
been
replaced with the Round 1 data released on NMES Public Use Tape 13. The
functional status data have been replaced with the data released on NMES
Public Use Tape 10, and the home health data have been replaced by data
on
Tape 14.2.
NMES Public Use Tape 4, 1987 Prescribed Medicine Event and Person Level
Data
for Medicare Beneficiaries. This data set from the NMES Household Survey
component provides full-year information on prescribed medicines obtained
by
the civilian noninstitutionalized Medicare population during 1987, as
well as
related conditions and demographic and insurance information.
NMES Public Use Tape 5, Institutional Population Component, Facility
Questionnaire Supplement. This tape provides data for a nationally
representative sample of nursing and personal care homes and facilities
for
the mentally retarded on facility characteristics from the Phase 3
facility
questionnaire supplement. The data supplement the information elicited
in the
Phase 1 facility questionnaire (NMES Public Use Tape 6). The data file
includes information on current and projected Alzheimer's Disease units
in
nursing and personal care homes and on accreditation status, resident
census,
and whether the facilities were part of life-care communities.
NMES Public Use Tape 6, Institutional Population Component, Facility
Questionnaire Weight Update. This tape updates the facility
questionnaire
file of the NMES Institutional Population Component, released as Public
Use
Tape 2, by including a revised weight variable. All other variables
remain
unchanged. Data items include facility size, ownership, Medicare and
Medicaid
certification status, services provided, and staffing levels.
NMES Public Use Tape 7, Institutional Population Component, Baseline
Questionnaire Data for the Current Resident Population, Update. The data
on
this tape have been merged with NMES Public Use Tape 8.
NMES Public Use Tape 8, Institutional Population Component, Baseline
Questionnaire Data for the Institutional Population. This tape from the
Institutional Population Component (IPC) provides person-level baseline
questionnaire data and sampling weights for a nationally representative
sample
of persons institutionalized at any time in 1987 in nursing and personal
care
homes and facilities for the mentally retarded. In conjunction with the
appropriate weight, the data (including demographic characteristics and
health
and functional status) can be used to make unbiased national estimates
for
1987 for the following institutional populations: (1) all persons who
spent
one or more nights in an IPC-eligible nursing or personal care home or a
facility for the mentally retarded at any time during 1987; (2) persons
who
were residents of IPC-eligible facilities on January 1, 1987; (3) persons
with
one or more admissions to a nursing or personal care home during 1987;
and (4)
all admissions in 1987 to nursing or personal care homes. Because of the
relatively small number of annual admissions to facilities for the
mentally
retarded, the IPC was not designed to provide separate estimates of
persons
admitted to these facilities during 1987. This data tape replaces
personlevel data released on Public Use Tape 2 by providing information for
both
current residents and persons sampled as admissions. Also included is a
revised current resident weight that has been adjusted for sampling frame
duplication.
NMES Public Use Tape 9, Household Survey, Health Status Questionnaires
and
Access to Care Supplement Data. This tape contains person-level data
from the
Household Survey health status questionnaire and the access to care
supplement. The data file contains one record each for a total of 30,038
Household Survey respondents who provided information for their entire
period
of survey eligibility and who responded to a minimum set of items in both
the
health status questionnaire and the access to care supplement. Children
less
than age 1 as of December 31, 1987 are excluded from the file. The
health
status questionnaire elicited information on current and past health
status as
well as health related behaviors, including care seeking, preventive
care, and
immunizations for children under age 18. The access to care supplement
contained questions about usual sources of medical and dental care,
including
characteristics of the usual source of care and reasons for the lack of a
usual source of care. This tape also contains the link variables
necessary to
merge characteristics of the usual source of care to home health visit
data
(Tape 14.2), hospital stays data (Tape 14.4), and ambulatory medical
visit
data (Tape 14.5). The file also contains basic demographic
characteristics
for respondents which replace data items previously released in Public
Use
Tape 3.
NMES Public Use Tape 10, Household Survey, Long-Term Care Supplement
Data.
This tape contains two data files. File 1 contains a person-level record
for
the 34,459 sampled persons who were eligible for the NMES Household
Survey and
who responded for their entire period of eligibility. File 1 includes
person
identifiers, selected demographic data, dates of interview, and weight
variables. The demographic data on this file replace corresponding data
items
previously released in Public Use Tape 3. The population on File 2 is a
subset of persons on File 1. File 2 contains long-term care (LTC)
supplement
data for 33,971 Round 1 respondents and 33,986 Round 4 respondents who
were
eligible when the supplement was administered. The LTC supplement
contained a
series of questions relating to functional status, including activities
of
daily living (ADLs) and instrumental activities of daily living (IADLs),
continence, and the use of special equipment, as well as the use of adult
day
care, senior centers, home-delivered and congregate meals, special
transportation, and telephone assurance for those having at least one ADL
or
IADL difficulty. In addition, the LTC supplement provides information
about
prior nursing home stays for this group of respondents. These data
replace
LTC data items previously released on Public Use Tape 3.
NMES Public Use Tape 11, Survey of American Indians and Alaska Natives,
Round
1 Person-Level Data. This tape was the first public use data file from
the
NMES SAIAN component. The SAIAN was designed to produce statistically
unbiased estimates that are representative of the civilian
noninstitutionalized population living on or near Federally recognized
reservations and eligible for services provided or supported by the
Indian
Health Service (IHS). Tape 11 contains one record for each person who
was
identified and responded in an eligible dwelling unit in Round 1 of the
SAIAN,
for a total of 7,071 person-level records. Each record includes
identifiers,
eligibility status indicator, demographic and family characteristics,
employment and health insurance status, and sampling weight and variance
estimation variables. This file was constructed to permit concatenation
of
NMES Public Use Tape 3 (which contains demographic, employment, and
insurance
data for Round 1 of the Household Survey) with the corresponding SAIAN
variables.
NMES Public Use Tape 13, Household Survey, Population Characteristics and
Utilization Data for 1987. This tape from the Household Survey of the
1987
NMES contains person-level characteristics and utilization data collected
in
Rounds 1-4 of the Household Survey. The tape is intended to serve as the
base
tape for all NMES Household Survey public use tapes containing full-year
1987
data and contains detailed information on eligibility status and survey
administration variables for all persons in the sample. There are two
personlevel data files on this tape, both files containing one record for each
of
38,446 persons. File 1 contains a combination of edited and constructed
variables describing demographic and family relationships, income,
disability,
employment, health insurance status, and utilization data for all of
1987.
File 2 contains the original unedited versions for the edited variables
on
File 1 as well as imputation flags for the edited and constructed
variables on
File 1. Full identifier variables and weight and variance estimation
variables are included on both files.
NMES Public Use Tape 14.1, Household Survey, Prescribed Medicine Data,
Calendar Year 1987. This tape from the Household Survey contains
information
on the use of and expenditures for prescribed medicines for calendar year
1987. The records on this file represent use, expenditures, and sources
of
payment by persons in the civilian noninstitutionalized population who
used
prescribed medicines during one or more reference periods during calendar
year
1987 and who responded for their entire period of eligibility. The data
file
contains one record per unique medication per reference period for each
eligible person in the Household Survey who reported having purchased or
otherwise obtained a prescribed medication during that reference period,
for a
total of 110,080 records. In addition, each record contains selected
personlevel demographic information for the respective user, household
respondent
reported medical conditions associated with the prescription, frequency
of
purchase, dates of use, and a range of medication-specific variables such
as
controlled substance status. The data file also includes full identifier
variables, which permit linkages to previously released NMES Household
Survey
Public Use Tapes and weight and variance estimation variables. This tape
can
be used to construct aggregate annual person-level variables of
expenditures,
sources of payment, and other aspects of prescribed medicines for persons
with
1987 prescribed medicine use. To make estimates about persons with no
prescribed medicine use, this tape must be linked to NMES Public Use Tape
13
or 18.
NMES Public Use Tape 14.2, Household Survey, Data for Calendar Year 1987
on
Home Health Care and Medical Equipment Purchases and Rentals. This tape
from
the Household Survey of the 1987 NMES contains information and related
documentation on the use of and expenditures and sources of payment for
home
health care and medical equipment, supplies, and other medical items for
calendar year 1987. The data on this tape represent all persons in the
civilian noninstitutionalized population who used home health care or
medical
equipment and supplies for one or more reference periods during calendar
year
1987 and who responded for their entire period of eligibility. File 1
(1,682
records) contains one record per unique home health provider for each
eligible
person in the Household Survey who reported having purchased home health
care
during the year. In addition to utilization, expenditure, and source-ofpayment information, each record contains selected person-level
demographic
information, household-reported medical conditions associated with the
use of
home health care, number of visits by that unique provider, and the
beginning
and end dates of those provider visits. This file does not include
information on informal care giving by friends and family. File 2
(11,010
records) contains one record per type of medical item per round for each
eligible person in the Household Survey who reported having purchased,
rented,
or otherwise obtained such medical item(s) during that reference period.
Like
the home health file (File 1), this file contains selected person-level
demographics and household-reported medical conditions. This tape can be
used
to construct summary variables of expenditures, sources of payment, and
other
aspects of utilization of home health care and other medical equipment
and
supplies. Each data file also includes full identifier variables, which
permit linkages to previously released NMES Household Survey Public Use
Tapes,
and weight and variance estimation variables. NMES Public Use Tape 13
provides information on persons in the Household Survey without home care
or
without purchase of other medical equipment and supplies in 1987 and
annual
person-level information on other health services use as well as detailed
demographic, employment, and insurance information, round-specific
eligibility
status indicators, and reference period dates for the entire civilian
noninsitutionalized population.
NMES Public Use Tape 14.3, Household Survey, Dental Visit Data, Calendar
Year
1987. This tape from the Household Survey of the 1987 NMES contains
information and related documentation on the use of and expenditures and
sources of payment for dental services for calendar year 1987. The
records on
this file represent dental visits, expenditures and sources of payment
for
persons in the civilian noninstitutionalized population who used any
dental
services during calendar year 1987 and who responded for their entire
period
of eligibility. The data file contains one record per dental visit for a
total of 38,429 records. In addition, each record contains selected
personlevel demographic information, household respondent reported medical
conditions associated with the dental visit, date of visit, and variables
describing the type of dental services received. Full identifier
variables
which permit linkages to previously released NMES Household Survey tapes
are
also included. This tape can be used to construct summary variables of
expenditures, sources of payment, and other aspects of utilization of
dental
services. NMES Public Use Tape 13 provides information on persons in the
Household Survey without dental visits in 1987 as well as detailed
demographic, employment, and insurance information for the entire
Household
Survey sample.
NMES Public Use Tape 14.4, Household Survey, Hospital Stays, Calendar
Year
1987. This tape contains information on the use of and expenditures and
sources of payment for inpatient hospital stays and associated physician
expenses for calendar year 1987. The records on this file represent
inpatient
hospital stays, length of stay, basic facility expenditures and separate
physician expenditures, and sources of payment for persons in the
civilian
noninstitutionalized population who reported having had at least one
inpatient
hospital stay during calendar year 1987 and who responded for their
entire
period of eligibility. The data file contains one record per inpatient
hospital stay for a total of 5,432 records. In addition, each record
contains
selected person-level demographic information, household-reported medical
conditions and procedures associated with the hospital stay, dates of
admission and discharge, the main reason for admission, and the number of
nights in the hospital. Full identifier variables that permit linkages
to
previously released NMES Household Survey tapes are also included. This
tape
can be used to construct summary variables of expenditures, sources of
payment, and other aspects of utilization of inpatient hospital services.
NMES Public Use Tape 13 provides information on persons in the Household
Survey without inpatient hospital stays in 1987 and annual person-level
information on other health services use as well as detailed demographic,
employment, and insurance information for the entire Household Survey
sample.
NMES Public Use Tape 14.5, Household Survey, Ambulatory Medical Visit
Data,
Calendar Year 1987. This tape from the Household Survey of the NMES
contains
information and related documentation on the use of and expenditures and
sources of payment for ambulatory medical services provided by physicians
and
other health care providers during calendar year 1987. The data on this
tape
represent all ambulatory services for persons in the civilian
noninstitutionalized population who reported having received at least one
ambulatory service during calendar year 1987 and who responded for their
entire period of eligibility. The three data files contain data on three
types of services. Each record per file represents a unique ambulatory
care
event: (1) visits and telephone calls to physicians and other providers
in
settings other than a hospital or home (156,957 records); (2) visits to
hospital outpatient departments (20,648 records); and (3) visits to
hospital
emergency rooms (8,249 records). Excluded from this tape are persons who
were
admitted and discharged from a hospital on the same day and who had no
other
ambulatory care visits; these are included on NMES Public Use Tape 14.4 Hospital Stays. In addition to utilization, expenditure, and source-ofpayment information, each record contains selected person-level
demographic
information, date of visit, household-reported medical conditions and
procedures associated with the visit, and the main reason for the visit.
This
tape can be used to construct summary variables of expenditures, sources
of
payment, and other aspects of utilization of ambulatory medical services.
Full identifier variables that permit linkages to previously released
NMES
Public Use Tapes are also included on each data file. NMES Public Use
Tape 13
provides information on persons in the Household Survey without
ambulatory
medical services in 1987 and annual person-level information on other
health
services use as well as detailed demographic, employment, and insurance
information for the entire Household Survey sample.
NMES Public Use Tape 15, Policyholders of Private Health Insurance:
Premiums,
Payment Sources, and Type and Source of Coverage. This tape is the first
release from the Health Insurance Plans Survey (HIPS) of the 1987 NMES.
HIPS
is a follow-up to the NMES Household Survey and was designed to verify
health
insurance status provided by the NMES Household Survey respondents as
well as
to provide supplementary information on private health insurance
coverage.
The tape provides information and related documentation on private health
insurance in force at the end of calendar year 1987 for employmentrelated and
other coverage of all policyholders in the U.S. noninstitutionalized
civilian
population. The tape contains two data files, one for employment-related
insurance (File 1) and one for insurance that is purchased directly from
insurance carriers or associations (File 2). With this tape it is
possible to
make estimates of total premiums for private health insurance as well as
estimates of employer and out-of-pocket contributions for these premiums.
Records on each data file contain selected person-level demographic
information for the respective policyholder as well as some
characteristics of
the policyholder's health insurance coverage and the provider of
employmentrelated insurance (File 1). The persons represented on these data files
are
not the universe of persons with private health insurance but rather
policyholders of private health insurance. The link variables provided
in
both Files 1 and 2 enable linkage of policyholders to their person and
socioeconomic characteristics provided on NMES Household Survey public
use
tapes (e.g., Public Use Tape 13). The present public use tape does not
provide linkage to the dependents of policyholders of private health
insurance
coverage. In particular, it is not possible to use information on
dependents
from the coverage data available in Public Use Tape 13 to link dependents
such
as family members to policyholders with records on the current tape
(these
links will be provided on NMES Tape 24). In addition, Tape 15 does not
contain benefit information abstracted from policy booklets collected as
part
of the HIPS (this information is provided for policyholders on NMES Tape
16).
The premium variables provided on Tape 15 will be updated with the
release of
NMES Tape 15U.
NMES Public Use Tape 16, Health Insurance Plans Survey Data:
Private
Insurance Benefit Database and Linkages to Household Survey
Policyholders.
This tape from the Health Insurance Plans Survey (HIPS) of the 1987 NMES
contains the Private Health Insurance Benefit Database and related
documentation that describe the private insurance benefits of persons in
the
NMES Household Survey and the Survey of American Indians and Alaska
Natives
(SAIAN). The 17 data files on this tape include two link files (Files 1
and
2) and the Benefit Database (Files 3-17), which includes unedited data
derived
from the abstracted contents of all descriptions of private health
insurance
policies obtained in the HIPS. The link files link the abstracted
benefit
data to Household Survey policyholders and can be used to make estimates
of
the types of coverage in force at the end of 1987. The link files
contain all
policyholders in the Household Survey who were eligible and responded
during
the Round 4 interview and who also responded for their entire period of
eligibility during 1987. The records in the two link files correspond
exactly
to the records in the two files on Public Use Tape 15, which contains
data on
premiums and other characteristics of coverage of Household Survey
policyholders (File 1 links to holders of employment-related insurance,
and
File 2 links to policyholders of insurance purchased directly from an
insurer
or association). Files 1 and 2 on the present tape also permit linkage
to the
personal and socioeconomic characteristics on other NMES Household Survey
public use tapes (e.g., Tape 13) for these policyholders. The Benefit
Database includes a header file (File 3), 10 section files (Files 4-13),
and 4
schedule files (Files 14-17). The section files include information on
the
types of coverage abstracted from policy descriptions (HMO, basic
coverage,
cost-containment basic coverage, major medical, cost-containment major
medical, dental care, prescription drugs, vision care, hearing care, and
Medigap/retiree coverage). The schedule files include specific
deductible,
coinsurance, and maximum benefit provisions. Future public use tapes
planned
from the HIPS will permit linkage of the Benefit Database (Files 3-17) to
dependents of policyholders in the Household Survey (NMES Tape 24) and to
persons in the SAIAN. The future link files will also permit analysis of
health insurance options offered by employers and unions. Documentation
includes the Insurance Abstraction Manual and Users' Guide, which
describes
coding procedures and conventions used for the coding of health insurance
policies.
NMES Public Use Tape 17, Institutional Population Component, Facility Use
and
Expenditure Data for Nursing and Personal Care Home Residents. This tape
from
the Institutional Population Component (IPC) of the 1987 NMES contains
personlevel, institutional stay-level, and bill-level data for a nationally
representative sample of persons institutionalized in nursing and
personal
care homes. The IPC includes a sample of persons residing in or admitted
to
nursing and personal care homes and facilities for the mentally retarded
at
any time in calendar year 1987. The three data files on this tape
contain
data for sample persons (SPs) who were sampled either as current
residents
(residents on January 1, 1987) or as new admissions (admitted between
January
1 and December 31, 1987) in nursing and personal care homes only. File 1
(a
person-level file) contains variables pertaining to survey
administration,
demographic characteristics (age, race, and sex), date of admission,
vital
status, residence history before admission to the sampled facility,
education,
veteran status, prior lifetime-use of long-term care, family
characteristics,
insurance coverage, home ownership, income, and medical conditions. File
2 (a
stay-level file) contains information on the SP's 1987 institutional
stay(s),
including episodes of institutional care, dates of the stays, and
characteristics of the institution of residence such as facility size,
ownership, certification status, and location. Stays in other types of
facilities (e.g., acute care hospitals) and in the community are not
included
(but will be on a future tape (Tape 27). File 3 (a bill-level file)
contains
expenditures and sources of payment for both basic and ancillary services
provided in nursing and personal care home facilities.
NMES Public Use Tape 18, Household Survey, Expenditures, Sources of
Payment,
and Population Data for 1987. This tape is one in a series of public use
tapes from the Household Survey (HS) of the 1987 National Medical
Expenditure
Survey (NMES). This tape contains 38,446 person-level records with
information on health care utilization, expenditures, and sources of
payment;
26 sources of income; assets; tax filing; and demographic characteristics
including month-specific insurance variables and HMO indicators. The
tape
also contains detailed information on eligibility status, record and
person
identifiers, link variables, weights and variance estimation, and other
survey
administration variables for all persons in the sample. This tape
supplements
Public Use Tape 13 (Household Survey - Population Characteristics and
Utilization Data for 1987) and provides data not previously released.
Most of
the person characteristics variables from Tape 13 are not duplicated
here; for
the convenience of the user, the annual utilization variables are
duplicated
on this tape, along with person-level expenditure and sources-of-payment
information released for the first time. Event-level expenditure and
sourceof-payment information was released on Public Use Tapes 14.1-14.5, which
can
be linked to this file.
In addition, Tape 18 can be used to make
familylevel estimates.
NMES Public Use Tape 20P, Survey of American Indians and Alaska Natives Preliminary Population Characteristics for 1987. This public use tape
contains person-level data from the NMES SAIAN component. The SAIAN was
designed to yield national estimates for the civilian noninstitutionalized
U.S. population living on or near Federally recognized reservations and
eligible for services provided or supported by the Indian Health Service
(IHS). The tape contains detailed information on eligibility status,
interview dates, demographic characteristics, employment and insurance
variables, link variables, and other survey administration variables for
all
persons (7,533) in the sample in Rounds 1-3 of the SAIAN. This file was
constructed to permit concatenation of NMES Public Use Tape 13 with the
corresponding SAIAN variables. The Round 1 person characteristics
previously
released on Public Use Tape 11 are being replaced by the data contained
on
this tape. This tape represents a preliminary release of these data; as
such,
it has not been subjected to the standard quality control procedures
applied
to NMES public use tapes. The final version, Public Use Tape 20, will
serve
as the base data for all NMES SAIAN public use tapes containing full-year
1987
data. Tape 20 will also contain data on final annual measures of medical
utilization and disability days. The data on Tape 20P do not include
information on medical utilization, expenditures, and sources of payment
associated with each of the health care services or goods used during the
survey year by each sampled person. This information, together with
details
associated with each health care event, will be available in Public Use
Tapes
23.1-23.5.
NMES Public Use Tape 21P, Survey of American Indians and Alaska Natives,
Preliminary Health Status and Access to Care Data, Calendar Year 1987.
This
tape contains person-level data from the NMES SAIAN component's health
status
questionnaires and the access to care supplement. The SAIAN was designed
to
yield national estimates for care the civilian noninstitutionalized U.S.
population living on or near Federally recognized reservations and
eligible
for services provided or supported by the Indian Health Service (IHS).
This
tape contains one record each for a total of 5,695 SAIAN respondents who
provided information for their entire period of survey eligibility and
responded to a minimum set of items in both the health status
questionnaires
and the access to care supplement. Children less than age 1 as of
December
31, 1987, are excluded from this file. The health status questionnaire
elicited information on current and past health status, including acute
and
chronic conditions, vision and hearing, dental status, mental health and
functional ability, as well as health-related behaviors, including care
seeking and preventive care, and immunizations for children under age 18.
The
access to care supplement contained questions about usual sources of
medical
and dental care, including characteristics of the usual source of care
and
reasons for the lack of a usual source of care. This file was
constructed to
permit concatenation of NMES Public Use Tape 9 with the corresponding
SAIAN
variables. The file also contains basic demographic characteristics for
respondents (age, race and sex) as established in the SAIAN, which
replace
data items previously released in Public Use Tape 11 (Round 1 SAIAN
data).
This tape represents a preliminary release of these data; as such, it has
not
been subjected to the standard quality control procedures applied to NMES
public use tapes. These data will be released in final form on NMES
Public
Use Tape 21. Tape 21 will also contain the link variables necessary to
merge
characteristics of the usual source of care to the home health visit data
(Tape 23.2), hospital stays data (Tape 23.4), and ambulatory medical
visit
data (Tape 23.5).
NMES Public Use Tape 23.1P, Survey of American Indians and Alaska
Natives,
Preliminary Prescribed Medicine Data, Calendar Year 1987. This tape from
the
NMES SAIAN component contains information and related documentation on
the use
of prescribed medicines during 1987 by the civilian noninstitutionalized
population living on or near Federally recognized reservations or in
Alaska
and eligible for services provided or supported by the Indian Health
Service
(IHS). The data file contains one record per unique medication per
reference
period for each of these persons who reported having purchased or
otherwise
obtained a prescribed medication during that reference period and who
responded for their entire period of eligibility (10,191 records). In
addition, each record contains selected person-level demographic
information
for the respective user, medical conditions associated with the
prescription,
frequency of purchase, dates of use, and the NCHS drug code for the
medication. When taken together, the set of records included for each
person
in this file represent all instances in which the person purchased or
otherwise obtained a medication (including refills) during 1987. The
file can
be used to construct summary variables of utilization of prescribed
medicines.
Only SAIAN-eligible persons with prescribed medicine use who responded
for
their entire period of eligibility are included on this tape. This file
was
constructed to permit concatenation of NMES Public Use Tape 14.1 with the
corresponding SAIAN variables. This tape represents a preliminary
release of
data; as such, it has not been subjected to the standard quality control
procedures applied to NMES public use tapes. These data will be released
in
final form on NMES Public Use Tape 23.1. Tape 23.1 will also contain
additional descriptive variables (including the generic equivalent of
drugs),
whether the drugs were obtained at an IHS or non-IHS sponsored provider,
and
edited expenditure and source- of-payment variables. NMES Tape 20 will
provide information on persons in SAIAN without use of prescribed
medicines in
1987 as well as detailed person-level information on demographics,
employment,
and insurance coverage (these data were released in preliminary form in
Tape
20P).
NMES Public Use Tape 23.2P, Survey of American Indians and Alaska
Natives,
Preliminary Data for Calendar Year 1987 on Home Health Care, Medical
Equipment
Purchases and Rentals, and Traditional Medicine. This tape from the NMES
SAIAN component contains information and related documentation on the use
of
formal home health care; the purchase and rental of medical equipment,
supplies and other medical items; and traditional medicine during 1987 by
the
civilian noninstitutionalized population living on or near Federally
recognized reservations or in Alaska and eligible for services provided
or
supported by the Indian Health Service (IHS). The tape provides three
data
files. The data file on home health services (File 1) contains one
record per
unique formal home care provider per reference period for each eligible
person
in the SAIAN who reported receiving home health services (296 records).
File
2 contains one record per type of medical item per reference period for
each
eligible person in the SAIAN who reported having purchased, rented, or
otherwise obtained such items during that round (1,315 records). File 3
contains one record for each use (one or more times) of a unique
practitioner
of traditional medicine services per reference period for each eligible
person
in the SAIAN who reported receiving at least one traditional medicine
service
in at least one round (340 records). All files on the tape also contain
household-reported medical condition and selected person-level
demographic
variables. Only SAIAN-eligible persons with home health use, purchase or
rental of medical equipment, and traditional medicine use who responded
for
their entire period of eligibility are included on this tape. This tape
represents a preliminary release of data; as such, it has not been
subjected
to the standard quality control procedures applied to NMES public use
tapes.
These data will be released in final form on NMES Public Use Tape 23.2.
Tape
23.2 will also contain additional descriptive variables on these
services,
edited expenditure and source of payment variables, an indicator of
whether
the service was provided by an IHS or non-IHS sponsored provider (on
Files 1
and 2 only), and an edited variable for the number of visits (on File 1
only).
NMES Tape 20 will provide information on persons in SAIAN without use of
home
health services, other medical equipment, or traditional medicine in 1987
(this data was released in preliminary form in Tape 20P).
NMES Public Use Tape 23.3P, Survey of American Indians and Alaska
Natives,
Preliminary Dental Visit Data, Calendar Year 1987. This tape from the
NMES
SAIAN component contains information and related documentation on dental
visits during 1987 by the civilian noninstitutionalized population living
on
or near Federally recognized reservations or in Alaska and eligible for
services provided or supported by the Indian Health Service (IHS). The
data
file contains one record per dental visit for each eligible person in the
SAIAN who reported having a dental visit during the year and who also
responded for their entire period of eligibility during 1987 (4,417
records).
In addition, each record contains basic person-level demographic
information
for the sample person, type of service obtained during the dental visit,
dates
of service, and medical conditions as reported by the household
respondent if
the visit was due to accident or injury. All dental visits reported by
respondents are included, regardless of whether the visit was to an IHS
or
non-IHS sponsored provider. This file was constructed to permit
concatenation
of NMES Public Use Tape 14.3 with the corresponding SAIAN variables.
This
tape represents a preliminary release of data; as such, it has not been
subjected to the standard quality control procedures applied to NMES
public
use tapes. These data will be released in final form on NMES Public Use
Tape
23.3. Tape 23.3 will also contain additional descriptive dental visit
variables including information on type of dental provider, edited
expenditure
and source of payment variables, and an indicator of whether the dental
visit
was to an IHS or non-IHS sponsored provider. NMES Tape 20 will provide
information on persons in SAIAN without use of dental services in 1987 as
well
as detailed person-level information on demographics, employment, and
insurance coverage (these data were released in preliminary form in Tape
20P).
NMES Public Use Tape 23.4P, Survey of American Indians and Alaska
Natives,
Preliminary: Hospital Stays, Calendar Year 1987. This tape from NMES
SAIAN
component contains information and related documentation on the use of
inpatient hospital stays during 1987 by the civilian noninstitutionalized
population living on or near Federally recognized reservations or in
Alaska
and eligible for services provided or supported by the Indian Health
Service
(IHS). The data file contains one record for each hospital stay for each
eligible person in the SAIAN who reported having had at least one
hospital
stay during 1987 and who also responded for their entire period of
eligibility
during 1987 (1,134 records). Each record contains selected person-level
demographic information for the respective patient, household-reported
medical
conditions and procedures associated with the hospitalization, and
information
on length of stay. This file was constructed to permit concatenation of
NMES
Public Use Tape 14.4 with the corresponding SAIAN variables. This tape
represents a preliminary release of data; as such, it has not been
subjected
to the standard quality control procedures applied to NMES public use
tapes.
These data will be released in final form on NMES Public Use Tape 23.4.
In
addition to edited versions of some of the unedited variables on the
current
tape, Tape 23.4 will also contain additional descriptive variables and
edited
expenditure and source-of-payment variables. NMES Tape 20 will provide
information on persons in SAIAN without hospital stays in 1987 as well as
detailed person-level information on demographics, employment, and
insurance
coverage (these data were released in preliminary form in Tape 20P).
NMES Public Use Tape 23.5P, Survey of American Indians and Alaska
Natives,
Preliminary Ambulatory Medical Visit Data, Calendar Year 1987. This tape
from
the NMES SAIAN component contains information and related documentation
on the
use of ambulatory medical services during 1987 by the civilian
noninstitutionalized population living on or near Federally recognized
reservations or in Alaska and eligible for services provided or supported
by
the Indian Health Service (IHS). This tape contains three data files:
(1)
visits and telephone calls to physicians and other providers in settings
other
than a hospital or at home (8,031 records); (2) visits to hospital
outpatient
departments, regardless of provider type (10,690 records); and (3)
hospital
emergency room visits, regardless of provider type (1,917 records). Only
SAIAN-eligible persons with ambulatory use who responded for their entire
period of eligibility are included on this tape. All ambulatory medical
services reported by respondents are included, regardless of whether they
were
provided at an IHS or non-IHS sponsored facility. A record on any of
these
data files represents a unique ambulatory visit. This file was
constructed to
permit concatenation of NMES Public Use Tape 14.5 with the corresponding
SAIAN
variables. In addition, each record contains selected person-level
demographic information for the respective user, dates of visits,
household
respondent-reported medical conditions associated with the visit, and
variables such as types of procedures performed and the main reason for
the
visit. This tape represents a preliminary release of data; as such, it
has
not been subjected to the standard quality control procedures applied to
NMES
public use tapes. These data will be released in final form on NMES
Public
Use Tape 23.5. Tape 23.5 will also contain additional descriptive
variables,
edited expenditure and source-of-payment variables, and an indicator of
whether the services were provided at an IHS or non-IHS sponsored
facility.
NMES Tape 20 will provide information on persons in SAIAN without use of
ambulatory medical services in 1987 as well as detailed person-level
information on demographics, employment, and insurance coverage (these
data
were released in preliminary form in Tape 20P).
III. NMES-2 Research Files
AHCPR releases to the research community a limited amount of NMES-2 data
on an
individual request basis. These data are not otherwise be released as
NMES
public use tapes. The requests for data are subject to resource
constraints.
Research files are intended for sophisticated users who are familiar with
the
NMES public use tapes and have experience analyzing complex survey data.
These files have not been subjected to the same level of editing and
imputation as the NMES public use tapes and generally include raw data.
On
occasion no sampling weights accompany the files. These data should be
analyzed and interpreted with care. The documentation provided is
extremely
limited. Research files are provided in this form because of the limited
audience of users for these data.
NMES-2 research files are released to individual users as EBCDIC files on
magnetic tape. Once a research file has been produced for one user, it
is
available to the public through NTIS and ICPSR at normal distribution
costs.
IV.
Merging Secondary Data and the NMES-2 Public Use Files
AHCPR will also merge secondary data items to NMES public use tapes and
research files, and make some of these data available to researchers.
These
files must be developed to comply with the statutory requirements to keep
the
identity of respondents, individuals and institutions, that might be
identified, confidential. Examples of secondary data items that might be
merged to public NMES data are: selected items from the Area Resources
File,
State-level characteristics, and indicators of urban/rural status.
AHCPR also provides cross-tabulations and executes other fully
functioning
customized software using non-public-use data. Examples of the latter
are (1)
a program that uses person characteristics (income, family size, etc.)
from
the Household Survey and State identifiers to create a variable with
state tax
rates, and (2) SAS programming code to execute a model that includes
variables
never to be released (e.g., Census region for the Institutional
Population
Component).
The individual user who makes the request for merging secondary data with
NMES-2 public use tapes pays the data processing costs involved in:
merging
the data, investigating issues of confidentiality, and executing the
software.
Only the person requesting the file will receive the merged and encrypted
file
(or computer output). The files will be provided as either EBCDIC or SAS
files. For details see the Guide to NMES-2 Special Data Requests, a
document
describing the procedures, costs, and limitations involved. The document
is
available from the AHCPR, Center for General Health Services Intramural
Research, (301) 594-1400/1406.
V.
Ordering Information
A.
NTIS Ordering Information
NMES public use tapes and research files are released to the public
through
the National Technical Information Service (NTIS), 5285 Port Royal Road,
Springfield, VA 22161, (703) 487-4650. To expedite processing by the
NTIS,
please complete the attached form (last page in this document) and
include it
with your NTIS order request.
The data for NMES Public Use Tapes 1 through 6 are available on magnetic
tape
as SAS and EBCDIC files. Beginning with Public Use Tape 8, NMES tapes
are
released as EBCDIC files only; however, these tapes also include an
EBCDIC
file containing the programming statements required to create a SAS data
file
and a SAS format library. Related documentation provided with each NMES
tape
consists of a description of NMES and the data file, codebooks, technical
and
programming information, copies of data collection instruments and
information
on weights and variance estimation.
Prompt access to the documentation only can also be obtained by calling
the
Agency for Health Care Policy and Research, Center for General Health
Services
Intramural Research at (301) 594-1406. There is no charge for this
service.
1.
NMES Public Use Tapes
NMES Public Use Tape 1, The 1986 Inventory of Long Term Care Places
(ILTCP)
NTIS accession number PB88-122387:
price: $15.95.
SAS file documentation only;
NTIS accession number PB88-122361:
price: $15.95.
EBCDIC file documentation only;
NTIS accession number PB88-122379:
documentation;
price: $210.
SAS data files and
NTIS accession number PB88-122353:
documentation;
price: $210.
EBCDIC data files and
NMES Public Use Tape 2, Institutional Population Survey, Phase 1
NTIS accession number PB89-178495: SAS file documentation only;
price: $49.95-hard copy, $6.95-microfiche.
NTIS accession number PB89-178479: EBCDIC file documentation only;
price: $49.95-hard copy, $6.95-microfiche.
NTIS accession number PB89-178487:
documentation;
price: $325.
SAS data files and
NTIS accession number PB89-178461:
documentation;
EBCDIC data files and
price:
$325.
NMES Public Use Tape 3, Round 1 Household Survey Population
Characteristics
and Home Health Provider Data
NTIS accession number PB90-112988: SAS file documentation only;
price: $67-hard copy, $16.50-microfiche.
NTIS accession number PB90-112970: EBCDIC file documentation only;
price: $61.95-hard copy, $15.50-microfiche.
NTIS accession number PB90-500232:
documentation;
price: $340.
SAS data files and
NTIS accession number PB90-500224:
documentation;
EBCDIC data files and
price:
$340.
NMES Public Use Tape 4, 1987 Prescribed Medicine Event and Person Level
Data
for Medicare Beneficiaries
NTIS accession number PB90-101254: SAS file documentation only;
price: $45-hard copy, $15-microfiche.
NTIS accession number PB90-101247: EBCDIC file documentation only;
price: $45-hard copy, $15-microfiche.
NTIS accession number PB90-501362:
documentation;
price: $340.
SAS data files and
NTIS accession number PB90-501388:
documentation;
EBCDIC data files and
price:
$340.
NMES Public Use Tape 5, Institutional Population Component, Facility
Questionnaire Supplement
NTIS accession number PB91-110480: SAS file documentation only;
price: $39-hard copy, $11-microfiche.
NTIS accession number PB91-110494: EBCDIC file documentation only;
price: $39-hard copy, $11-microfiche.
NTIS accession number PB91-505453:
documentation;
price: $340.
SAS data files and
NTIS accession number PB91-505461:
documentation;
EBCDIC data files and
price:
$340.
NMES Public Use Tape 6, Institutional Population Component, Facility
Questionnaire Weight Update
NTIS accession number PB91-146266: SAS file documentation only;
price: $39-hard copy, $11-microfiche.
NTIS accession number PB91-146258: EBCDIC file documentation only;
price: $39-hard copy, $11-microfiche.
NTIS accession number PB91-506683:
documentation;
price: $340
SAS data files and
NTIS accession number PB91-506675:
documentation;
EBCDIC data files and
price:
$340
NMES Public Use Tape 8, Institutional Population Component, Baseline
Questionnaire Data for the Institutional Population
NTIS accession number PB91-146274: documentation only;
price: $45-hard copy, $15-microfiche.
NTIS accession number PB91-506691:
price: $340.
tape and documentation;
NMES Public Use Tape 9, Household Survey, Health Status Questionnaires
and
Access to Care Supplement Data
NTIS accession number PB91-190165: documentation only;
price: $53-hard copy, $17-microfiche.
NTIS accession number PB91-507533:
price: $340.
tape and documentation;
NMES Public Use Tape 10, Household Survey, Long-Term Care Supplement Data
NTIS accession number PB91-221739: documentation only;
price: $60-hard copy, $17-microfiche.
NTIS accession number PB91-509828:
price: $340.
tape and documentation;
NMES Public Use Tape 11, Survey of American Indians and Alaska Natives,
Round
1 Person-Level Data
NTIS accession number PB91-227926: documentation only;
price: $60-hard copy, $17-microfiche.
NTIS accession number PB91-509885:
price: $340.
tape and documentation;
NMES Public Use Tape 13, Household Survey, Population Characteristics and
Utilization Data for 1987
NTIS accession number PB92-100189: documentation only;
price: $73-hard copy, $27-microfiche.
NTIS accession number PB92-500057:
price: $360.
tape and documentation;
NMES Public Use Tape 14.1, Household Survey, Prescribed Medicine Data,
Calendar Year 1987
NTIS accession number PB92-139096: documentation only;
price: $59-hard copy, $26-microfiche.
NTIS accession number PB92-501287:
price: $480.
tape and documentation;
NMES Public Use Tape 14.2, Household Survey, Data for Calendar Year 1987
on
Home Health Care and Medical Equipment Purchases and Rentals
NTIS accession number PB93-100279: documentation only;
price: $84-hard copy, $27-microfiche.
NTIS accession number PB93-500213:
price: $480.
tape and documentation;
NMES Public Use Tape 14.3, Household Survey, Dental Visit Data, Calendar
Year
1987
NTIS accession number PB92-155423: documentation only;
price: $59-hard copy, $19-microfiche.
NTIS accession number PB92-501865:
price: $480.
tape and documentation;
NMES Public Use Tape 14.4, Household Survey, Hospital Stays, Calendar
Year,
1987
NTIS accession number PB92-169671: documentation only;
price: $73-hard copy, $26-microfiche.
NTIS accession number PB92-503150:
price: $360.
tape and documentation;
NMES Public Use Tape 14.5, Household Survey, Ambulatory Medical Visit
Data,
Calendar Year 1987
NTIS accession number PB92-218510: documentation only;
price: $91-hard copy, $32-microfiche.
NTIS accession number PB92-504307:
price: $480.
tape and documentation;
NMES Public Use Tape 15, Policyholders of Private Health Insurance:
Premiums,
Payment Sources, and Type and Source of Coverage
NTIS accession number PB92-221852: documentation only;
price: $77-hard copy, $27-microfiche.
NTIS accession number PB92-504349:
price: $480.
tape and documentation;
NMES Public Use Tape 16, Health Insurance Plans Survey Data: Private
Insurance Benefit Database and Linkages to Household Survey Policyholders
NTIS accession number PB93-213940: documentation only;
price: $147-hard copy, $72-microfiche.
NTIS accession number PB93-506400:
price: $360.
tape and documentation;
NMES Public Use Tape 17, Institutional Population Component, Facility Use
and
Expenditure Data for Nursing and Personal Care Home Residents
NTIS accession number PB93-192763: documentation only;
price: $91-hard copy, $32-microfiche.
NTIS accession number PB93-506046:
price: $360.
tape and documentation;
NMES Public Use Tape 18, Household Survey, Expenditures, Sources of
Payment,
and Population Data for 1987.
NTIS accession number PB94-104619: documentation only;
price: $xx -hard copy, $ -microfiche.
NTIS accession number PB94-500071:
price: $360.
tape and documentation;
NMES Public Use Tape 20P, Survey of American Indians and Alaska Natives,
Preliminary Population Characteristics for 1987
NTIS accession number PB94-xxxxx:
price: xx.
documentation only;
NTIS accession number PB94-500139 tape and documentation;
price: $360.
NMES Public Use Tape 21P, Survey of American Indians and Alaska Natives,
Preliminary Health Status Questionnaires and Access to Care Supplement
(Preliminary) Data, Calendar Year 1987
NTIS accession number PB93-213858:
price: xx.
documentation only;
NTIS accession number PB93-506228:
price: $360.
tape and documentation;
NMES Public Use Tape 23.1P, Survey of American Indians and Alaskan
Natives,
Preliminary Prescribed Medicine Data, Calendar Year 1987
NTIS accession number PB93-213981: documentation only;
price: $77-hard copy, $27-microfiche
NTIS accession number PB93-506871:
price: $360.
tape and documentation;
NMES Public Use Tape 23.2P, Survey of American Indians and Alaskan
Natives,
Preliminary Data for Calendar Year 1987 on Home Health Care, Medical
Equipment
Purchases and Rentals, and Traditional Medicine
NTIS accession number PB93-233708: documentation only;
price: $77-hard copy, xx-microfiche.
NTIS accession number PB93-507036:
price: $360.
tape and documentation;
NMES Public Use Tape 23.3P, Survey of American Indians and Alaska
Natives,
Preliminary Dental Visit Data, Calendar Year 1987
NTIS accession number PB93-214005: documentation only;
price: $61-hard copy, $19.50-microfiche
NTIS accession number PB93-506897:
price: $360.
tape and documentation;
NMES Public Use Tape 23.4P, Survey of American Indians and Alaska
Natives,
Preliminary: Hospital Stays, Calendar Year 1987
NTIS accession number PB93-218428: documentation only;
price: $84-hard copy, $27-microfiche.
NTIS accession number PB93-505962:
price: $360.
tape and documentation;
NMES Public Use Tape 23.5P, Survey of American Indians and Alaskan
Natives,
Preliminary Ambulatory Medical Visit Data, Calendar Year 1987
NTIS accession number PB93-218451: documentation only;
price: $77-hard copy, $27-microfiche.
NTIS accession number PB93-506970:
price: $360.
tape and documentation;
2.
NMES Research Files
As of mid-October 1993, NTIS has not released any NMES research files.
VARIANCE ESTIMATION PROGRAMS FOR USE WITH COMPLEX SURVEY DATA
I.
Variance Estimation Procedures
All component surveys of the National Medical Expenditure Survey (NMES)
are
characterized by complex sample designs such as stratification,
clustering,
and disproportionate sampling. This departure from simple random
sampling
assumptions requires special consideration with regard to variance
estimation
and analysis. Several methods for approximating sampling variances,
which
incorporate the components of a complex survey design, have been
developed and
can be considered for application to NMES data. The three most generally
accepted and frequently used techniques are the method of balanced
repeated
replication (BRR), the "jackknife" method, and the Taylor series
linearization
method. These variance estimation strategies have been incorporated as
procedures in several of the widely used statistical packages.
II.
Variance Estimation Procedures and NMES
Each NMES public use tape is released with the variables necessary to
estimate
variances using the Taylor series linearization method. See the tapespecific
NMES documentation for variable names.
Sections III-V lists several variance estimation programs that are
appropriate for use with complex survey data:
III.
Mainframe
A. The following programs were developed by the Research Triangle
Institute
(Research Triangle Park, N.C.) and all use the Taylor Series
linearization method for complex survey data.
SESUDAAN: Standard Errors Program for Computing of Standardized Rates
from
Sample Survey Data, accessible through SAS, and developed by the Research
Triangle Institute (Shah, 1981a). Uses Taylor series linearization method
for
complex survey data.
RATIOEST: Standard Errors Program for Computing Ratio Estimates from
Sample
Survey Data, accessible through SAS, and developed by the Research
Triangle
Institute (Shah, 1981b). Uses Taylor series linearization method for
complex
survey data.
SURREGR: Standard Errors of Regression Coefficients from Sample Survey
Data
accessible through SAS, and developed by the Research Triangle Institute
(Holt, 1982). Uses Taylor series linearization method for complex survey
data.
RTILOGIT: Survey Data Analysis Software for Logistic Regression, used in
conjunction with supplementary SAS procedure, PROC LOGIST, and developed
by
the Research Triangle Institute (Shah et al., 1984). Uses the Taylor
series
linearization method
SUDAAN: SUrvey DAta ANalysis software. Incorporates the above four
packages
plus several new ones. Can read in both SAS and text data files, and was
developed by Research Triangle Institute (Shah, Barnwell, Hunt, & La
Vange,
1991).
B. The following programs were developed by Westat, Inc., and use either
the
balanced half-sample replication (BRR) or Jackknife replication
methods for complex survey data.
WESVAR: Computes basic survey estimates and associated sampling errors,
as
well as confidence intervals and Chi-square tests of independence, and is
accessible through SAS (WESTAT, INC., 1989). Uses either balanced
repeated
half-sample replication (BRR) or jacknife replication methods for complex
survey data.
WESREG: Computes sampling errors of multiple regression estimates, and is
accessible through SAS developed by WESTAT, INC. (1989). Use the balanced
half
sample replication technique.
WESLOG: Computes sampling errors for the logistic model, and is
accessible
through SAS developed by WESTAT, INC. (1989). Uses the balanced repeated
replication method.
C. The following were developed by the Survey Research Center of the
Institute
for Social Research, University of Michigan.
PSALMS: Sampling Error Analysis procedure, accessible through OSIRIS IV
(Statistical Analysis and Data Management Software Systems Package), and
developed by the Survey Research Center of the Institute for Social
Research,
University of Michigan (Van Eck, 1979). Uses the Taylor series
linearization
method.
REPERR: Repeated Replication Sampling Error analysis procedure,
accessible
through OSIRIS IV, and developed by the Survey Research Center of the
Institute for Social Research, University of Michigan (Van Eck, 1979).
Uses
any of three repeated replication procedures: balanced half-sample,
jackknife,
or user specified.
D.
Other mainframe variance estimation programs include the following:
SUPER CARP: Cluster Analysis and Regression Program developed by the
Survey
Section of the Statistical Laboratory at Iowa State University
(Hidirouglou,
Fuller, Hickman, 1980). Uses Taylor series linearization method. Reads
in
text data files only.
HESBRR: Health Examination Survey Variance and Crosstabulation Program,
developed by the National Center for Health Statistics (Jones, 1983).
Uses
balanced half-sample method.
CPLX/VPLX: Developed by the Census Bureau.
IV.
For the PC:
SUDAAN: PC and VAX version of the mainframe SUDAAN package described
above and
developed by Research Triangle Institute (Shah, Barnwell, Hunt, and La
Vange,
1991).
PC CARP: PC version of the mainframe SUPER CARP package described above,
but
with added features, and has a supplementary logistic regression module,
and
developed by Survey Section of the Statistical Laboratory at Iowa State
University (Fuller, et al, 1989).
CPLX/VPLX: PC and VAX version of mainframe CPLX/VPLX package mentioned
above
and developed by the Census Bureau..
V.
Estimation capabilities of several variance estimation programs
Computes standard errors for:
Means
Logistic
proportions
regression
Program
coefficients
Ratios, rates
totals
Regression
coefficients
SESUDAAN
X
SUDAAN
X
X
X
X
SUPER CARP
X
X
X
PC CARP
X
X
X
WESVAR
X
X
HESBRR
X
X
PSALMS
X
X
RATIOEST
X
X
SURREGR
X
REPERR
X
WESREG
X
RTILOGIT
X
WESLOG
X
VI.
References
Fuller, W.A., W. Kennedy, D. Schell, G. Sullivan and H.J. Park. (1989).
PC
CARP (Version 1.3). Statistical Laboratory, IOWA State University , Ames,
Iowa
Hidiroglou, M.A., Fuller, W.A. and Hickman R. (1980). SUPERCARP (6th ed.)
Ames, Iowa, Iowa State University, Survey Section, Statistical
Laboratory.
Holt, M.M., (1982). SURREGR: Standard errors of regression coefficients
from
sample survey data. Technical report, Research Triangle Park, North
Carolina:
Research Triangle Institute.
Jones, G.K., (1983). HESBRR (HES Variance and Crosstabulation Program,
Version
3). Unpublished report, Hyattsville, Maryland: National Center for Health
Statistics.
Shah, B.V., (1981a). SESUDAAN: Standard Errors Program for Computing of
Standardized Rates From Sampled Data. Technical report, Research Triangle
Park, North Carolina: Research Triangle Institute.
Shah, B.V., (1981b). RATIOEST: Standard errors program for computing
ratio
estimates for sample survey data. Technical report, Research Triangle
Park,
North Carolina: Research Triangle Institute.
Shah, B.V., B.G. Burnwell, P.N. Hunt and L.M. La Vange, (1992). SUDAAN
User's
Manual. Professional Software for SUrvey DAta ANalysis for Multi-stage
Sample
Design, Release 6.0, Research Triangle Park, N.C.
Shah, B.V., R.E. Folsom, F.E. Harrell, C.N. Dillardz. (1984). RTILOGIT:
Survey
Data Analysis Software for Logistic Regression. Technical report,
Research
Triangle Park, North Carolina: Research Triangle Institute.
Van Eck, N., (1979). OSIRIS IV Users Manual: 15th edition. Survey
Research
Center, Institute for Social Research, The University of Michigan, Ann
Arbor,
MI.
WESTAT, Inc. 1989. The WESREG Procedure, Rockville, Maryland.
WESTAT, Inc. 1989. The WESLOG Procedure, Rockville, Maryland.
WESTAT, Inc. 1989. The WESVAR Procedure, Rockville, Maryland.
NATIONAL HEALTH INTERVIEW SURVEY PROCEDURE CODES FOR USE WITH
THE NMES HOUSEHOLD DATA
INDEX OF OPERATIONS AND NON-OPERATIVE PROCEDURES, FOR HIS
CLASSIFICATION OF OPERATIONS AND NON-OPERATIVE PROCEDURES,
FOR HIS
I.
INDEX OF OPERATIONS AND NON-OPERATIVE PROCEDURES, FOR HIS
Note: See Part II of this section for the Classification of Operations
and Non-Operative Procedures used by HIS, with a general explanation of
its content and form. In the following Index of Operations and
Non-Operative Procedures, for HIS, names of operations and procedures
are listed in alphabetical order. Operations for certain specified
conditions
are listed in the alphabetical order of the condition. For
example: Cataract operation 13; Harelip operation 27; Pilonidal
cyst operation 86. Codes for operations which are classified
according to site--and which are not classified elsewhere to a
particular kind of operation or condition--are found by site
under the heading "OPERATION, NEC." The abbreviation "OP NEC,"
seen frequently in this Index, means "operation not elsewhere
classified."
Operations are classified in nine groups of procedures:
1-Incision
2-Excision
3-Amputation
4-Introduction
5-Endoscopy
6-Repair
7-Destruction
8-Suturing
9-Manipulation
These procedures are defined as follows:
1. Incision is a cutting into; an opening.
used are:
-
otomy--a cutting out (to cut into)
ostomy--a cutting into to form an opening
centesis--a puncture (aspiration)
2. Excision is a cutting out.
-
Suffixes commonly
Suffixes commonly used are:
ectomy--a cutting out (to cut out, excise, or excision)
exeresis--removal (to strip out)
3. Amputation is cutting off. No suffix is used.
these words mean amputation:
However,
Disarticulation
Dismemberment
4. Introduction.
introduction:
No suffix is used.
However, these words mean
Injections
Insertions
Implantations
Transfusions
5. Endoscopy is viewing or looking within.
-
The suffix used is:
scopy (view)
In this procedure a scope is used.
procedure are:
Some examples of this
Anoscopy--viewing of the anus
Bronchoscopy--viewing of bronchus
Cystoscopy--viewing of the urinary bladder
Otoscopy--viewing of the external ear
6. Repair means to form.
Suffixes commonly used are:
-
plasty (to form)
ostomy (a mouth)
desis (a binding)
pexy (a fixing)
Procedures are as follows:
plasty (repair or reform) (lengthen or shorten) (graft)
(attach or reattach) (advancement) (recessions)
(open reduction)
ostomy(join together and form permanent openings between
two distinct spaces.)
desis(fusion) (stabilization) Example: Arthrodesis--a
surgical stabilization of a joint.
pexy (fixation) (suspension)
7. Destruction is a breaking down.
-
Suffixes commonly used are:
clasis (destroy) (to break down)
tripsy (crush)
lysis (to loosen) (to free)
Some procedures for which no suffixes are used but are of the
destructive type are:
cauterization (a branding iron)
debridement (clean out)
diathermy (heating through)
fulguration (lightening)
8.
Suturing is a sewing.
-
The suffix used is:
rrhaphy (a seam)
Some examples of this procedure are:
Laryngorrhapy--suturing of larynx
Arteriorrhaphy--suturing of artery
Bronchorrhaphy--suturing of bronchus
Enterorrhaphy--suturing of intestine
9. Manipulation is handling.
-
Suffixes commonly used are:
tasis (a stretching)
ectasia (out--a stretched condition or dilatation)
Some procedures are:
Closed reduction (of fracture)
Application (of cast)
II.
CLASSIFICATION OF OPERATIONS AND NON-OPERATIVE PROCEDURES, FOR HIS
ICD9-CM3 contains a detailed classification and an index of
surgical operations and other therapeutic and diagnostic
procedures, constructed to be useful within hospitals for
hospital record-keeping.
The Health Interview Survey uses only the first two digits of
this classification. HIS recognizes that the detail about the
specific type of operation is lost. It is felt that, for HIS,
the body system or region (on which the operation was performed)
will be sufficient for data analyses.
As does ICD9-CM3, HIS recognizes 16 broad groups, each of which
is subdivided into several 2-digit categories. These
subdivisions describe operations within a system in one or more
of the following ways:
a.
a specified operation with the part of body specified
or implied, as in "excision of larynx" (30).
b.
operations without reference to procedures, for some
conditions which are commonly surgical conditions, as
in "operations for appendix" (47).
c.
operations, except as in a or b above (without
reference to procedure or condition) on a specified
part of body, as in "operations on esophagus" (42).
Additionally, HIS has a single code category "00" for any
operation of ill-defined or unknown type, with site unspecified.
For the alphabetical arrangement of operations, or to determine
the "broad" category for inclusion of a specific operation or
procedure, see Index of Operations and Non-Operative Procedures
(this Manual) or refer to ICD9-CM3. The ICD9-CM3 index can also
be used for the classification of operations and procedures.
Remember, however, that HIS only uses the first two digits.
1.
OPERATION, TYPE UNKNOWN, SITE UNKNOWN
00
2.
Operation, no site or type
Includes: operation NEC on gland NOS, or "side," or
other very ill-defined site. Use 00 when it is known
that an operation was performed, but there is no
information about the kind of operation or about the
body system or part involved.
OPERATIONS ON THE NERVOUS SYSTEM (01-05)
01
Incision and excision of skull, brain, and cerebral
meninges
02
Other operations on skull, brain, and cerebral meninges
03
Operations on spinal cord and spinal canal structures
04
Operations on cranial and peripheral nerves
05
3.
4.
5.
6.
Operations on sympathetic nerves or ganglia
OPERATIONS ON THE ENDOCRINE SYSTEM (06-07)
06
Operations on thyroid and parathyroid glands
07
Operations on other endocrine glands
OPERATIONS ON THE EYE (08-16)
08
Operations on eyelids
09
Operations on lacrimal system (tear ducts)
10
Operations on conjunctiva
11
Operations on cornea
12
Operations on iris, ciliary body, sclera, and anterior
chamber
13
Operations on lens
14
Operations on retina, choroid, vitreous, and posterior
chamber
15
Operations on extraocular muscles
16
Operations on orbit and eyeball
OPERATIONS ON THE EAR (18-20)
18
Operations on external ear
19
Reconstructive operations on middle ear
20
Other operations on middle and inner ear
OPERATIONS ON THE NOSE, MOUTH AND PHARYNX (21-29)
21
Operations on the nose
Includes: operations on bone and skin of nose
22
Operations on nasal sinuses
23
Removal and restoration of teeth
24
Other operations on teeth, gums and alveoli
25
Operations on tongue
7.
8.
9.
10.
26
Operations on salivary glands and ducts
27
Other operations on mouth and face
Includes: operations on lips, palate and soft tissue
of face and mouth, except tongue and gingiva.
28
Operations on tonsils and adenoids
29
Operations on pharynx
OPERATIONS ON THE RESPIRATORY SYSTEM (30-34)
30
Excision of larynx
31
Other operations on larynx and trachea
32
Excision of lung and bronchus
33
Other operations on lung and bronchus
34
Operations on chest wall, pleura, mediastinum and
diaphragm
OPERATIONS ON THE CARDIOVASCULAR SYSTEM (35-39)
35
Operations on valves and septa of heart
36
Operations on vessels of heart
37
Other operations on heart and pericardium
38
Incision, excision and occlusion of vessels
39
Other operations on vessels
OPERATIONS ON THE HEMIC AND LYMPHATIC SYSTEM (40-41)
40
Operations in lymphatic system
41
Operations on bone marrow and spleen
OPERATIONS ON THE DIGESTIVE SYSTEM (42-54)
42
Operations on the esophagus
43
Incision and excision of stomach
44
Other operations on stomach
11.
12.
45
Incision, excision, and anastomosis of intestine
46
Other operations on intestine
47
Operations on appendix
48
Operations on rectum and perirectal tissue
49
Operations on anus
50
Operations on liver
51
Operations on gallbladder and biliary tract
Includes: operations on common bile duct, cystic duct
and hepatic duct
52
Operations on pancreas
53
Repair of hernia
54
Other operations on abdominal region
Includes: operations on epogastric region, flank,
groin region, inguinal region, loin region, male pelvic
cavity, mesentery, omentum, peritoneum and
retroperitoneal tissue space.
OPERATIONS ON THE URINARY SYSTEM (55-59)
55
Operations on kidney
Includes: operations on renal pelvis
56
Operations on ureter
57
Operations on urinary bladder
58
Operations on urethra
59
Other operations on urinary tract
OPERATIONS ON MALE GENITAL ORGANS (60-64)
60
Operations on prostate and seminal vesicles
61
Operations on scrotum and tunica vaginalis
62
Operations on testes
63
Operations on spermatic cord, epididymis, and vas
deferens
64
Operations on penis
13.
14
15.
OPERATIONS ON THE FEMALE GENITAL ORGANS (65-71)
65
Operations on ovary
66
Operations on fallopian tubes
67
Operations on cervix
68
Other incision and excision of uterus
69
Other operations on uterus and supporting structures
70
Operations on vagina and cul-de-sac
71
Operations on vulva and perineum
OBSTETRICAL PROCEDURES (72-75)
72
Forceps, vacuum, and breech delivery
73
Other procedures inducing or assisting delivery
Includes: spontaneous delivery with manual assistance.
74
Caesarean section and removal of fetus
75
Other obstetric operations
For HIS, includes also "normal delivery"
OPERATIONS ON THE MUSCULOSKELETAL SYSTEM (76-84)
76
Operations on facial bones and joints
Excludes: accessory sinuses (22); nasal bones (21);
and skull (01) (02).
77
Incision, excision and division of other bones
Excludes: operations on facial bones (76); joint
structures (80-81); nasal bones (21); and skull (01-
78
Other operations on bones, except facial bones
Excludes: operations on joint structures (80-81);
nasal bones (21); and skull (01-02).
79
Reduction of fracture and dislocation
Includes: application of cast or splint; reduction
with insertion of traction device.
Excludes: external fixation alone for immobilization
of fracture (93); internal fixation without reduction
of fracture (78); operations on facial bones (76);
nasal bones (21); orbit (76); skull (02); vertebrae
(03); removal of cast or splint (97); replacement of
02).
cast or splint (97); and traction alone for reduction
of fracture (93).
16.
80
Incision and excision of joint structures
Includes: operations on capsule of joint; cartilage;
condyle; ligament; meniscus; and synovial membrane.
Excludes: cartilage of ear (18); nose (21); and joints
of face (76)
81
Repair and plastic operations on joint structures
Includes: operations on ankle; knee; shoulder; elbow;
wrist; hip; vertebrae; fingers; and toes not codable
elsewhere and when condition is not specified and
tissue (such as skin, bone, etc.) is not apparent.
82
Operations on muscle, tendon and fascia of hand
Includes: operations on synovial membrane and tendon
sheath.
83
Operations on muscle, tendon, fascia and bursa, except
hand
Includes: operations on synovial membrane and tendon
sheaths.
Excludes: hand (82); diaphragm (34); and muscles of
eye (15).
84
Other procedures on musculoskeletal system
OPERATIONS ON THE INTEGUMENTARY SYSTEM (85-86)
85
Operations on the breast
Includes: operations on skin of breast and previous
mastectomy site (male or female).
86
Operations on skin and subcutaneous tissue
Includes: operations on hair follicles; male perineum;
nails; sebaceous glands, subcutaneous fat pads; and
superficial fossae.
Includes also: operations on regions such as arm;
armpit; back; cheek; buttock; chin; feet; forearm;
forehead; hand; head; heel; leg; neck; scalp; temple;
temporal region; and thigh when specific tissue (such
as bone; cartilage; joint; etc.) involved is not
mentioned.
Excludes: those on skin of anus (49); breast (85); ear
(18); eyebrow (08); eyelid (08); female perineum (71);
lips (27); nose (21); penis (64); scrotum (61); and
vulva (71).
Excludes also: operations on the head when a specific
part (such as brain) is mentioned.
17.
MISCELLANEOUS DIAGNOSTIC AND THERAPEUTIC PROCEDURES (87-99)
87
Diagnostic radiology
Includes: diagnostic X-Rays of face, head, neck,
brain, skull, spine, chest, digestive tract, urinary
system, genital organs, abdomen and breast.
Excludes: angiography (88).
88
Other diagnostic radiology and related techniques
Includes: CAT scan of abdomen; skeletal X-Rays of
extremities; arteriograms using contrast material; and
X-Rays of veins
Excludes: angiogram of eye (95).
89
Interview, evaluation, consultation, and examination
Includes: diagnostic interviews; neurological exams;
gynecological exams; dental exams; digital exams of
rectum; pacemaker checks; electrocardiograms and
general physical exams.
90
Microscope examination-I
Includes: microscopic examination of specimen from
nervous system, spinal fluid, endocrine glands, eye,
ear, nose, throat, larynx, trachea, bronchus, pleura,
lung, of sputum, and blood.
91
Microscope examination-II
Includes: microscope examination of specimen from
liver, bile ducts or passage, pancreas, peritoneal,
retroperitoneal, kidney, ureter, perirenal,
periureteral tissue, bladder, urethra, prostate,
seminal vesicle, urine, semen, and female genital
tract.
92
Nuclear medicine
Includes: scans, radiation therapy (cobalt) (iodine)
93
Physical therapy, respiratory therapy, rehabilitation,
and related procedures
Includes: diagnostic physical therapy; physical
therapy exercises such as breathing exercises; manual
traction; training in use of prosthesis; whirlpool
treatments; heat therapy; skeletal traction; speech and
reading training for blind; play therapy; education
therapy; artificial respiration, mouth to mouth
resuscitation; oxygen and helium therapy.
94
Psychiatric interviews, consultations and evaluationsIncludes:
routine psychiatric visits; psychoanalysis;
psychiatric electroshock therapy and other nonoperative procedures relating to the psyche.
95
Ophthalmologic and otologic diagnosis and treatment
Includes: eye exams, functional tests of eye; fitting
glasses, contact lens; hearing tests; and fitting
hearing aids.
96
Non-operative intubation and irrigation
Includes: insertion of airway tubes; ear packing; vaginal
packing;
insertion of vaginal diaphragm; rectal
packing; dilation of rectum and anus; manual reduction
of hernia; gastric lavage; irrigation of ostomies;
cleaning of eye, ear and nose; lavage of bronchus and
trachea.
97
Replacement and removal of therapeutic appliances
Includes: replacement of ostomy tubes; replacement of
casts; removal of nasal packing, removal of dental
wiring; removal of sutures from head and neck; removal
of drainage tubes; removal of IUD and removal of
sutures from genital tract.
98
Non-operative removal of foreign body
Includes: removal of foreign body from digestive system, ear,
nose,
larynx, vagina, etc., WITHOUT
INCISION.
99
Other non-operative procedures
Includes: blood transfusion, exchange transfusions,
injections or infusions of therapeutic or prophylactic
substances; cardiac pacemaker (battery and sensing
types), acupuncture and fitting of dentures.
X-CODES FOR SPECIAL IMPAIRMENTS (X00-X99) BY TYPE, SITE AND ETIOLOGY
NATIONAL HEALTH INTERVIEW SURVEY
ICD-9 REVISION (NCHS, 1979): X-CODES
U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Center for Health Statistics
Division of Health Interview Statistics
I.
History and Development of the X-Code
The X-Code for Special Impairments, by Type, Site and
Etiology, was developed in 1955-1956 by the, at that time,
Division of Public Health Methods of the Public Health
Service. It had been tried and found useful in coding and
tabulating various kinds of defects and deformities as
reported in household health surveys, and in certain other
studies of handicapping conditions, requiring relatively
simple detail for statistical presentation. It provided a
plan by which all three elements of type, site, and etiology
(cause) could be expressed by means of a single diagnostic
code, and it brought together similar types of defects by
type and site; etiology was supplied by adding an additional
1-digit code to the code for the type and site. HIS elected
to use this plan for impairments, using the ICD revision in
effect at that time for coding all other conditions.
HIS had continued to use this X-Code, making some changes in
it since the beginning of the Survey, and will use it instead
of the present ICD for the coding of impairments.
Part III of this section, which contains the X-Code and explains it,
has
been rewritten as of January 2, 1979 but the
methods are similar to what they were before
the lists of etiological codes, and the full
of impairments by type, see V and VI of this
principles and
that time. For
classification
section.
In developing the X-Code it had been necessary to make a
selection of conditions to be called "impairments." The term
"impairment" has no actual definitive medical significance.
Cardiac, mental, or arthritic patients are "impaired" as well
as amputees, the blind, the deaf. However, defects of the
heart, lungs, other internal or respiratory organs are in
general excluded from the X-Code except when these sites are
involved in paralysis, absence of part, or postoperatively in
the formation of an artificial opening to the surface.
Chronic progressive disease processes of all systems are
excluded (to be coded as per ICD), but the line between what
is a "chronic disease" and what is an "impairment" is, in
some areas, admittedly thin. For example: speech defects,
mental retardation, cerebral palsy are included in the XCode, but epilepsy, multiple sclerosis, Parkinson's disease,
and personality defects are to be coded as chronic diseases
in terms of ICD codes.
II. General Characteristics of Special Impairments
1. Special impairments (to be referred to hereinafter as
impairments) are often late effects of past and inactive
pathological processes. (See also Item D, following, for
discussion of "late effects.") But they may sometimes
coexist with and be due to a currently active progressive
chronic disease such as diabetes, arteriosclerosis, cancer.
2. Impairments are often, but by no means necessarily,
permanent, and some are relatively minor in nature. Many
respond to corrective therapy, medical or surgical. However,
they must be chronic or long-continuing or of chronic type in
order to be coded to the X-Code. For rules for coding
impairments in relation to date of onset, see specific
instructions set forth elsewhere in the HIS Medical Coding
Manual.
III. Table of X-Codes for Special Impairments
ICD
CODE
NUMBER(S)
NAME OF IMPAIRMENT
X-CODE
NUMBERS
317-319
Mental Retardation (various degrees)
X19
342
X41
Hemiplegia
343
Infantile cerebral palsy
X50
Other paralytic syndromes
For
344.0-344.9:
X40-X49,
X50-X59,
X60-X63
by site and extent
344.0
344.2
344.3
344.4
344.5
344.6
344.8
344.9
Quadriplegia
Diplegia of upper limbs
Monoplegia of lower limbs
Monoplegia of upper limbs
Unspecified monoplegia
Cauda equina syndrome
Other
Unspecified
369
Blindness and low vision
X00-X03
389
Deafness
Deaf mutism
X05-X09
X05
520.0
520.1
520.2
520.5
Anodontia
Supernumerary teeth
Abnormalities of size and form
Hereditary disturbances, tooth
structure
X92
X92
X92
521.6
Ankylosis, teeth
X92
524
Dentofacial anomalies, including
malocclusion
X92
718.6
Unspecified Protrusio Acetabuli
X75
728.4
Laxity of ligament
X80-X89, by
site
728.6
Contracture of palmar fascia
X74
734
Flatfoot
X77
735
Acquired deformities of toe
X76
736
Other acquired deformities of limbs
X73-X76, by site
X92
737
Curvature of spine
738
738.0
738.1
738.2
738.3
738.4
738.5
Other acquired deformities
Acquired deformity of nose
Other acquired deformity of head
Acquired deformity of neck
Acquired deformity of chest and rib
Acquired spondylolisthesis
Other acquired deformity of back
and spine
Acquired deformity of pelvis
Cauliflower ear
Acquired deformity of other
specified site
738.6
738.7
738.8
738.9
X70
X90
X93
X79
X79
X70
X70
X75
X90
X70-X79,
X90, X92,
X93 by site
Acquired deformity of unspecified
site
X99
741
Spina bifida (congenital)
X71
742.0
742.1
742.3
Encephalocele
Microcephalus
Congenital hydrocephalus
X93
X93
X93
743.0
Anophthalmos, one or both eyes
743.1
Microphthalmos, NEC
X00, X02,
X03
X01
744.0
Anomalies of ear, causing hearing
impairment
X05-X09
Accessory auricle
Other specified anomalies of ear
Unspecified anomalies of ear
Webbing of neck
X90
X90
X90
X79
Other specified anomalies of:
face (disfiguring) NEC
neck NEC
X90
X79
Unspecified anomalies of:
face NEC
neck NEC
X90
X79
749
Cleft palate and cleft lip
X91
750.0
750.1
Tongue tie
Other anomalies of tongue (with
speech defect)
X11
X11
Renal agenesis and dysgenesis
X31
744.1
744.2
744.3
744.5
744.8
744.9
753.0
Congenital musculoskeletal
754.2
754.3
754.4
754.5
754.6
754.7
754.8
755
deformities:
spine
dislocation of hip
bowleg(s), deformity leg(s)
various deformities of feet
valgus deformities of feet:
flatfoot
other deformities of feet:
clubfoot NOS
other specified deformities:
chest wall
dislocation of elbow
chest, funnel chest
clubhand, hand
lower limb joints
Other congenital anomalies of limbs:
absence
X70
X75
X76
X76
X76
X77
X76
X78
X79
X73
X79
X74
X76
X20-X29,
X35, by site
X70-X79,
deformity
by site
756.0
756.1
756.2
756.3
Anomalies of skull and face bones:
face
skull, NEC
Anomalies of spine:
absence of specified segment
of spine
other deformity of spine
Cervical rib
Other anomalies of rib and sternum:
absence of rib, sternum
other deformity of rib and sternum
758.0
Down's syndrome
759.7
759.9
781.5
Multiple congenital anomalies, type
and site not specified
Clubbing of fingers
Traumatic amputation of:
thumb(s)
other finger(s)
arm(s) and hand(s)
885
886
887
895
896
897
905.6
905.7
905.8
905.9
effect
effect
effect
effect
of
of
of
of
X33
X70
X79
X33
X79
X19
toe(s)
feet, foot
leg, one or both
Late
Late
Late
Late
X90
X93
dislocation
sprain and strain
tendon injury
traumatic amputation
X99
X74
X22, X25
X22, X25
X20-X24
X27, X29
X27, X29
X26, X28
X80-X89
X80-X89
X80-X89
X20-X29, X35
IV. Late Effects of Diseases, Injuries, and Poisonings
A "late effect" is regarded generally as any abnormal
condition resulting from a pathological process after this
causative process has become inactive or healed. A late
effect may consist of an impairment as defined, or it could
be any other abnormal condition. For HIS, an impairment may
be a late effect as defined above, but it could be due to
some active pathological process. By means of the X-Code,
impairments can be collected whether the cause is present or
not. Instructions for coding impairments in relation to
active diseases causing them are set forth elsewhere in the
HIS Medical Coding Manual.
For facts about the HIS method of coding late effects of
injury or poisoning, see notes for categories 800-999, in
Appendix III.
ICD has a few categories specific for late effects of certain
diseases--with "late effects" in the title.
Following are the ICD codes for late effects of diseases,
which are not used by HIS for any purpose--as shown also in
Appendix III:
137
138
139
268.1
326
438
Late effects of tuberculosis
Late effects of acute poliomyelitis
Late effects of other infectious and parasitic
diseases
Late effects of rickets
Late effects of intracranial abscess or pyogenic
infection
Late effects of cerebrovascular disease
Since the above ICD late effects codes for diseases are not
used by HIS, the method for coding late effects is as
follows:
1. When the late effect is a specified impairment, the
appropriate X-Code is selected and the appropriate
etiological code is added; for example, "Blindness, both
eyes, due to old trachoma" is coded by HIS to X00.8, only.
2. When the late effect is specified but it is not an
impairment, the condition is coded to the ICD code for the
condition, but never to the above-mentioned ICD late effects
codes; for example, "Personality disorder due to old
encephalitis" is coded by HIS to 301.9 only.
3. If the past disease is known, but the present difficulty
is ill-defined or not specified, the above ICD late effects
codes will not be used. Instead, if the past disease is one
indicated in these late effects codes, or is an old birth
injury, or "Brain damage NEC," X99 (with the appropriate
etiological code) will be used. Thus, for example, "Postpolio" would be coded to X99.4. However, for "After effects
of stroke," the stroke only will be coded.
Coding Late Effects, other than those on the preceding page, and
the original disease.
1. ICD does not have late effect codes for diseases other than
the ones mentioned on preceding page. However, HIS coding
requires that late effects of many diseases be coded; which is
usually a special impairment. When the disease causing the late
effect or special impairment is given, the question arises as to
when to code the causative disease also. HIS has devised a
definition for an active disease and an inactive disease, as
described below. When a causative disease meets HIS' definition
of "active" disease, the disease will be coded in addition to any
special impairment.
Inactive disease processes will be used to determine etiology and
will not be coded as a separate diagnosis.
The terms "active" and "inactive" (i.e., past disease or
condition) are distinguished by considering ALL of the Condition
Pages for each person.
The CAUSE is "Active" if:
1.
it is reported in Item 1 or 3b of a Condition Page AND NO
explicit indication that the condition is cured or no longer
present. "Explicit indication" would include: (1) Questions
10-12 completed and "cured" is checked in Item 12b; (2) the
person says the condition is cured, corrected, arrested, no
longer present, or the equivalent; (3) the name of the
condition indicates it is no longer present ("childhood
rheumatic fever" and the person is an adult)
2.
it is reported in Item 3c or 3e, and the condition is on the
list of conditions which are coded as chronic regardless of
onset, and there is no explicit indication (as defined in #1
above) that the condition is cured, corrected, arrested or no
longer present
3.
it is stated in the footnotes or written entries of the
Condition Page(s) for this person that the disease causing
the impairment is still present.
The CAUSE is "Inactive" if:
1.
it is reported in Item 1 or 3b if a Condition Page AND there
is explicit indications (as defined in #1 above) that the
condition is cured, corrected, arrested or no longer present
2.
it is reported in Item 3c or 3e, AND either the condition is
NOT on the list of conditions which are coded as chronic
regardless of onset, or, if it is on the list, there is
explicit indication (as defined in #1 above) that the
condition is cured or no longer present
3.
there is no footnote or written entry on the Condition Pages
for this person stating that the condition causing the
impairment is still present.
V.
List of Etiology Codes
Note: For complete instruction for coding impairments by
etiology, see HIS Medical Coding Manual.
These codes are listed in the order of priority in which they
should be assigned when more than one etiology is given, none
of them is an accident or injury, and it cannot be determined
which was the earlier cause of impairment. Where the earlier
cause can be determined, that fourth digit is always assigned
regardless of the priority shown below. Accident or injury
ALWAYS has priority whether it occurred earlier or later than
other causes.
.0
Accident or injury except at birth
.1
Cerebrovascular disease (stroke)
(with arteriosclerosis) (with hypertension)
.2
Neoplasm
.3
Diabetes (with cataract or glaucoma)
.4
Poliomyelitis
.5
Cataract with glaucoma
.6
Cataract without glaucoma
.7
Glaucoma without cataract
.8
Other eye diseases (as in ICD)
(any infection of eye)
.9
Congenital origin NEC or birth injury
.X
Other conditions not in .0-.9 (non-congenital) (nontraumatic) (heredity) (old age) ("age" NOS)
.Y
Unknown or unspecified origin
VI. Classification of Impairments, by Type and Site (X00-X99)
Note: For complete instructions for coding all types of
impairments and their causes, see HIS Medical Coding Manual,
Section V.
X00-X03
BLINDNESS AND IMPAIRMENT OF VISION (Only one code in
this range may be used per person)
X00
Blind in both eyes
X01
Visual impairment in both eyes
X02
Blind in one eye, visually impaired in the other eye
X03
Blind or visually impaired in one eye only; other eye,
good vision or not mentioned
X05-X09
DEAFNESS AND IMPAIRMENT OF HEARING (Only one code in
this range may be used per person.)
X05
Deafness, both ears
Includes persons who are reported "deaf" in both ears,
or reported to have no useful hearing in both ears, or
can't hear, both ears. Excludes terms such as "a
little deaf," "partially deaf"; code as for hearing
impairment.
X06
Other hearing impairment involving both ears
Any bilateral hearing impairment which cannot be coded
to X05.
X07
Deafness or hearing impairment of any degree involving
only one ear
X08
Deafness, NOS
Includes "deafness," "deaf," "can't hear," unknown
whether one or both ears are involved. Excludes such
terms as "a little deaf," "partially deaf"; code as for
hearing impairment.
X09
Impaired hearing, NOS
Hearing impairment unknown whether one or both ears are
involved.
X10-X19
IMPAIRMENT OF SPEECH, SPECIAL SENSE AND INTELLIGENCE
X10-X11
IMPAIRMENT OF SPEECH (Only one code in this range may
be used per person.)
X10
Stammering and Stuttering
X11
Other speech defects
Includes persons with absence of larynx or tongue even
when speech defect is not reported.
X12
X12
X14
IMPAIRMENT OF SPECIAL SENSE, EXCEPT VISION OR HEARING
Loss or impairment of sensation
Includes taste, smell and loss or disturbances of
sensation (burning) and numbness of any body parts.
This code will NOT be used if a code in the range of
X40-X99 had been assigned.
SPECIAL LEARNING DISABILITY
(Prefer X19 if both X14 and X19 are present per person)
X14
X19
X19
Special learning disability (reading) (mathematics)
("mirror writing or reading".) Does not include
learning disability resulting only from deficiency in
intelligence.
MENTAL RETARDATION
Mental retardation: Any degree or any type, including
"mongolism" ("Down's (Downes) Syndrome")
X20-X35
ABSENCE, LOSS, EXTREMITIES, AND CERTAIN OTHER SITES
X20-X25
ABSENCE, LOSS, UPPER EXTREMITY
(For X20-X22, code only one of these codes per person,
and no other code in the range of X20-X25.)
X20
Arms, both
X21
Hands, both
X22
One or more fingers (excludes tip only-below first
joint (thumb(s)) of both hands
X23
Arm, one
Person may also have X24 or X25
X24
Hand, one
Person may also have X23 or X25
X25
One or more fingers, (excludes tip only-below first
joint), thumb, of only one hand. Person may also have
X23 or X24.
X26-X29
ABSENCE, LOSS, LOWER EXTREMITY
(For X26-X27, code only one of these codes per person,
and no other code in the range of X26-X29.)
X26
Legs, both
X27
Feet or toes (excludes tip only-below first joint)
only, both
X28
Leg, one
Person may also have X29
X29
Foot or toes (excludes tip only-below first joint)
only, one
Person may also have X28
X30-X35
ABSENCE, LOSS, CERTAIN OTHER SITES
X30
Lung
X31
Kidney
X32
Breast
X33
Rib, bone, joint, or muscle of trunk, one or more
X34
Bone, joint, or muscle of extremity (including hip)
without loss of extremity, one or more
X35
Tips of fingers or toes (below first joint) only
X40-X64
PARALYSIS, COMPLETE OR PARTIAL
X40-X49
PARALYSIS NOS (COMPLETE) OF EXTREMITIES
X40
Entire body or four limbs (Prohibits X41-X62)
X41
One side of body only, including limbs; or
"hemiplegia." (Prohibits X42, X44, X46, or X48)
X42
Arms, both
X43
Arm, one (Prohibits X44)
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X44
Hands, both, and/or finger(s) (thumb) on one or both
hands only. (Prohibits X45)
X45
Hand, one, and/or finger(s) (thumb) on one hand, only.
(When the corresponding body part on the other side has
been coded, "one" means "other.")
(Prohibits X43-X45)
X46
Legs, both; or "paraplegia."
X47
Leg, one (Prohibits X48)
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X48
Feet, both, and/or toe(s) on one or both feet, only.
(Prohibits X49)
X49
Foot, one, and/or toe(s) on one foot, only.
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X50-X59
(Prohibits X47-X49)
CEREBRAL PALSY AND PARALYSIS PARTIAL OF EXTREMITIES
X50
Cerebral palsy (and synonyms)
Includes "spastic" if present since birth (congenital)
(Prohibits X51-X64)
X51
One side of body only, including limbs; or
"hemiparesis."
(Prohibits X52, X54, X56, or X58)
X52
Arms, both
X53
Arms, one (Prohibits X54)
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X54
Hands, both, and/or finger(s) (thumb) on one or both
hands only. (Prohibits X55)
X55
Hand, one, and/or finger(s) (thumb) on one hand only.
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X56
Legs, both; or "paraparesis"
X57
Leg, one (Prohibits X58)
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X58
Feet, both, and/or toe(s) on one or both feet, only
(Prohibits X59)
X59
Foot, one, and/or toe(s) on one foot, only
(When the corresponding body part on the other side has
been coded, "one" means "other.")
X60-X64
X60
(Prohibits X53-X55)
(Prohibits X57-X59)
PARALYSIS, COMPLETE OR PARTIAL, SITES EXCEPT
EXTREMITIES
Trunk, any part except parts included in X40, X41, or
X51. If PARTIAL paralysis of ENTIRE body is indicated,
code X60 only.
X61
Face (Bell's palsy or paralysis)
X62
Bladder or anal sphincter
X63
Paralysis, complete or partial, sites NOT of
extremities, trunk, nor affecting special senses or
speech
X64
Paralysis, complete or partial, NEC
X70-X79
Includes:
SPECIFIED DEFORMITY OF LIMBS, TRUNK, BACK
specified structural deformities of limbs, trunk,
back, described as: contracture; atrophy; accessory
("extra"); short or shortness; crippled; shrivelled;
"drawn up"; "twisted"; "withered"; and scarring (with
contracture) involving limbs, neck, back, trunk.
X70
Curvature and other structural deformities of spine or
back, except as in X71.9
Includes: all structural deformities of spine or back
except spina bifida (X71.9)
Excludes: chronic back conditions NEC in X80
X71.9
Spina bifida (with meningocele) (always congenital)
Excludes: X80
X73
Deformity of shoulder or upper extremity
Excludes: deformity of hand(s), finger(s), thumb(s),
only
(Prohibits X74)
X74
Deformity of hand(s), finger(s), thumb(s), only
X75
Dislocation, congenital, and other deformity hip and/or
pelvis
X76
Deformity of any site on lower extremity, one or both
Includes: genu valgum (knock knee); genu varum
(bowleg); tibial torsion; hammer toe; hallux valgus or
varus; any deformity of toe; deformity leg NOS, foot
NEC, knee. Exludes X77 and X78.
X77
Flatfoot (including weak or fallen arches and other
difficulty with arches)
X78
Clubfoot (congenital)
X79
Deformity, neck, trunk bones, NEC
Includes: pigeon breast; cervical rib; postural defect
NEC
X80-X89
NON-PARALYTIC ORTHOPEDIC IMPAIRMENT (CHRONIC) NEC
Excludes:
"disc conditions" (ICD 722)
Includes:
Limitation of motion NEC; stiffness (complete or
partial); "flail joint"; instability of joint;
symptomatic, but chronic difficulty, weakness,
"trouble", pain, swelling, "limping," involving
muscles, joints, limbs, back or trunk, of unknown
cause or due to healed injuries 3 months + or to past
and now inactive diseases; old (3 months +) sprains,
strains, or dislocations with effect not elsewhere
classifiable, or not stated.
Note:
Orthopedic impairment NEC, as in X80-X89, is not to be
coded as a separate diagnosis if due to specified
disease; code disease only.
ORTHOPEDIC IMPAIRMENT NEC (CHRONIC) INVOLVING:
X80
Back, any part
Includes: neck
X84
Shoulder(s) and/or upper extremity(ies)
X85
Hip and/or pelvis
Excludes: Congenital dislocation of hip (X75.9)
X86
Lower extremity
Excludes: impairments involving arches of foot, feet
(X77)
X89
Other and ill-defined sites
Includes: rib; trunk, NOS; "side," NOS; joint, NOS;
limping; staggering; stumbling; trouble in walking, NOS
Excludes: jaw (X92); and ataxic gait, which if
chronic, is coded as for Paralysis, partial.
X90-X99
DEFECT, ABNORMALITY, SPECIAL IMPAIRMENT, NEC
X90
Disfigurement, scarring, face, nose, lips, ears
Includes: absence of nose, lips, ears; accessory
auricle; other abnormality NEC of face, nose, ears,
mouth, teeth, jaws if stated to be disfiguring. If
speech defect is present, code it also.
Excludes: cleft palate and harelip whether or not
disfiguring (X91.9.)
X91.9
Cleft palate and harelip (with speech defect)
(disfiguring)
Includes: cleft palate and cleft lip (as in ICD 749)
with or without speech defect and whether or not stated
to be disfiguring.
X92
Other dentofacial handicap
Includes: acquired absence of teeth, onset 3 months +;
and abnormalities of teeth, malocclusion, and other jaw
and dentofacial anomalies as in ICD 520.0, 520.1,
520.2, 520.5, 521.6 and 524. If speech defect is
present, code it also.
Excludes: cleft palate and harelip (X91.9); and other
dentofacial handicaps if stated to be disfiguring
(X90).
X93
Deformity of skull (hydrocephaly) (microcephaly).
mental retardation is present, code it also.
X94
Artificial orifice (opening) or valve (surgical) any
site (colostomy)
X99
Special impairment, ill-defined
Includes: deformed NOS; cripple NOS; "birth injury" or
"brain damage" NOS, at ages 3 months or over without
specification as to type of impairment; ill-defined
"after effects" of tuberculosis, encephalitis,
poliomyelitis, trachoma, toxoplasmosis, other infective
and parasitic diseases, rickets, intracranial abscess.
See also Item D, this Appendix.
Excludes: stroke, or ill-defined "after effects" of
stroke; code the stroke--not X99.Section Q
If
MEDICINE NAMES AND CODES
The system adopted for processing prescribed medicine data in NMES was
first
developed as part of the 1980 National Ambulatory Medical Care Survey
(NAMCS)
by the National Center for Health Statistics (Koch 1980).
99999
99980
00010
00095
00100
00105
00110
60000
00140
00163
00210
00220
00223
ILLEGIBLE
OTHER
A AND D
A.P.L.
A.S.A.
A.S.A. & CODEINE
A.S.A. COMPOUND
A.S.A. ENSEAL
A-FIL
A/T/S
ACCELERASE
ACCURBRON
ACCUTANE
00245
00260
00265
00270
00275
00280
00283
00288
00295
00305
00320
00340
60030
00345
00355
60035
00395
00455
00475
00481
00480
00487
60040
00510
00525
60045
00540
60050
00560
00570
00585
60060
00590
60065
00595
00597
00598
00615
00645
41870
41825
00685
00705
00735
00740
00790
00805
00810
00825
00830
00835
00845
00850
00880
ACETA
ACETAMINOPHEN
ACETAMINOPHEN NO. 2
ACETAMINOPHEN NO. 3
ACETAMINOPHEN NO. 4
ACETAMINOPHEN W/CODEINE
ACETAMINOPHEN W/OXYCODONE
ACETASOL
ACETAZOLAMIDE
ACETIC ACID
ACETONE
ACHROMYCIN
ACHROMYCIN OPHTHALMIC
ACHROMYCIN V
ACI-JEL
ACLOVATE
ACNE
ACTH
ACTIFED
ACTIFED WITH CODEINE
ACTIFED-C
ACTRAPID
ADALAT
ADAPIN
ADEFLOR
ADEFLOR M
ADIPEX
ADIPEX-P
ADRENALIN
ADRIAMYCIN
ADSORBOCARPINE
ADSORBOCARPINE OPHTHALMIC
ADSORBONAC
ADSORBONAC OPHTHALMIC
ADSORBOTEAR
ADVIL
AEROBID
AEROSEB-HC
AFRIN
AK-SPORIN
AKARPINE
AKINETON
AL-AY
ALBALON
ALBALON-A
ALCOHOL
ALCOHOL RUBBING
ALCON
ALDACTAZIDE
ALDACTONE
ALDOCLOR
ALDOMET
ALDORIL
ALKA-SELTZER
00905
00915
00925
00935
00960
00975
00976
00979
00980
00990
01030
60070
01100
01145
01155
01221
01225
01235
01250
01255
01258
01290
01305
60075
01315
01325
01335
01375
01395
01410
01420
01450
01525
01530
01535
01615
01630
01635
01640
01660
01670
01685
01690
01700
01725
01730
01755
01758
01775
01780
01820
01838
01840
01850
ALKALOL
ALKERAN
ALLBEE
ALLBEE W/C
ALLEREST
ALLERFRIN
ALLERGAN
ALLERGINE
ALLERGY RELIEF OR SHOTS
ALLERNADE T.D. IMPROVED
ALLOPURINOL
ALPHA-TREX
ALPHADERM
ALTERNAGEL
ALU-CAP
ALUMINUM ACETATE
ALUMINUM HYDROXIDE
ALUMINUM MAGNESIUM HYDROXIDE
ALUMINUM-MAGNESIUM HYDROX W/SIMETHICO
ALUPENT
ALUPRIN
AMANTADINE
AMBENYL
AMBENYL EXPECTORANT
AMCILL
AMEN
AMERICAINE
AMICAR
AMIDOXINE
AMIKIN
AMINO-CERV
AMINOPHYLLINE
AMITRIL
AMITRIPTYLINE
AMITRIPTYLINE HCL W/PERPHENAZINE
AMOLIN
AMOXICILLIN
AMOXICILLIN TRIHYDRATE
AMOXIL
AMPHETAMINE
AMPHOJEL
AMPICILLIN
AMPICILLIN TRIHYDRATE
AMQUINTUSSIN
AMYTAL
ANA EMERGENCY INSECT STING KIT
ANACIN
ANACIN-3 WITH CODEINE
ANALGESIC
ANALGESIC BALM
ANAMINE
ANAPROX
ANASPAZ
ANATUSS
01853
01855
01860
01983
01995
01990
02050
02053
02070
02075
02080
02088
02113
02115
02120
02135
02150
02155
02125
02157
02158
02159
02165
35410
35415
35420
35425
35440
35445
35450
35455
35460
35465
02180
35475
35480
35483
35490
35495
02195
02205
02215
02220
02225
35505
02235
02250
35510
02285
02310
02315
02335
02340
02345
ANATUSS W/CODEINE
ANAVAR
ANBESOL
ANESTHETIC
ANEXSIA
ANEXSIA W/CODEINE
ANOQUAN
ANOREXIC AGENT
ANSPOR
ANTABUSE
ANTACID
ANTACID AND ADSORBENT
ANTHELMINTIC AGENT
ANTHRA-DERM
ANTHRALIN
ANTI-ITCH
ANTI-TUSS
ANTI-TUSS DM
ANTIACID
ANTIANEMIA AGENT
ANTIBIOTIC AGENT
ANTIBIOTIC EAR DROPS
ANTICOAGULANT
ANTICONVULSANT AGENT
ANTIDEPRESSANT AGENT
ANTIDIABETIC AGENT
ANTIDIARRHEAL AGENT
ANTIFLATULENT AGENT
ANTIFUNGAL AGENT
ANTIHISTAMINE
ANTIINFECTIVE AGENT
ANTIINFLAMMATORY AGENT
ANTILIPEMIC AGENT
ANTIMINTH
ANTINAUSEANT AGENT
ANTINEOPLASTIC AGENT
ANTIOBESITY AGENT
ANTIPRURITIC AGENT
ANTIPYRETIC AGENT
ANTIPYRINE
ANTISEPTIC MOUTHWASH
ANTISEPTIC SOLUTION
ANTISPAS
ANTISPASMODIC
ANTITUBERCULAR AGENT
ANTIVENIN SPIDER BITE
ANTIVERT
ANTIVIRAL AGENT
ANTURANE
ANUSOL
ANUSOL-HC
APAP
APAP W/CODEINE
APAP W/CODEINE ELIXIR
02395
02405
02410
02445
02465
02473
02485
02510
02513
02520
02570
02575
02580
02605
02625
02627
02645
02660
02690
02705
02725
41980
02748
02805
02820
02803
02828
02835
02870
02875
02880
02900
02910
02925
02940
02950
02980
02982
60115
02987
60120
60125
60130
02995
03005
03020
03025
03040
03045
03050
03065
03070
03110
03113
APRESAZIDE
APRESOLINE
APRESOLINE-ESIDRIX
AQUACARE
AQUAMEPHYTON
AQUAPHYLLIN
AQUASOL A
AQUATENSEN
AQUEOUS BENZALKON CHLOR
ARALEN
ARISTO-PAK
ARISTOCORT
ARISTOCORT A
ARISTOCORT R
ARLIDIN
ARMOUR THYROID
ARTANE
ARTHRITIS PAIN FORMULA
ASBRON G
ASCORBIC ACID
ASCRIPTIN
ASCRIPTIN A/D
ASENDIN
ASPIRIN
ASPIRIN COMPOUND #3
ASPIRIN W/CODEINE
ASPIRIN W/OXYCODONE
ASPIRIN-PHENACETIN-CAFFEINE
ATABRINE
ATARAX
ATARAXOID
ATIVAN
ATRIDINE
ATROMID-S
ATROPINE
ATROPINE SULFATE
ATROPISOL
ATROVENT
AUGMENTIN
AUGMENTIN 125
AUGMENTIN 250
AUGMENTIN 500
AURAFAIR OTIC SOLUTION
AURALGAN
AUREOMYCIN
AUROTO DROPS
AVALGESIC LOTION
AVC
AVC/DIENESTROL
AVEENO
AVEENO-BAR
AVENTYL HCL
AXOTAL
AYGESTIN
03123
03125
03130
40170
03135
03140
03205
03225
03250
03265
03275
03330
03263
03355
03365
03395
03410
03415
03420
03423
35530
03430
03435
03480
03485
03510
03515
03518
03520
03540
03560
03605
03635
40185
03700
03705
03709
03715
03743
03740
03741
03785
03800
03805
03825
03845
03850
03880
03885
03890
03900
03905
03920
03955
AZATHIOPRINE
AZENE
AZMA-AID
AZMA-CORT
AZO GANTANOL
AZO GANTRISIN
AZOLID
AZULFIDINE
B COMPLEX
B COMPLEX FORTE
B COMPLEX W/ASCORBIC ACID & B-12
B-C-BID
B-COMPLEX C W/IRON
B-12
BABY COUGH SYRUP
BACID
BACITRACIN
BACITRACIN-NEOMYCIN-POLYMYXIN
BACITRACIN-POLYMYXIN
BACLOFEN
BACTINE
BACTRIM
BACTRIM DS
BALNEOL LOTION
BALNETAR
BANALG LINIMENT
BANCAP
BANCAP HC
BANCAP W/CODEINE
BANTHINE
BARBIDONNA
BAROPHEN ELIXIR
BASALJEL
BAYER ASPIRIN
BECLOMETHASONE
BECLOVENT
BECONASE
BECOTIN
BEE STING ANTIVENIN
BEELITH
BEEPEN VK
BELLADENAL
BELLADONNA
BELLADONNA ALKALOIDS W/PHENOBARBITAL
BELLADONNA W/PHENOBARBITAL
BELLERGAL
BELLERGAL-S
BEMEX
BEMINAL
BEMINAL FORTE W/VITAMIN C
BEN GAY
BENADRYL
BENAHIST
BENEMID
03970
03985
04000
04015
04020
04025
04030
60175
04055
04065
04085
04088
60180
04100
04105
04188
04120
04125
04135
60185
04160
04170
60200
04180
40205
04190
60205
40210
04225
04235
04240
04250
04295
04323
04355
04365
04370
04385
04425
04433
04480
04485
04511
04513
04515
04580
04585
04590
04595
50000
60235
04650
04660
04668
BENOQUIN
BENSULFOID
BENTYL
BENYLIN SYRUP
BENZAC
BENZAC W GEL
BENZAGEL
BENZAMYCIN
BENZOCAINE
BENZODENT
BENZOYL
BENZOYL PEROXIDE
BENZTROPINE MESYLATE
BEROCCA
BEROCCA-C
BETA-VAL
BETADINE
BETADINE PERINEAL WASH CONCENTRATE
BETADINE VAGINAL GEL
BETAGAN LIQUIFILM
BETALIN
BETAMETHASONE
BETAMETHASONE VALERATE
BETAPEN-VK
BETATREX
BETHANECHOL
BETOPTIC
BI-K
BICARBONATE OF SODA
BICILLIN
BICILLIN C-R
BICITRA
BILRON
BIONATE
BIOZYME
BIPHETAMINE
BISACODYL
BISCODYL
BISMUTH SUBGALLATE
BISMUTH SUBGALLATE FORMULA W/HYDROCOR
BLEPH
BLEPHAMIDE
BLOCADREN
BLOOD FORMATION AND COAGULATION
BLUBORO
BONINE
BONTRIL PDM
BORAX
BORIC ACID
BRETHAIRE
BRETHANCER
BRETHINE
BREVICON
BREXIN
04670
04760
04770
04790
04803
04808
04845
04825
04873
04875
04895
04915
04920
04925
04930
04970
04975
05010
05015
05018
05024
05043
05055
60270
05070
05085
05095
05098
05103
40250
05110
05125
05145
05210
05250
05255
05300
05310
05320
05335
05347
05355
05370
05375
05390
05393
05394
05415
05395
05405
05445
05465
60285
05533
BRICANYL
BROMANATE
BROMANYL EXPECTORANT
BROMATAPP
BROMFED
BROMOCRIPTINE
BROMPHENIRAMINE
BROMPHENIRAMINE COMPOUND ELIXIR
BRONCHODILATOR
BRONDECON
BRONKAID
BRONKOLIXIR
BRONKOMETER
BRONKOSOL
BRONKOTABS
BUCLADIN-S SOFTAB
BUF ACNE CLEANSING BAR
BUFFERIN
BUFFERIN ARTHRITIS STRENGTH
BUFFERIN W/CODEINE
BUMEX
BURN OINTMENT
BUROW'S SOLUTION
BUSPAR
BUTABARBITAL
BUTAL
BUTALBITAL
BUTALBITAL W/AC
BUTALBITAL W/CODEINE
BUTALBITAL/ASPIRIN/CAFFEINE
BUTAZOLIDIN
BUTIBEL
BUTISOL
C-RON FORTE
CAFERGOT
CAFERGOT P-B
CAL-NOR
CALADRYL
CALAMINE
CALAMINE LOTION
CALAN
CALCET
CALCIDRINE
CALCIFEROL
CALCIMAR
CALCITONIN
CALCITREL
CALCIUM
CALCIUM ACETATE
CALCIUM CARBONATE
CALCIUM LACTATE
CALCIUM-D
CALEL-D
CALORIC AGENT
40285
05543
05550
05570
05598
05600
05640
05645
05648
60290
41875
05663
05668
05675
05680
05690
40290
05750
05758
05760
05785
05788
05789
05810
05820
05870
05885
05895
05900
05903
05908
05955
05975
05983
05990
06005
06030
06050
06095
06100
06110
06120
06125
06128
06130
06133
06135
06170
06190
06210
06215
06225
06260
06265
CALTRATE
CALTRO
CAMA
CAMPHOR
CANTHARONE
CANTIL
CAPITAL W/CODEINE
CAPITROL
CAPOTEN
CAPOZIDE
CAPTOPRIL
CARAFATE
CARAMIPHEN W/PP
CARBACHOL
CARBAMAZEPINE
CARBENICILLIN
CARBODEC
CARDEC-DM
CARDIAC AGENT
CARDILATE
CARDIOQUIN
CARDIOVASCULAR AGENT
CARDIZEM
CARISOPRODOL
CARMOL
CASCARA SAGRADA
CASTOR OIL
CATAPRES
CATARASE
CATHARTIC AGENT
CDP PLUS
CECLOR
CEENU
CEFADROXIL
CEFOL
CELESTONE
CELONTIN
CENAFED
CENTRAX
CENTRUM
CEPACOL
CEPASTAT
CEPHALEXIN
CEPHALOSPORINS
CEPHALOTHIN
CEPHRADINE
CEPHULAC
CERUMENEX
CETAMIDE
CETAPHIL
CETAPRED
CETYL ALCOHOL
CHARCOAL
CHARCOCAPS
06275
06294
40335
06300
06374
40350
06400
06405
06415
06430
06440
06455
06465
06470
06495
06500
06503
06520
06535
06540
06555
06565
06570
06580
06590
06595
06605
60310
06620
06625
06645
06663
06665
06680
06695
06710
06720
06734
06745
06755
06780
06800
06815
06838
06839
06860
06865
60325
06905
06913
06920
06930
40410
06935
CHARCOTABS
CHEMOTHERAPY
CHEMSTRIP UGK
CHERACOL
CHILDREN'S TYLENOL
CHLOR-PRO
CHLOR-TRIMETON
CHLOR-TRIMETON DECONGESTANT
CHLOR-TRIMETON REPETAB
CHLORAFED
CHLORAL HYDRATE
CHLORAMBUCIL
CHLORAMPHENICOL
CHLORASEPTIC
CHLORDIAZEPOXIDE
CHLORDIAZEPOXIDE HCL W/CLIDINIUM BROM
CHLORDINIUM SALTS
CHLOROFON-F
CHLOROMYCETIN
CHLOROMYCETIN OTIC
CHLOROMYCETIN-HYDROCORTISONE
CHLOROPHYLL
CHLOROPTIC
CHLOROQUINE
CHLOROTHIAZIDE
CHLOROTHIAZIDE W/RESERPINE
CHLORPHENIRAMINE
CHLORPHENIRAMINE W/PHENYLPROPANOLAMIN
CHLORPRAMAZINE
CHLORPROPAMIDE
CHLORTHALIDONE
CHLORZOXAZONE W/ACETAMINOPHEN
CHLORZOXAZONE W/APAP
CHOLAN HMB
CHOLEDYL
CHOLESTYRAMINE RESIN DRIED
CHOLINE
CHOLINERGIC BLOCKING AGENT
CHOLOXIN
CHOREX
CHROMAGEN
CHRONULAC SYRUP
CIMETIDINE
CINOBAC PULVULE
CIPRO
CITRATE OF MAGNESIA
CITRIC ACID
CITRUCEL
CLEOCIN
CLEOCIN T
CLINDAMYCIN
CLINDEX
CLINITEST
CLINORIL
06940
06945
06968
06970
06975
06980
06985
06990
06993
07003
07010
60335
07015
60340
07067
07075
07180
07185
07190
07195
07200
07215
07250
07265
07270
07275
07280
07285
07293
07300
07313
07315
07330
07355
07405
07410
60355
07435
07465
07467
07470
07478
07480
07495
07528
07535
07543
07553
07560
04368
60370
07660
07665
07670
CLIPOXIDE
CLISTIN
CLODERM
CLOFIBRATE
CLOMID
CLONAZEPAM
CLONIDINE
CLONOPIN
CLORAZEPATE
CLOTRIMAZOLE
CLOXACILLIN
CLOXACILLIN
CLOXAPEN
CO-GESIC
CO-TRIMOXAZOLE
COAL TAR
CODEINE
CODEINE PHOSPHATE
CODEINE SULFATE
CODIMAL
CODIMAL DH SYRUP
CODIMAL L.A.
COGENTIN
COLACE
COLBENEMID
COLCHICINE
COLCHICUM
COLD CAPSULE
COLD RELIEF
COLD TABLET
COLDRINE
COLESTID
COLLYRIUM
COLREX
COLY-MYCIN
COLY-MYCIN S
COLYTE
COMBIPRES
COMHIST
COMPAL
COMPAZINE
COMPOUND W
COMTREX
CONAR
CONGESS
CONHIST
CONJUGATED ESTROGENS
CONSTANT-T
CONTAC
CONTRACEPTIVE AGENT
CORDARONE
CORDRAN
CORDRAN-N
CORGARD
07680
07740
07745
07755
07760
07770
07775
07778
07780
07795
07800
60385
07805
07820
40445
07888
07910
07913
07920
07930
07945
07960
07990
08015
08040
08060
08065
08090
08120
08130
08135
08140
08145
08150
40455
08160
08175
08180
08205
08230
08245
08280
08285
08345
08350
08355
08369
08385
08390
08397
08410
08420
08425
08440
CORICIDIN
CORRECTOL
CORT-DOME
CORTAID
CORTEF
CORTENEMA
CORTICAINE
CORTICOTROPIN
CORTIFOAM
CORTISONE
CORTISPORIN
CORTISPORIN OPHTHALMIC
CORTONE
CORTROSYN
CORZIDE
COTRIM
COTYLENOL
COUGH FORMULA
COUGH SYRUP
COUMADIN
COVANGESIC
CPA
CREAMALIN
CROMOLYN
CRYSTODIGIN
CUPRIMINE
CURRETAB
CYANOCOBALAMIN
CYCLANDELATE
CYCLAPEN
CYCLOCORT
CYCLOGYL
CYCLOMYDRIL
CYCLOPAR
CYCLOPENTOLATE
CYCLOSPASMOL
CYLERT
CYPROHEPTADINE
CYSTOSPAZ
CYTOMEL
CYTOXAN
D.S.S.
D.S.S. W/CASANTHRANOL
DACRIOSE
DAILY MULTIPLE VITAMIN
DAILY MULTIPLE VITAMIN W/IRON
DALCAINE
DALLERGY
DALMANE
DAMASON-P
DANOCRINE
DANTRIUM
DANTROLENE
DAPSONE
08445
08455
08460
08470
08475
08480
08490
08510
08535
08545
08565
08585
08590
08608
08605
08625
08635
08640
08660
08670
08680
08695
08700
08705
08730
08745
08753
08765
08770
08775
08780
08785
08795
08805
08810
08835
08836
08840
08860
08865
08870
08875
08880
08885
60400
40515
08905
08910
08915
08935
08918
08955
08960
08975
DARANIDE
DARBID
DARICON
DARVOCET-N
DARVON
DARVON COMPOUND
DARVON-N
DATRIL
DDAVP
DE CAL
DEBROX
DECADRON
DECADRON ELIXIR
DECADRON TURBINAIRE
DECADRON-LA
DECASPRAY
DECHOLIN
DECLOMYCIN
DECONAMINE
DECONGESTANT
DECONGESTANT ELIXIR
DECONGEX
DEGEST 2
DEHIST
DELATESTRYL
DELESTROGEN
DELSYM
DELTALIN
DELTASONE
DEMAZIN
DEMEROL
DEMEROL SYRUP
DEMI-REGROTON
DEMULEN
DEMULEN-28
DEPAKENE
DEPAKOTE
DEPEN
DEPO-ESTRADIOL
DEPO-MEDROL
DEPO-PROVERA
DEPO-TESTADIOL
DEPO-TESTOSTERONE
DEPOGEN
DEPONIT
DEPROIST W/CODEINE
DEPROL
DERFULE
DERIFIL
DERMA PH LOTION
DERMACAINE
DERMACORT
DERMAL RUB
DERMAVAL
09000
09010
09015
09020
09040
09045
09050
40520
09058
09060
60405
40525
09075
09080
09085
09088
60415
09110
09116
09117
35545
35550
09118
09120
09125
09170
09173
09175
09185
09190
09220
42245
40580
09250
09273
09290
09295
09305
09343
09352
09360
09365
09370
09385
09390
09395
09425
09433
09435
09445
09455
09460
09465
09470
DERMOPLAST
DESENEX
DESFERAL
DESIPRAMINE
DESOXYN
DESQUAM-X
DESQUAM-X WASH
DESYREL
DETUSS
DETUSSIN
DEXACIDIN
DEXAIR
DEXAMETHASONE
DEXAMETHASONE ACETATE
DEXAMETHASONE ELIXIR
DEXAMETHASONE OPHTH
DEXAMETHASONE/NEOMYCIN/POLYMIX
DEXAPED
DEXASPORIN OPHTHALMIC
DEXBROMPHENI/PSEUDOEPHED
DEXBROMPHENIRAMINE
DEXBROMPHENIRAMINE/D-ISOEPHED
DEXCHLORPHENIRAMINE
DEXEDRINE
DEXON
DEXTROAMPHETAMINE
DEXTROMETHORPHAN COUGH
DEXTROSE
DEXTROSTIX
DEZONE
DI-GEL
DI-GESIC
DIABETA
DIABINESE
DIAGARD
DIALOSE
DIALUME
DIAMOX
DIARAL
DIASORB
DIASTIX
DIATRIZOATE
DIAZEPAM
DIBENZYLINE
DIBUCAINE
DICAL-D
DICARBOSIL
DICLOXACILLIN
DICODID
DICUMAROL
DICYCLOMINE
DICYCLOMINE HCL W/PHENOBARBITAL
DIDREX
DIDRONEL
09475
09490
09495
09500
09535
09540
09545
09550
09555
09585
09590
40590
09593
09600
09625
09630
09635
09638
09640
09650
09660
09670
09675
09680
09690
09697
09710
09720
09730
09735
09770
09775
09823
09835
09838
09850
09840
09860
09875
40605
40610
09880
09890
09990
40615
09915
09920
09925
09935
09945
09955
60470
09970
09975
DIENESTROL
DIETHYL-PROPION
DIETHYLPROPION
DIETHYLSTILBESTROL
DIGITALIS
DIGITOXIN
DIGOXIN
DIHISTINE
DIHISTINE ELIXIR
DILANTIN
DILANTIN W/PHENOBARBITAL
DILATAIR
DILATRATE
DILAUDID
DILOR
DILOR-G
DIMACOL
DIMALIX
DIMENHYDRINATE
DIMENTABS
DIMETANE
DIMETANE EXPECTORANT
DIMETANE EXPECTORANT-DC
DIMETANE EXTENTAB
DIMETAPP
DIMOTAL
DIOCIO
DIOCIO SYRUP
DIOCTYL SODIUM SULFOSUCC W/CASANTHRAN
DIOCTYL SODIUM SULFOSUCCINATE
DIONIN
DIOSTATE D
DIPHENADRIL
DIPHENATOL
DIPHENCEN
DIPHENHYDRAMINE
DIPHENHYDRAMINE COMPOUND EXPECTORANT
DIPHENHYDRAMINE HCL ELIXIR
DIPHENHYDRAMINE HCL 22 GA
DIPHENOXY/ATROP
DIPHENOXYLATE
DIPHENOXYLATE HCL & ATROPINE SULFATE
DIPHENYLHYDANTOIN SODIUM
DIPHTHERIA TETANUS TOXOIDS PERTUSSIS
DIPROLENE
DIPROSONE
DIPYRIDAMOLE
DISALCID
DISIPAL
DISOLAN
DISOPHROL
DISOPYRAMIDE PHOSPHATE
DISPATABS
DISULFIRAM
09980
09995
10000
10005
10010
10015
10020
10025
10030
10040
10045
10087
10089
40625
10115
10126
10130
10140
10145
10150
10180
10200
10205
10210
10213
10215
10220
10230
10250
10255
60485
10273
10275
10285
10325
10330
10335
10340
10364
60500
10355
10358
10380
10440
10455
10485
10490
10518
10575
10605
10615
10620
10630
10650
DITAN
DITROPAN
DIUCARDIN
DIULO
DIUMEAD
DIUPRES
DIURETIC
DIURIL
DIUTENSEN
DM-PLUS COUGH SYRUP
DOAK OIL
DOCUSATE
DOCUSATE CALCIUM
DOCUSATE POTASSIUM
DOLENE
DOLOBID
DOLOPHINE
DOME-PASTE BANDAGE
DOMEBORO
DOMEBORO OTIC
DONATUSSIN
DONNAGEL
DONNAGEL-PG
DONNATAL
DONNATAL NO.2
DONNAZYME
DONPHEN
DOPAR
DORC0L PEDIATRIC COUGH SYRUP
DORIDEN
DORYX
DOSS COMPOUND PLUS
DOSS 300
DOVACET
DOXEPIN
DOXIDAN
DOXINATE
DOXY C
DOXY-TABS
DOXY-100
DOXYCYCLINE
DOXYLAMINE B-6
DRAMAMINE
DRISDOL
DRISTAN
DRIXORAL
DRIZE
DRYSOL
DULCOLAX
DUO-C.V.P.
DUO-K
DUO-MEDIHALER
DUOFILM
DUOLUBE
10675
10705
10755
10758
10760
10765
10800
10803
10805
10810
10815
10820
10835
10840
10845
10865
10875
10895
10905
10910
10925
10948
10949
10970
10975
10985
11005
11025
11045
11050
11065
11075
11095
11100
11120
11130
11140
11145
11150
11152
11190
11210
11230
11245
11250
11260
11265
11268
11325
11340
11345
11350
11372
11390
DUOVENT
DURACILLIN
DURAQUIN
DURASIL
DURATEARS
DURATEST
DURICEF
DURRAX
DUVOID
DV
DYAZIDE
DYCILL
DYMELOR
DYMENATE
DYNAPEN
DYRENIUM
E.E.S
E-FEROL
E-MYCIN
E-PILO
EAR DROPS
EASPRIN
EAZOL
ECONOPRED
ECOTRIN
EDECRIN
EFFERSYLLIUM
EFUDEX
ELASE
ELASE-CHLOROMYCETIN
ELAVIL
ELDEC
ELDERCAPS
ELDERTONIC ELIXIR
ELDOQUIN
ELECTROLYTE
ELIXOPHYLLIN
ELIXOPHYLLIN S.R.
ELIXOPHYLLIN-KI
ELOCON
EMETROL
EMPIRIN
EMPIRIN COMPOUND #3
EMPIRIN NO. #2
EMPIRIN NO. #3
EMPIRIN W/CODEINE
EMPRACET
EMPRACET W/CODEINE
ENDEP
ENDURON
ENDURONYL
ENDURONYL FORTE
ENKAID
ENSURE
11395
11400
11433
11450
11525
11530
11540
11548
11555
11580
11585
11616
11635
11640
11645
11658
11651
60535
11653
40725
11655
11657
11668
11660
11665
11688
11690
11695
11700
11725
11740
60545
11745
11760
11765
11770
11800
11815
11845
11850
11855
11860
11865
11870
11920
11945
11960
11965
11975
11980
12035
11978
12050
12055
ENTEX
ENTOZYME
ENZYME
EPHEDRINE
EPIFRIN
EPINAL
EPINEPHRINE
EPIPEN
EPPY
EQUAGESIC
EQUANIL
ERGOLOID MESYLATES
ERGOSTAT
ERGOTAMINE
ERGOTRATE
ERY-TAB
ERYC
ERYCETTE
ERYDERM
ERYMAX
ERYPAR
ERYPED
ERYTHRO-RX
ERYTHROCIN
ERYTHROMYCIN
ESGIC
ESIDRIX
ESIMIL
ESKALITH
ESTINYL
ESTRACE
ESTRADERM
ESTRADIOL
ESTRATAB
ESTRATEST
ESTRAVAL
ESTROGEN
ESTRONE
ESTROVIS
ETHAMBUTOL
ETHAMIDE
ETHAQUIN
ETHATAB
ETHAVERINE HCL
ETRAFON
EUCERIN
EURAX
EUTHROID
EUTRON
EVAC-Q-KIT
EXCEDRIN
EXPECTORANT
EXSEL LOTION
EXTENDRYL
60550
12078
50025
12134
12140
12150
12160
12193
12225
60560
12235
12255
12260
12275
12285
12290
12300
12305
12310
12340
12345
12350
12410
60575
12415
12430
12465
12480
12490
60590
12510
12515
12523
12525
12530
12535
12540
12545
60595
12550
12565
12570
12585
12620
12635
12663
12665
12670
12690
12695
12730
12735
12740
12750
EYE DROPS
EYE PREPARATION
FAMILY TABS WITH IRON
FANSIDAR
FASTIN
FEBRINOL
FEDAHIST
FELDENE
FEMIRON
FEMSTAT
FENDOL
FEOSOL
FEOSOL ELIXIR
FEOSTAT
FER-IN-SOL
FERANCEE
FERGON
FERGON ELIXIR
FERGON PLUS
FERO-FOLIC-500
FERO-GRAD-500
FERO-GRADUMET
FERRO
FERRO BC
FERRO-SEQUEL
FERROLIP
FERROUS FUMARATE
FERROUS GLUCONATE
FERROUS SULATE
FERROUS-DS
FESTAL
FESTALAN
FIBERMED
FILIBON
FILIBON F.A.
FILIBON FORTE
FILIBON OT
FIOGESIC
FIORICET
FIORINAL
FIORINAL NO. 3
FIORINAL W/CODEINE
FLAGYL
FLEET ENEMA
FLEXERIL
FLORICAL
FLORINEF
FLORONE
FLUOCINOLONE
FLUOGEN
FLUORI-METHANE SPRAY
FLUORIDE
FLUORIDENT
FLUORINSE
12755
12763
12765
12780
12785
12805
12810
12825
12845
42380
40755
12865
12880
12905
12920
12940
12945
12955
12963
40760
12970
12975
12995
13045
13085
13096
13100
13105
13118
13120
13153
13170
13195
13200
13205
13208
13209
13220
13245
13295
13300
13310
40775
60635
13320
60640
13325
13350
13390
13440
13455
13465
13495
13530
FLUORITAB
FLUOROMETHOLONE
FLUOROPLEX
FLUPHENAZINE
FLURA-DROPS
FLURA-VITE
FLURAZEPAM
FLUROSYN
FML LIQUIFILM
FML-FORTE OPHTHALMIC
FOLEX
FOLIC ACID
FOLVITE
FORCOLD SYRUP
FORMALIN
FORMULA 2
FORMULA 44 COUGH MIXTURE
FORMULA 44-D COUGH MIXTURE
FORTA
FORTABS
FORTESPAN
FOSFREE
FOSTRIL
FULVICIN
FUNGIZONE
FUNGOID
FURACIN
FURADANTIN
FUROSEMIDE
FUROXONE
GALLBLADDER MEDICATION
GAMMAR
GANTANOL
GANTRISIN
GARAMYCIN
GARGLE
GASTRIC AGENT
GAVISCON
GEL-KAM
GELUSIL
GEMONIL
GENOPTIC
GENTACIDIN
GENTAFAIR
GENTAMICIN
GENTAMICIN OPHTHALMIC
GENTIAN VIOLET
GEOCILLIN
GERIATRIC ELIXIR
GERIPLEX
GERITOL
GERIX ELIXIR
GEVRABON
GLAUCON
13550
13553
13585
13595
60665
41820
13640
13675
13705
13715
13750
13752
42425
13775
13780
13785
13790
13795
13800
13825
13818
13835
13830
13838
13845
13850
13865
13875
13880
13885
13890
13895
13930
40785
13955
13980
13995
13999
14000
14005
14035
60675
14040
14045
14050
14135
14180
14190
14195
14203
14240
14275
14279
14320
GLUCOSE
GLUCOTROL
GLUTOL
GLY-OXIDE
GLYCERIN
GLYCERIN SUPPOSITORIES
GLYCINE
GLYCOTUSS
GLYDEINE SYRUP
GLYESTRIN
GOLD SODIUM THIOSULFATE
GOLYTELY
GOLYTELY
GRANULEX
GREEN SOAP
GRIFULVIN
GRIS-PEG
GRISACTIN
GRISEOFULVIN
GUAIATRATE SYRUP
GUAIFED
GUAIFENESIN
GUAIFENESIN & DEXTROMETHORPHAN HBR
GUAIFENESIN W/CODEINE
GUANETHIDINE
GUANIDINE
GUIATEX
GUIATUSS
GUIATUSS A.C. SYRUP
GUIATUSSIN
GUIATUSSIN W/CODEINE
GUIATUSSIN W/DEXTROMETHORPHAN
GYNE-LOTRIMIN
H.E.A.
H.H.R.
H-H
HALAZONE
HALCION
HALDOL
HALDRONE
HALOG
HALOG-E
HALOPERIDOL
HALOTESTIN
HALOTEX
HEMATINIC
HEMORRHOIDAL
HEMORRHOIDAL HC
HEMORRHOIDAL SUPPOSITORY
HEMOSTATIC AGENT
HEPARIN
HEPRON
HEPTAVAX-B
HEXACHLOROPHENE
14340
14370
14378
14425
14440
14489
14500
14505
14510
14515
14535
14545
14550
14595
14625
14645
14683
14713
14717
14720
14725
14727
41895
14770
14768
14790
14795
14805
60710
14820
14840
14855
14860
14870
14875
14895
14900
14888
14905
14917
40845
14935
14945
14955
14960
14903
14965
14980
14985
40850
14990
15002
15010
15020
HEXADROL
HEXAVITAMIN
HHR
HIGH POTENCY B-VITAMINS W/C NEO-VADRI
HIPREX
HISTAFED C
HISTALET
HISTALET FORTE
HISTALET SYRUP
HISTALET X
HISTAMINE
HISTASPAN
HISTASPAN-D
HISTOPLASMIN DILUTED SOLUTION
HMS
HOMATROPINE
HORMONE
HUMAN CHORIONIC GONADOTROPIN
HUMATROPE
HUMIST SPRAY
HUMORSOL
HUMULIN
HUMULIN INSULIN
HYCODAN
HYCODAPHEN
HYCOFF
HYCOMINE
HYCOTUSS
HYDEGINE LIQUID CAPSULE
HYDERGINE
HYDRALAZINE
HYDRALAZINE-HYDROCHLOROTHIAZIDE-RESER
HYDRAMINE
HYDRATE
HYDREA
HYDRO-CHLOR
HYDRO-CHLORO-THIAZIDE
HYDRO-ERGOT
HYDRO-RESERPINE
HYDROCET
HYDROCHLOR/RESERPINE/HYDRAL
HYDROCHLOROTHIAZIDE W/RESERPINE
HYDROCIL
HYDROCOCONE
HYDROCODONE SYRUP
HYDROCORT
HYDROCORTISONE
HYDROCORTONE
HYDRODIURIL
HYDROFLUMETHAZIDE
HYDROGEN PEROXIDE
HYDROMINE
HYDROMOX
HYDROPHED
15025
15035
15043
15045
15058
15070
15100
15095
15105
15115
15138
41840
15160
15238
15240
15243
15285
15305
15307
15320
15370
15375
15380
15395
15455
15460
15475
60730
15490
15495
15515
15520
15545
15555
15570
15575
15580
15590
15600
15615
15630
15678
15680
15685
15710
15727
15728
15730
15755
15760
15773
15780
60750
60755
HYDROPHILIC OINTMENT
HYDROPRES
HYDROSERP
HYDROSERPINE
HYDROXACEN
HYDROXYCHLOROQUINE
HYDROXYZINE
HYDROXYXINE COMPOUND SYRUP
HYDROXYZINE PAMOATE
HYGROTON
HYLOREL
HYOSCINE
HYOSOPHEN
HYPNOTIC AGENT
HYPOTEARS
HYPOTENSIVE AGENT
HYTAKEROL
HYTONE
HYTRIN
HYZINE
IBERET
IBERET-FOLIC-500
IBERET-500
IBUPROFEN
ICY HOT ANALGESIC BALM
IDENAL
ILETIN
ILETIN II
ILOSONE
ILOTYCIN
IMFERON
IMIPRAMINE
IMODIUM
IMURAN
INCREMIN W/IRON
INDERAL
INDERIDE
INDOCIN
INDOMETHACIN
INFLAMASE
INH
INSULATARD NPH
INSULIN
INTAL
INULIN
IODINATED GLYCEROL W/CODEINE
IODINATED GLYCEROL W/DM
IODINE
IODOCHLOR W/HYDROCORTISONE
IODOCHLORHYDROXYQUIN
IODOFORM
IONAMIN
IOPHEN
IOPHEN DM
15798
15865
15870
15885
15920
15930
15945
15955
15960
15965
15980
15985
15990
16003
16025
40905
16035
16040
16045
16050
16055
16070
16075
16095
16105
16115
16130
16140
60775
16210
41915
16215
16220
16222
16245
16268
16310
16315
16325
16340
16360
16365
16380
16385
16390
16415
16455
41850
16472
16475
16480
16482
16485
16490
IOPHEN-C
IRON & B COMPLEX PLUS
IRON PREPARATION
IRON W/VITAMIN C
ISMELIN
ISO-BID
ISOCLOR
ISOCLOR TIMESULE
ISODINE
ISOETHARINE
ISOLLYL
ISOLYTE
ISONIAZID
ISOPHANE INSULIN SUSPENSION
ISOPROTERENOL
ISOPTIN
ISOPTO ATROPINE
ISOPTO CARBACHOL
ISOPTO CARPINE
ISOPTO CETAMIDE
ISOPTO CETAPRED
ISOPTO HOMATROPINE
ISOPTO HYOSCINE
ISORDIL
ISOSORBIDE
ISOXSUPRINE
ISUPREL
ISUPREL HCL MISTOMETER
K-DUR
K-LOR
K-LYTE
K-LYTE DS
K-LYTE/CL
K-NORM
K-PHOS
K-TAB
KANTREX
KANULASE
KAOCHLOR
KAOLIN & PECTIN
KAON
KAOPECTATE
KAPECTOLIN
KAPECTOLIN PG
KAPECTOLIN W/BELLADONNA
KARIDIUM
KAYEXALATE
KCL
KEFLET
KEFLEX
KEFLIN
KEFTAB
KEFZOL
KELEX
16495
16500
16505
16520
16525
16595
16635
16640
60790
16710
16720
16725
16728
16750
16765
16780
16785
16800
50030
16845
16865
16870
16895
40908
41890
16905
60795
16915
16923
16940
16950
16955
60805
16975
17055
17070
17113
17115
17130
17145
17150
17160
17165
17243
17265
17270
17275
17304
17325
17322
60815
17340
17365
17370
KEMADRIN
KENACORT
KENALOG
KERALYT
KERI
KETO-DIASTIX
KIE
KINESED
KLONOPIN
KLOR-CON
KLORVESS
KLORVESS EFFERVESCENT GRANULE
KLOTRIX
KOLYUM
KOMED
KONAKION
KONDREMUL
KONSYL
KRONOFED-A
KU-ZYME
KUTRASE
KWELL
L-THYROXINE
L-TRYPTOPHANE
L/DOPA
LABID
LACHYDRIN
LACRI-LUBE
LACRISERT OPHTH
LACTIC ACID
LACTINEX
LACTOBACILLUS ACIDOPHILUS
LACTRASE
LACTULOSE
LANIAZID
LANOLIN
LANOXICAPS
LANOXIN
LANVISONE
LARODOPA
LAROTID
LASAN
LASIX
LAXATIVE
LECITHIN
LEDERCILLIN VK
LEDERPLEX
LENTE INSULIN SUSPENSION
LEUKERAN
LEUKOVORIN CALCIUM
LEVLEN
LEVO-DROMORAN
LEVOTHROID
LEVOTHYROXINE
17375
17380
17390
17395
17410
17440
17445
17450
17475
17485
17530
17540
17548
17560
17595
17600
17630
17668
17670
17680
17715
17725
17730
17735
17765
17820
17825
17834
17840
17860
17865
17870
17875
17878
17880
17883
17885
40950
17889
17888
17890
17925
60835
17930
17945
40955
17975
17978
17980
17990
18000
18010
60845
18020
LEVSIN
LEVSIN-PB DROPS
LEVSINEX
LEVSINEX/PHENOBARBITAL
LEXOR
LIBRAX
LIBRITABS
LIBRIUM
LIDEX
LIDOCAINE
LIMBITROL
LINCOCIN
LINDANE
LIORESAL
LIPODERM
LIPOFLAVONOID
LIPOTRIAD
LIQUID PRED
LIQUIFILM
LIQUIPRIN
LITHIUM
LITHOBID
LITHONATE
LITHOTABS
LIVITAMIN
LO-TUSSIN SYRUP
LO/OVRAL
LOCOID
LOESTRIN
LOMANATE
LOMOTIL
LONALAC
LONITEN
LONOX
LOPERAMIDE
LOPID
LOPRESSOR
LOPROX
LOPURIN
LORAZEPAM
LORELCO
LOTRIMIN
LOTRISONE
LOTUSATE
LOXITANE
LOZOL
LUBRIDERM
LUDIOMIL
LUFA
LUFYLLIN
LUFYLLIN-GG
LUGOL'S SOLUTION
LURIDE
LURIDE DROPS
18050
18070
18125
18130
18159
18195
18200
18215
18221
18315
18365
18375
18440
18445
18480
18490
18515
18518
35555
18520
60875
18523
18781
18550
18552
18553
18555
18556
18558
18595
60880
18610
18620
60885
60890
18635
18640
18643
18655
40975
18664
18665
18670
18685
18695
18698
18735
18745
18755
18760
18775
18795
18798
18800
LYSINE
LYTREN
MAALOX
MACRODANTIN
MAGNACAL
MAGNESIUM CITRATE
MAGNESIUM GLUCONATE
MAGNESIUM SULFATE
MAGNESIUM/ALUMINUM HYDROXIDE
MANDELAMINE
MANTADIL
MARAX
MARNAL
MARPLAN
MATERNA
MATULANE
MAXIDEX
MAXIFLOR
MAXIMUM STRENGTH ASPIRIN
MAXITROL
MAXIVATE
MAXZIDE
ME-PREDNISOLONE
MEBARAL
MEBENDAZOLE
MECLAN
MECLIZINE
MECLOFENAMATE SODIUM
MECLOMEN
MEDIATRIC
MEDICATED PADS
MEDICONE DRESSING
MEDIHALER-EPI
MEDIPLAST PLASTERS
MEDIPREN
MEDRALONE
MEDROL
MEDROXYPROGESTERONE
MEGACE
MEGATON
MELANEX
MELFIAT
MELLARIL
MELPHALAN
MENEST
MENI-D
MENRIUM
MENTHOL
MEPERGAN
MEPERIDINE
MEPHYTON
MEPROBAMATE
MEPROGESIC
MEPROSPAN
18820
60895
18900
18910
18915
18920
18925
18930
18935
18940
18945
18960
18965
18985
19035
19045
19070
19090
19100
19118
19140
19155
60905
19175
19178
19180
19185
19200
19205
19208
19210
19218
19230
19231
60915
19233
19234
19242
60920
40990
19270
19280
19290
19305
19313
50035
19320
19337
19343
19360
19375
19405
19415
19445
MERCAPTOPURINE
MERITAL
MERTHIOLATE
MERVALDIN
MESANTOIN
MESTINON
METAHYDRIN
METAMUCIL
METANDREN
METAPREL
METAPROTERENOL
METAJENSIN
METH
METHADONE
METHENAMINE
METHERGINE
METHOCARBAMOL
METHOTREXATE
METHOXANOL
METHYCLOTHIAZIDE
METHYLCELLULOSE
METHYLDOPA
METHYLDOPA W/HCTZ
METHYLPHENIDATE
METHYLPRED-40
METHYLPREDNISOLONE
METHYLTESTOSTERONE
METICORTEN
METIMYD
METOCLOPRAMIDE
METOLAZONE
METOPROLOL
METRETON
METRO
METRODIN
METRONIDAZOLE
METRYL
MEVACOR
MEXITIL
MG-AL HYDROX W/SIMETH
MI-CEBRIN
MICATIN
MICONAZOLE
MICRIN PLUS
MICRO-K EXTENCAPS
MICRONASE
MICRONOR
MICROX
MIDAMOR
MIDRIN
MILK OF MAGNESIA
MILPATH
MILTOWN
MINERAL OIL
19455
42705
60925
60930
19460
19465
19478
19490
19553
19568
19595
19600
19605
19610
19618
19625
19633
19635
42720
19644
19648
19650
19675
19698
19710
19715
19735
19780
19795
19835
19853
19925
60955
41135
19948
19995
20000
20010
20035
20045
20055
20060
20065
20070
20075
20080
20095
20105
20110
20135
20140
20153
60985
41145
MINIPRESS
MINIZIDE
MINIZIDE 1
MINIZIDE 2
MINOCIN
MINOCYCLINE
MINOXIDIL
MINTEZOL
MITROLAN
MIXTARD
MODANE
MODERIL
MODICON
MODICUM
MODURETIC
MOL-IRON
MOMENTUM
MONISTAT
MONISTAT-DERM
MONO-GESIC
MONOTARD
MORPHINE
MOTRIN
MOXAM
MUCILOSE
MUCOMYST
MUDRANE
MULTI-VI-FLOR DROPS
MULTICEBRIN
MULTIPLE VITAMINS W/MINERALS
MULTIVITAMIN/FLUORIDE
MURINE
MURO TEARS
MURO'S OPCON-A
MUSCLE RELAXANT
MYADEC
MYAMBUTOL
MYCELEX
MYCITRACIN
MYCO TRIACET
MYCOLOG
MYCOSTATIN
MYDFRIN
MYDRAPRED
MYDRIACYL
MYLANTA
MYLICON
MYOCHRYSINE
MYOFLEX
MYSOLINE
MYSTECLIN F
MYTREX
NA SAL
NAFAZAIR
20190
20195
20200
20210
20215
20220
20255
20260
20270
20285
20290
20300
20315
20320
20325
41150
20338
20360
20365
20370
20385
20390
20395
20415
20420
20435
20440
20490
20505
20530
20555
20580
20585
20595
20655
61015
20688
20690
20730
42780
20760
20770
20795
20798
20805
20818
20835
20855
20885
20890
20935
20945
20950
20960
NALDECON
NALDEGESIC
NALDELATE SYRUP
NALFON
NALIDIXIC ACID
NAMIDE
NAPHAZOLINE
NAPHCON
NAPHCON-A
NAPROSYN
NAPROXEN
NAQUA
NARDIL
NASAHIST
NASAL DECONGESTANT
NASALCROM
NASALIDE
NATABEC
NATABEC RX
NATABEC W/FLUORIDE
NATAFORT
NATALINS
NATALINS RX
NATURETIN
NATURETIN W/K
NAVANE
NAZAC DECONGESTANT
NEGGRAM
NEMBUTAL
NEO-CORTEF
NEO-MEDROL
NEO-POLYCIN
NEO-SYNALAR
NEO-SYNEPHRINE
NEODECADRON
NEODEXAIR
NEOM/POLY M GRAMICIDIN OPHTH
NEOMYCIN
NEOSPORIN
NEOSPORIN OPHTHALMIC
NEOTHYLLINE
NEOTRIZINE
NEPHRAMINE
NEPHROCAPS
NEPTAZANE
NETROMYCIN
NEUTRA-PHOS
NEUTROGENA
NIACIN
NIACINAMIDE
NICO-SPAN
NICO-400
NICOBID
NICOLAR
61025
20970
20980
21010
21065
21125
21130
21143
21144
21145
61030
21155
21160
21165
21170
21175
21185
61035
21203
21205
21213
21215
21220
21225
21228
21280
21290
21300
21330
21335
21340
42800
21373
61040
21385
21390
21400
21403
61620
21405
21425
21430
21440
21445
21450
21455
21460
21465
21500
61045
41855
21530
21535
41205
NICORETTE
NICOTINAMIDE
NICOTINIC ACID
NIFEREX
NILSTAT
NITRO T.D.
NITRO-BID
NITRO-DUR
NITRODISC
NITROFURANTOIN
NITROGARD
NITROGEN
NITROGLYCERIN
NITROGLYN
NITROL
NITROLIN
NITROSTAT
NIX
NIZORAL
NOCTEC
NOLAHIST
NOLAMINE
NOLUDAR
NOLVADEX
NORDETTE
NORFLEX
NORGESIC
NORINYL
NORLESTRIN
NORLUTATE
NORLUTIN
NORMAL SALINE
NORMODYNE
NOROXIN
NOROXINE
NORPACE
NORPRAMIN
NORTRIPTYLINE
NORWICH ASPIRIN
NOSE DROPS
NOVAFED
NOVAFED A
NOVAHISTINE
NOVAHISTINE COUGH FORMULA
NOVAHISTINE DH
NOVAHISTINE DMX
NOVAHISTINE ELIXIR
NOVAHISTINE EXPECTORANT
NOVOCAIN
NOVOLIN
NPH INSULIN
NU-IRON
NU-IRON ELIXIR
NU-TEARS
21550
21555
21585
21590
61060
21605
21650
21670
21695
21700
21701
21698
21703
21750
21752
42835
61070
21754
41210
61075
21755
21765
21795
21802
21850
21855
21893
21900
21920
21930
21970
21995
22005
22015
22030
22055
22060
22065
22080
22090
22095
61100
22110
22120
22125
22170
41220
22180
22185
22195
22200
22210
22215
22220
NUBAIN
NUCOFED
NUPERCAINAL
NUPERCAINE
NUPRIN
NUTRACORT
NYLIDRIN
NYQUIL
NYSTATIN
NYSTATIN VAGINAL TABLET
NYSTATIN W/TRIAMCINOLONE
NYSTATIN/NEO/GRAMICD/TRIAMCIN
NYSTEX
OCEAN MIST
OCTAMIDE
OCTICAIR
OCTICAIR SOLUTION
OCUFEN
OCUGESTRIN
OCUMYCIN
OCUSOL
OGEN
OMNIPEN
ONE-A-DAY-ESSENTIAL
OPHTHOCHLOR
OPHTHOCORT
OPTICROM
OPTIMINE
ORABASE HCA PASTE
ORABASE W/BENZOCAINE PASTE
ORASONE
ORETIC
ORETON
ORGANIDIN
ORINASE
ORNADE
ORNEX
ORPHENADRINE
ORTHO-CREME
ORTHO-NOVUM
ORTHOXICOL
ORUDIS
OS-CAL
OS-CAL 500
OS-CAL-FORTE
OTIC-HC
OTICAIR
OTOBIOTIC
OTOCORT
OTOREID-HC
OTRIVIN
OVCON
OVRAL
OVRETTE
22225
22233
22242
22270
22273
22303
22305
22306
22308
22315
22323
22338
22340
22348
22350
61125
22410
22435
22470
61130
22490
22520
22578
22630
22635
22640
22670
22675
22690
22695
22730
22770
22805
22810
22840
22845
22860
22875
22885
22890
22910
22935
22945
22965
22975
23006
23010
23015
23045
23047
23803
61135
23100
23115
OVULEN
OXACILLIN
OXAZEPAM
OXSORALEN
OXTRIPHYLLINE
OXYCODONE HCL
OXYCODONE HCL & ACETAMINOPHEN
OXYCODONE W/APAP
OXYCODONE W/ASPIRIN
OXYGEN
OXYMETAZOLINE HCL
OXYSTAT
OXYTETRACYCLINE
OYSCO 500
OYSTER SHELL & VITAMIN D
P-A-C
P-A-C COMPOUND
P-V TUSSIN
PABALATE
PAIN RELIEVER
PAIN RELIEVER-E
PAMELOR
PANADOL
PANCREASE
PANCREATIC HORMONE
PANCREATIN
PANMYCIN
PANOXYL
PANTERIC
PANTHODERM
PANTOTHENOL (D) ALCOHOL
PAPAVERINE
PARAFLEX
PARAFON FORTE
PAREDRINE W/BORIC ACID
PAREGORIC
PAREPECTOLIN
PARLODEL
PARNATE
PARSIDOL
PATHIBAMATE
PATHOCIL
PAVABID
PAVAGEN
PAVARINE
PAXIPAM
PAZO HEMORRHOID
PBZ
PBZ-SR
PCE
PEDI-CORT V
PEDIACARE
PEDIACOF
PEDIAFLOR DROPS
23120
23125
61140
23140
23150
23158
23170
23185
23200
23210
23215
23220
23225
23228
23230
61145
23250
23285
23305
23315
61160
23370
23385
23390
23400
23415
23425
23430
23435
23440
23450
23490
23523
23524
23525
23535
23550
23560
23570
23610
23630
23645
23660
23670
23675
23680
23695
23700
23710
23715
23755
23760
23765
23770
PEDIALYTE
PEDIAMYCIN
PEDIAPRED
PEDIATROL
PEDIAZOLE
PEDICULICIDE
PEGANONE
PEN-VEE, K
PENAPAR VK
PENICILLAMINE
PENICILLIN
PENICILLIN G
PENICILLIN V
PENICILLIN V POTASSIUM
PENICILLIN VK
PENNTUSS
PENTAERYTHRITOL
PENTAZOCINE
PENTIDS
PENTOTHAL
PEPCID
PEPTO-BISMOL
PERCOCET-5
PERCODAN
PERCOGESIC
PERDIEM GRANULE
PERGONAL
PERI-COLACE
PERI-DOSS
PERIACTIN
PERIDIN-C
PERITRATE
PERPHENAZINE
PERPHENAZINE W/AMITRIPTYLINE
PERSA-GEL
PERSANTINE
PERTOFRANE
PERTUSSIN
PETRO-PHYLIC SOAP
PHAZYME
PHEDRAL
PHEN-DIMETRAZINE
PHENAPHEN
PHENAPHEN NO. 3
PHENAPHEN NO. 4
PHENAPHEN W/CODEINE
PHENATAPP ELIXIR
PHENATE
PHENAZODINE
PHENAZOPYRIDINE
PHENERGAN
PHENERGAN COMPOUND
PHENERGAN EXPECTORANT PLAIN
PHENERGAN EXPECTORANT W/CODEINE
23775
23780
23785
23790
23795
23823
23825
23845
23855
23870
23970
24005
24015
24018
24025
41280
24033
24045
24075
24080
24100
24120
24125
24130
61180
24140
24190
24195
41295
24280
24285
24300
24340
24395
24400
24410
24478
24415
24418
24420
24435
24465
24470
24510
24515
24525
24545
24550
24590
24595
24650
24695
24710
24765
PHENERGAN EXPECTORANT W/DEXTROMETHORP
PHENERGAN SYRUP
PHENERGAN VC EXPECTORANT PLAIN
PHENERGAN VC EXPECTORANT W/CODEINE
PHENERGAN-D
PHENHIST
PHENHIST DH W/CODEINE
PHENOBARBITAL
PHENOBARBITAL & BELLADONNA
PHENOBARBITAL ELIXIR
PHENTERMINE
PHENYLBUATZONE
PHENYLEPHRINE
PHENYLHISTINE DH
PHENYLPROPANOLAMINE
PHENYLPROPANOLAMINE W/CPM
PHENYLPROPYLAMIN/GUAIFENESIN
PHENYTOIN
PHISODERM
PHISOHEX
PHOS-FLUR
PHOSPHATE ENEMA
PHOSPHO-SODA
PHOSPHOLINE
PHOSPHOLINE IODIDE
PHRENILIN
PILOCAR
PILOCARPINE
PILOKAIR
PLACEBO
PLACIDYL
PLAQUENIL
PLEGINE
POISON IVY SPRAY
POLARAMINE
POLLEN ANTIGEN
POLY-PRED
POLY-VI-FLOR
POLY-VI-FLOR W/IRON
POLY-VI-SOL
POLYCILLIN
POLYMOX
POLYMYXIN
POLYSPORIN
POLYTAR
POLYVITAMIN
PONDIMIN
PONSTEL
POT CHLOR
POTABA
POTASSIUM
POTASSIUM GLUCONATE
POTASSIUM IODIDE
POVIDONE
61205
24770
24780
24785
24790
24795
24804
24805
24830
24850
24855
41345
24885
24890
24910
24925
24945
24950
24960
24965
24975
24980
24985
24988
24995
25015
25025
25033
25040
25055
25065
25100
25115
25140
25150
25155
25180
25185
25195
25200
25213
25220
25240
25250
25255
25305
25330
25335
25338
25358
25359
25365
25375
25380
POVIDON-IODINE
POXY COMPOUND-65
PRAGMATAR
PRAMET FA
PRAMILET FA
PRAMOSONE
PRAZEPAM
PRAZOSIN
PRE-NATAL VITAMINS
PRED FORTE
PRED MILD
PREDAIR
PREDNISOLONE
PREDNISONE
PREFRIN
PREGNYL
PRELUDIN
PREMARIN
PREMARIN VAGINAL
PREMARIN W/METHYLTESTOSTERONE
PRENATAL FORMULA (VITAMINS)
PRENATAL STUART
PRENATAL W/FOLIC ACID
PRENATAL W/FOLIC ACID & IRON
PREPARATION H
PRESALIN
PRESUN
PREVIDENT LIME
PRIMATENE MIST
PRIMIDONE
PRINCIPEN
PRO-BANTHINE
PRO-PHEN
PROBEN-C
PROBENECID
PROBENECID W/COLCHICINE
PROCAINAMIDE
PROCAINE
PROCAMIDE
PROCAN SR
PROCARDIA
PROCHLORPERAZINE
PROCTOCORT
PROCTOFOAM
PROCTOFOAM-HC
PROGESTERONE
PROLIXIN
PROLOID
PROLOPRIM
PROMETH
PROMETH W/COD
PROMETHAZINE
PROMETHAZINE COMPOUND W/CODEINE
PROMETHAZINE EXPECTORANT
25385
25390
25400
25405
25410
25420
25430
25455
61240
25463
25470
25475
25493
25495
25510
25505
25515
25530
25545
42985
61245
25550
25560
25570
25575
41380
25618
25635
25638
25640
25660
25691
41928
25695
25696
61260
41830
41845
35575
35576
25750
25775
25800
25805
25810
25815
25825
25875
25880
25890
25900
25930
25945
25965
PROMETHAZINE EXPECTORANT DM PEDIATRIC
PROMETHAZINE EXPECTORANT W/CODEINE
PROMETHAZINE HCL EXPECTORANT W/CODEINE
PROMETHAZINE HCL SYRUP
PROMETHAZINE HCL VC EXPECTORANT
PROMETHAZINE HCL W/DEXTROMETHORPHAN
PROMETHAZINE VC W/CODEINE
PRONESTYL
PROPACET
PROPAGEST
PROPANOLOL
PROPANTHELINE
PROPINE
PROPION GEL
PROPOXYPHENE
PROPOXYPHENE COMPOUND 65
PROPOXYPHENE HCL COMPOUND
PROPOXYPHENE HCL W/ACETAMINOPHEN
PROPOXYPHENE W/APAP
PROPRANOLOL
PROPRANOLOL HCL
PROPYLENE GLYCOL
PROPYLTHIOURACIL
PROSOBEE
PROSTAPHLIN
PROTAMINE ZINC INSULIN
PROTOSTAT
PROVAL
PROVENTIL
PROVERA
PROXENE
PSEUDO-CAR DM
PSEUDOEPHED/CABINOXAMINE/DM
PSEUDOEPHEDRINE
PSEUDOEPHEDRINE W/TRIPROLIDINE
PSORCON
PSYLLIUM
PTU
PURIFIED BEEF INSULIN
PURIFIED PORK INSULIN
PURINETHOL
PYOCIDIN
PYRAZINAMIDE
PYRIDIATE
PYRIDIUM
PYRIDIUM PLUS
PYRIDOXINE
PYRROXATE
PYRROXATE Q/CODEINE PHOSPHATE
P2E1
P4E1
QUADRINAL
QUARZAN
QUESTRAN
41385
25970
25975
25980
26015
26020
41390
26025
26030
26035
41395
26040
26045
26055
26073
26090
26135
26170
26185
26190
26240
26255
26260
26265
26275
26287
26300
26305
26320
26325
26335
26340
26425
26428
41400
41405
26438
61285
26440
26445
26453
26465
26475
26495
26565
26665
26695
61290
26705
26710
26715
26720
26740
26750
QUIAGEL PG
QUIBRON
QUIBRON BIDCAP
QUIBRON ELIXIR
QUINAGLUTE
QUINAMM
QUINATIME
QUINE
QUINIDEX EXTENTAB
QUINIDINE
QUINIDINE GLUCONATE
QUINDINE SULFATE
QUININE SULFATE
QUINOLOR COMPOUND
QUIPHILE
RABIES VACCINE
RAUDIXIN
RAUTRAX
RAUWOLFIA
RAUZIDE
REDISOL
REGLAN
REGONOL
REGROTON
REGUL-AIDS
REHYDRALYTE
RELA
RELAXADON
RENACIDIN
RENALGIN
RENESE
RENESE-R
RESERPINE
RESERPINE/HYDRALAZINE/HCTZ
RESICORT HYDROCORTISONE
RESPAIRE
RESPBID
RESPINOL LA
RESPINOL-G
RESPIROL
RESTORIL
RETICULEX
RETIN-A
RHEABAN
RHINIDRIN
RHUS TOX ANTIGEN
RID
RIDAURA
RIFADIN
RIFAMATE
RIFAMPIN
RIMACTANE
RIOPAN
RIOPAN PLUS
26760
26761
26785
26790
26795
26800
26805
26825
26830
26835
26840
26845
26850
26855
26860
26865
26870
61295
61300
26885
26890
26905
26930
26935
26940
26945
41420
27045
27050
27060
27065
27080
27085
27103
27130
27175
27180
27190
27195
27210
27225
27320
27335
27340
27345
27368
27415
27420
27423
61315
27435
27440
27459
27498
RITALIN
RITODRINE
ROBAXIN
ROBAXISAL
ROBICILLIN VK
ROBIMYCIN
ROBINUL
ROBITET
ROBITUSSIN
ROBITUSSIN A-C SYRUP
RUBITUSSIN-CF
ROBITUSSIN-CF SYRUP
ROBITUSSIN-DAC SYRUP
ROBITUSSIN-DM COUGH CALMERS
ROBITUSSIN-DM SYRUP
ROBITUSSIN-PE SYRUP
ROCALTROL
ROCEPHIN
ROFERON-A
ROGENIC
ROLAIDS
ROMILAR
RONDEC
RONDEC-DM
RONDOMYCIN
RONIACOL
ROXANOL
RU-TUSS
RU-TUSS EXPECTORANT
RU-TUSS W/HYDROCODONE
RU-VERT
RUBESOL
RUBRAMIN PC
RUFEN
RUTIN
RYNA-C
RYNA-CX
RYNATAN
RYNATUSS
S.A.S.-500
S.T. 37
SALETO
SALICYLAMIDE
SALICYLATE
SALICYLIC ACID
SALINE
SALURON
SALUTENSIN
SANDIMMUNE SANDOPAK
SANDOGLOBULIN
SANOREX
SANSERT
SARNA
SATRIC
27525
27545
27625
27635
27650
27660
27665
61330
27708
61340
27725
27730
27735
41440
27785
27820
27835
27840
27845
27855
27865
27890
27900
27905
27928
27950
27960
27965
27978
27985
27995
28015
28020
28030
28040
28045
28080
28085
28100
28135
28138
28145
28155
28165
28200
28205
28215
28258
28270
28285
28295
28350
28358
35580
SCHAMBERG LOTION
SCOPOLAMINE
SEBIZON LOTION
SEBULEX
SECONAL
SECRAN
SECRAN PRENATAL
SECTRAL
SEDATIVE
SELDANE
SELENIUM
SELSUN
SELSUN BLUE
SENECOT
SENOKOT
SEPP ANTISEPTIC APPLICATOR
SEPTRA
SEPTRA DS
SER-AP-ES
SERAX
SERENTIL
SERPASIL
SERPASIL-APRESOLINE
SERPASIL-ESIDRIX
SHEPARD'S CREAM LOTION
SIBLIN
SIGTAB
SILAIN-GEL
SILICONE SKIN SPRAY
SILVADENE
SILVER NITRATE
SILVER SULFADIAZINE
SIMAAL GEL
SIMETHICONE
SIMPLE SYRUP
SIMRON
SINEMET
SINEQUAN
SINGLET
SINUBID
SINUFED
SINULIN
SINUS
SINUTAB
SK-AMITRIPTYLINE
SK-AMPICILLIN
SK-APAP W/CODEINE
SK-DOXYCYCLINE HYCLATE
SK-LYGEN
SK-PENICILLIN VK
SK-PRAMINE
SKELAXIN
SKIN PREPARATION
SLO-BID
28365
28375
28380
41470
28390
28399
28430
28495
28510
28560
28595
28610
28660
28675
28683
28685
28734
28745
28755
28760
28790
28810
28825
28815
28820
28833
28835
28840
28880
28905
28910
28920
29015
29038
29045
41505
29075
29078
29240
41510
29245
29250
29255
29275
29315
29328
29365
29420
29435
29498
29505
29533
29565
29575
SLO-PHYLLIN
SLO-PHYLLIN GYROCAP
SLO-PHYLLIN SYRUP
SLOW FE
SLOW-K
SMZ
SODESTRIN
SODIUM CHLORIDE
SODIUM CHLORIDE (PHYSIOLOGICAL SALINE)
SODIUM CHLORIDE IRRIGATION
SODIUM FLUORIDE
SODIUM HYPOCHLORITE
SODIUM PERBORATE
SODIUM SALICYLATE
SODIUM SULFACETAMIDE OPHTH
SODIUM SULFATE
SOLAQUIN
SOLATENE
SOLFOTON
SOLGANAL SUSPENSION
SOLU-CORTEF
SOLUREX
SOMA
SOMA COMPOUND
SOMA COMPOUND W/CODEINE
SOMINEX
SOMLYN W/PHENOBARBITAL
SOMOPHYLLIN
SOPOR
SORBIDE T.D.
SORBITOL
SORBITRATE
SPARINE
SPASMOLYTIC AGENT
SPASQUID ELIXIR
SPECTAZOLE
SPECTRO-BIOTIC
SPECTROBID
SPIRITEX
SPIRON W/HCTZ
SPIRONAZIDE
SPIRONOLACTONE
SPIRONOLACTONE W/HYDROCHLOROTHIAZIDE
SSKI
STAPHCILLIN
STATICIN
STELAZINE
STERAMINE
STERAPRED
STEROID(S)
STILBESTROL
STOOL SOFTENER
STREPTOMYCIN
STRESS-VITES
29580
41550
29585
61380
29615
29655
29705
29710
29720
29725
29760
29780
29785
29795
29800
29805
29810
29815
61385
29825
41570
29830
29843
29840
29844
29850
29860
29865
29870
29888
29895
29898
29900
29925
29955
29998
61390
30015
30030
30035
30100
61395
30155
30175
30195
30235
61400
30255
30302
30305
30309
30329
30330
30335
STRESSCAPS
STRESSTABS W/IRON
STRESSTABS 600
STUART PRENATAL
STUARTNATAL 1+1
SUCARYL
SUDAFED
SUDAFED PLUS
SUDAFED S.A.
SUDAFED SYRUP
SUFEDRIN
SULADYNE
SULAMYD SODIUM
SULF-10
SULFA VAGINAL
SULFACEL-15
SULFACET-R LOTION
SULFACETAMID
SULFACETAMIDE SODIUM
SULFADIAZINE
SULFAIR
SULFALAR
SULFAMETHOX W/TRIMETHOPRIM
SULFAMETHOXAZOLE
SULFAMIDE OPHTHALMIC
SULFANILAMIDE
SULFAPYRIDINE
SULFASALAZINE
SULFASOX
SULFATRIM
SULFEM
SULFINPYRAZONE
SULFISOXAZOLE
SULFONAMIDES DUPLEX
SULFUR
SULINDAC
SULPRED
SULTRIN
SUMSCREEN
SUMYCIN
SUPER B COMPLEX W/C LIVER IRON & B-12
SUPROL
SURBEX
SURBEX-T
SURFAK
SURMONTIL
SUS-PHRINE
SUSTAIRE
SYMADINE
SYMMETREL
SYMPATHOMIMETC AGENT
SYNACORT
SYNALAR
SYNALGOS
30340
30365
30370
30395
30398
30400
30468
30475
30480
30485
30495
30513
30535
61405
30545
30553
30555
30565
30575
30585
30590
30595
30630
61415
61420
30650
30655
30660
30670
30690
30723
61435
30725
30730
30735
30740
30745
30755
30756
61440
41595
30760
61445
30775
30777
30781
61450
30782
30790
30795
30805
30810
30815
30820
SYNALGOS-DC
SYNEMOL
SYNKAYVITE
SYNTHROID
SYNTHROX
SYNTOCINON
T-STAT
TABRON
TACARYL
TACE
TAGAMET
TALACEN
TALWIN
TAMBOCOR
TAMINE
TAMOXIFEN
TANDEARIL
TANNIC ACID
TAO
TAPAZOLE
TAR
TARACTAN
TAVIST
TAZIDIME
TEARFAIR
TEARISOL
TEARS NATURALE
TEARS PLUS
TEDRAL
TEDRAL SA
TEGAMIDE
TEGISON
TEGOPEN
TEGRETOL
TEGRIN
TELDRIN
TELEPAQUE
TEMARIL
TEMAZEPAM
TEMOVATE
TEMPO
TEMPRA
TEN-K
TENAX
TENEX
TENORETIC 100
TENORETIC 50
TENORMIN
TENUATE
TEPANIL
TERBUTALINE
TERFONYL
TERPHAN ELIXIR
TERPIN HYDRATE
30825
30835
30850
30870
30880
30915
31000
31020
31045
31050
31058
31075
31085
31093
31120
31140
41610
31145
31165
31175
31200
31205
31215
31225
31230
31235
31240
31258
31260
31263
31265
31275
31324
31325
31330
31335
31365
31390
31395
31400
31410
31428
31430
31440
31455
31460
31483
31485
31508
31543
31515
31542
31545
31550
TERPIN HYDRATE & CODEINE ELIXIR
TERPIN HYDRATE ELIXIR
TERRAMYCIN
TES-TAPE
TESSALON PERLE
TESTOSTERONE
TETANUS ANTITOXIN
TETRA
TETRACYCLINE
TETRACYCLINE HCL
TETRAHYDROZOLINE HCL
TETREX
TEXACORT
THALITONE
THEO-DUR
THEO-ORGANIDIN
THEO-24
THEOBID
THEOCLEAR
THEODRINE
THEOLAIR
THEOLATE
THEOPHED
THEOPHYL
THEOPHYLLIN ELIXIR
THEOPHYLLINE
THEOPHYLLINE COMPOUND
THEOPHYLLINE EPHEDRINE HYDROXYZINE
THEOPHYLLINE-EPHEDRINE-PHENOBARBITAL
THEOPHYLLINE/GUAIFENESIN
THEOSPAN
THEOVENT
THERA-GESIC BALM
THERAGRAN
THERAGRAN HEMATINIC
THERAGRAN-M
THERAPADS
THERAPEUTIC MULTIVITAMIN
THERAPEUTIC VITAMIN
THERAPEUTIC VITAMIN & MINERAL THERAVIT HEMATINIC
THEX FORTE
THI-CIN
THIACIDE
THIAMINE
THIAMINE HCL ELIXIR
THIOCYL
THIODYNE
THIORIDAZINE
THIORIDAZINE
THIOSULFIL
THIOTHIXENE
THIURETIC
THORAZINE
31580
31588
31600
31615
31620
31630
31635
41905
31655
31659
31658
31660
31670
31695
31715
31725
31728
31740
61475
31750
31755
31760
31770
31775
31780
61480
31790
31810
61490
31825
61495
31835
31850
61505
31870
31900
31925
31933
31938
31939
31940
31945
31995
31997
32013
32049
32065
61515
41670
32110
32140
41680
32150
32155
THROAT DISC
THROAT PREPARATION
THYMOL
THYRAR
THYRO-TERIC
THYROID
THYROLAR
THYROXINE
TIGAN
TIMOLIDE
TIMOLOL
TIMOPTIC
TINACTIN
TINVER LOTION
TITAN
TOBRAMYCIN
TOBREX OPTHALMIC
TOFRANIL
TOLAZAMIDE
TOLAZOLINE
TOLBUTAMIDE
TOLECTIN
TOLFRINIC
TOLINASE
TOLMETIN
TOLNAFTATE
TONACON
TONELAX
TONOCARD
TOPIC
TOPICORT
TOPICYCLINE
TORECAN
TORNALATE
TOTACILLIN
TRAC
TRANCOPAL
TRANQUILIZER
TRANSDERM-NITRO
TRANSDERM-SCOP
TRANTOIN
TRANXENE
TRAVERT 10% IN SODIUM CHLORIDE 0.9%
TRAZODONE
TRENTAL
TRI STATIN
TRI-HYDROSERPINE
TRI-LEVLEN
TRI-NORINYL
TRI-PHEN-CHLOR
TRI-VI-FLOR
TRI-VI-FLOR W/IRON
TRIACET
TRIACIN
32175
32185
32190
32195
32200
32210
32245
32215
32220
32225
32235
32255
32265
32273
61625
32290
32298
32300
32340
32345
32350
32353
32355
32360
32363
32390
32393
32395
32405
32422
35590
32438
32423
35595
32430
32433
32443
32460
32490
32495
32505
32515
32530
61535
32540
32550
32558
32555
TRIAFED
TRIAFED SYRUP
TRIAM
TRIAMCINOLONE
TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE NYSTATIN
TRIAMINIC
TRIAMINIC DM
TRIAMINIC EXPECTORANT
TRIAMINIC EXPECTORANT DH
TRIAMINIC INFANT DROPS
TRIAMINICIN
TRIAMINICOL SYRUP
TRIAMTERENE
TRIAMTERENE W/HCTZ
TRIAVIL
TRIBIOTIC OPHTHALMIC
TRICHLORMETHIAZIDE
TRICONOL
TRIDESILON
TRIDIHEXETHYL CL 25MG MEPROBAMATE 200
TRIDIL
TRIDIONE
TRIETHANOLAMINE
TRIFLUOPERAZINE
TRIHEXYPHENIDYL
TRIKATES
TRILAFON
TRILISATE
TRIMCAPS
TRIMETHOBENZAMIDE HCL
TRIMETHOPRIM
TRIMETHOPRIM W/SULFASOXAZOLE
TRIMETHOPRIM/SULFAMETHOXAZOLE
TRIMOX
TRIMPEX
TRINALIN REPETABS
TRINSICON
TRIPELENNAMINE
TRIPHED
TRIPHENYL
TRIPLE ANTIBIOTIC
TRIPLE SULFA
TRIPLE SULFA VAGINAL
TRIPLE VITAMIN DROPS
TRIPROLIDINE
TRIPROLIDINE PSEUDOEPHED W/CODEINE
TRIPROLIDINE W/PSEUDOEPHEDRINE
32580
32610
32625
32660
32665
TRISORALEN
TRIVITAMIN DROPS
TROCAL
TRYPTOPHAN
TRYSUL VAGINAL
32670
32710
32720
32735
32767
32770
32790
32805
32810
32825
32830
32835
32845
32840
32855
32870
32880
32890
32905
32910
32915
32920
32925
32930
32935
32945
32955
32990
33068
33073
33105
41730
33149
33130
33140
53148
33148
33155
41745
33160
33170
33190
33215
33225
33240
33250
33275
33280
33290
33300
33330
33355
33375
33405
TU-CILLAN
TUCKS
TUINAL
TUMS
TUSS ALLERGINE
TUSS-ORNADE
TUSSANIL EXPECTORANT
TUSSAR
TUSSAR-2 SYRUP
TUSSEND
TUSSEND EXPECTORANT
TUSSEX COUGH SYRUP
TUSSI-ORGANIDIN
TUSSI-ORGANIDIN DM
TUSSIONEX
TUZON
TWIN-K
TWO-DYNE
TYLENOL
TYLENOL NO. 1
TYLENOL NO. 2
TYLENOL NO. 3
TYLENOL NO. 4
TYLENOL W/CODEINE
TYLENOL W/CODEINE ELIXIR
TYLOX
TYMPAGESIC
TYZINE
ULTRACEF
ULTRALENTE INSULIN
UNDECYLENIC ACID COMPOUND
UNI LOM
UNI NATAL PLUS
UNIBASE
UNICAP
UNIFAST UNICELLES
UNILAX
UNIPHEN
UNIPHYL
UNIPRES
UNISOM
URACEL
UREA
URECHOLINE
UREX
URIDON
URINARY ANTISEPTIC
URISED
URISEP
URISPAS
URITIN
UROBIOTIC-250
UROLOGIC G
UTICORT
33410
33425
33430
33448
33478
33480
33550
33555
33570
33573
33574
35600
33575
33585
33588
33600
33625
33670
33677
33685
33690
33700
33705
33710
33713
33750
61565
33760
33780
33805
33808
33843
33858
33895
33903
33965
33970
33975
33980
33995
34010
34085
34090
34110
34115
34120
34125
34130
34145
34160
34210
34215
34220
34235
UTIMOX
V-CILLIN
V-CILLIN K
VACCINATION
VAGINAL SULFA
VAGISEC
VALISONE
VALIUM
VALPIN 50
VALPROIC ACID
VALRELEASE
VANCENASE
VANCERIL
VANCOCIN HCL
VANCOMYCIN
VANOXIDE
VAPONEFRIN
VASELINE
VASERETIC
VASOCIDIN
VASOCLEAR
VASOCON
VASOCON-A
VASODILAN
VASODILATOR
VASOSULF
VASOTEC
VASOTRATE SUBLINGUAL
VEETIDS
VELOSEF
VELOSULIN
VENTOLIN
VERAPAMIL
VERMOX
VERSACAPS
VI-DAYLIN
VI-DAYLIN DROPS
VI-DAYLIN F
VI-DAYLIN F ADC DROPS
VI-DAYLIN F PLUS IRON DROPS
VI-DAYLIN PLUS IRON
VIBRA
VIBRAMYCIN
VICODIN
VICON
VICON FORTE
VICON-C
VICON-PLUS
VIGRAN
VINCRISTINE
VIOFORM
VIOFORM-HYDROCORTISONE
VIOKASE
VIRA-A
34240
34245
34248
34250
34255
42228
34260
34263
41765
34265
34268
34270
34275
34280
34285
34290
34293
34295
34300
34305
34310
61585
34315
34320
34325
34330
34335
34340
34345
34350
34355
34360
00005
34375
00005
34380
34385
34390
00005
34400
34405
34410
34415
34420
03250
34430
34435
34440
34445
03275
34455
34460
34465
34470
VIRILON
VIROMED
VIROPTIC
VISALENS WETTING
VISCULOSE
VISIDEK II
VISINE
VISKEN
VIST-ED
VISTACON
VISTAJECT
VISTARIL
VISTAZINE
VISTRAX
VITA IRON
VITA TOT
VITA-FLOR
VITA-GLEN
VITA-KAPS
VITA-METRAZOL
VITABEE
VITACARN
VITACEE
VITACEE SYRUP
VITADEX-B
VITADYE
VITAGETT
VITAKAPS-M
VITAL
VITALITY-E
VITALYNE
VITAMIN A
VITAMIN A & D
VITAMIN A & D HI-POTENCY
VITAMIN A + VITAMIN D
VITAMIN A NATURAL
VITAMIN A NATURAL NEO-VADRIN
VITAMIN A PALMITATE
VITAMIN A PLUS D
VITAMIN A SOLUBILIZED
VITAMIN A SOLUBLE
VITAMIN A SOLUBLE NEO-VADRIN
VITAMIN A SYNTHETIC
VITAMIN A WATER SOLUBLE
VITAMIN B COMPLEX
VITAMIN B COMPLEX B-12 W/C
VITAMIN B COMPLEX ELIXIR
VITAMIN B COMPLEX HI POTENCY
VITAMIN B COMPLEX W/B-12
VITAMIN B COMPLEX W/VITAMIN C
VITAMIN B-1
VITAMIN B-1 & B-12
VITAMIN B-1 & B-12 TONIC
VITAMIN B-1 & B-12 W/IRON
34475
34480
34485
34490
34495
34500
61590
34505
34510
34515
34520
34525
34530
34535
34540
34545
34550
34555
34560
34565
34570
34575
34580
34585
34590
34595
34600
34605
34610
34618
34615
34620
34623
08350
08355
34630
34635
34636
34640
34641
34642
61595
34643
34645
34650
34655
34660
34665
34670
34673
34675
34680
34685
34690
VITAMIN B-1 ELIXIR
VITAMIN B-1 NEO-VADRIN
VITAMIN B-1 W/B-6
VITAMIN B-1 W/B-6 & B/12
VITAMIN B-12
VITAMIN B-12 CRYSTALLINE
VITAMIN B-12 W/THIAMINE HCL
VITAMIN B-2
VITAMIN B-6
VITAMIN B-6 NEO-VADRIN
VITAMIN C
VITAMIN C & E
VITAMIN C CRYSTAL
VITAMIN C FLAVORED
VITAMIN C NEO-VADRIN
VITAMIN C PLUS E
VITAMIN C SYRUP
VITAMIN C T.O.
VITAMIN CHEWABLE CHILDREN'S
VITAMIN D
VITAMIN D-2 IN OIL
VITAMIN E
VITAMIN E & C
VITAMIN E NATURAL
VITAMIN E NATURAL NEO-VADRIN
VITAMIN E NATURAL SOLUBLE
VITAMIN E NEO-VADRIN
VITAMIN E SKIN OIL
VITAMIN E SYNTHETIC
VITAMIN E W/SELENIUM
VITAMIN E WAFER
VITAMIN E ZESTAB
VITAMIN K
VITAMIN (S)
VITAMINS AND MINERALS
VITANATE
VITANATE FA
VITANEED
VITAPHEN
VITASOL
VITAZIN
VITEC
VITERNA
VITERRA
VITERRA C
VITERRA HIGH POTENCY
VITERRA RDA
VITERRA RDA PLUS IRON
VITERRA-E
VITORMAINS
VITRON-C
VITRON-C PLUS
VIVACTIL
VIVARIN
34693
34695
34700
34698
34705
34710
34715
34720
34725
34730
34735
34740
34745
34748
34750
34755
34765
34760
34991
34992
34993
34770
42248
61600
34775
34780
34785
34790
34795
34800
34805
34810
34815
34820
34825
34830
34835
61605
34838
41770
34839
34840
34845
34850
34855
34856
34857
34858
34860
34865
34870
34873
34875
34880
VIVIKON
VIVONEX
VLEM-DOME LIQUID CONCENTRATE
VLEMASQUE
VLEMINOKX' SOLUTION
VOCALZONES
VOLAXIN,MODIFIED
VOLEX IN SODIUM CHLORIDE
VONCE SHAMPOO
VONTROL
VORAMIL
VOSOL
VOSOL HC
VOXIN
VULVAELINE
VYTONE
W-T LOTION
W.D.D.
W/W-ANTI-SPAS
W/W-FED
W/W-HISTINE
WAMPOCAP
WANS SUPPRETTE
WANS SUPPRETTE NO.2
WARFARIN
WART OFF
WASH 'N DRI TOWELETTE
WATER DISTILLED
WATER FOR INJECTION
WATER FOR IRRIGATION
WATER PURIFIED
WEHAMIWE
WEHDRYL
WEHGEN
WEHLESS
WEHVERT
WEIGHTROL
WELLBUTRIN
WELLCORTIN
WELLCOVORIN
WES B/C
WESCOMEX SURGICAL SCRUB
WESLAX
WESTADOME
WESTCORT
WESTHROID
WESTRIM
WESTVITE
WET N SOAK
WETTING & SOAKING
WETTING SOLUTION BARNES HIND
WEXAPHOS
WHEAT GERM OIL
WHITE PINE COMPOUND
34885
34888
34890
34893
34895
34900
34905
34910
34915
34920
34925
34928
34930
34935
34940
34945
34950
34955
34965
34970
34975
34980
34985
34990
35603
35604
34995
35000
35005
35008
35010
35015
35020
42258
35023
35025
35030
35035
35040
35045
35050
35055
35060
35065
35070
35075
35080
35085
41775
35090
35095
35100
35105
35110
WHITFIELD S
WIBI LOTION
WIGRAINE
WIGRETTES
WILD CHERRY SYRUP
WINE
WINGEL
WINSTROL
WINTERGREEN OIL
WITCH HAZEL
WOLFINA
WOMAGEN
WOOD ALCOHOL
WUN-TABS
WUN-TABS W/IRON
WYAMINE SULFITE
WYAMYCIN
WYANOID
WYANOIDS HC
WYCILLIN
WYCILLIN INJECTION & PROBENECID TABLET
WYDASE
WYGESIC
WYNOX
WYTENSIN
WYVAC
X SEB H.C. SCALP LOTION
X SEB SHAMPOO
X SEB T SHAMPOO
X-CAINE
X-DTAG
X-PREP
X-PREP BOWEL EVACUANT KIT
X-SEB
XANAX
XERAC AC
XERAC BP10
XERAC BP5
XERAC GEL
XERO-LUBE
XEROFOAM DRESSING
XYLO-PFAN
XYLOCAINE
XYLOCAINE FLAVORED
XYLOCAINE HCL
XYLOCAINE HCL W/DEXTROSE
XYLOCAINE HCL W/EPINEPHRINE
XYLOCAINE VISCOUS
XYLOCAINE W/GLUCOSE
XYLOMET SPRAY
XYLOMETAZOLINE
XYLOSE CP
YEAST
YELLOW FEVER VACCINE
35113
35115
35120
35123
35130
35135
35138
35125
35140
35145
35148
41780
35150
35155
35160
35165
35170
35175
35180
35185
35190
35195
35200
35205
35210
35215
35220
35225
35230
35233
35235
41785
35240
35240
35240
41790
35245
35250
35255
41795
35260
35265
35270
35275
35280
42263
35285
35290
35295
35300
35305
35310
35313
35315
YF-VAX
YODOXIN
YOHIMBINE
YUTOPAR
Z-BEC
Z-PRO-C
Z-TEC
Z.B.T. BABY POWDER
ZACTANE
ZACTIRIN
ZANOSAR
ZANTAC
ZARONTIN
ZAROXOLYN
ZARUMIN
ZEASORB MEDICATED
ZEM HISTINE
ZEMACOL MEDICATED LOTION
ZEMACON
ZEMALD SKIN CLEANSER
ZENI-B W/C
ZENIVITES M
ZENTINIC
ZENTRON
ZEPHIRAN CHLORIDE
ZESTE
ZESTE M.T.
ZETAR
ZETRAN
ZIBA-RX
ZIDE
ZINACEF
ZINC
ZINC 15
ZINC 25
ZINC CHLORIDE
ZINC GLUCONATE
ZINC OXIDE
ZINC PASTE (LASSARS)
ZINC STEARATE
ZINC SULFATE
ZINC SULFATE COMPOUND
ZINC SULFATE MUROCOLL NO.
ZINC SULFATE NEO-VADRIN
ZINC SULFIDE CONPOUND LOTION
ZINC TRACE METAL
ZINC-20
ZINC-220
ZINCATE
ZINCFRIN
ZINCOFAX
ZINCON
ZINCTRACE
ZIPAN
35320
35323
35325
35330
35335
35338
35340
41880
35341
35342
35343
35344
61610
35345
35350
35355
35360
35365
35370
35375
35380
ZIRADRYL LOTION
ZNG
ZOLINE-M
ZOLINE-S
ZOLYSE
ZOMAX
ZONIUM CHLORIDE
ZORPRIN
ZOVIRAX
ZOXAPHEN
ZS-220
ZWOLFE
ZYDONE
ZYLAN
ZYLOPRIM
ZYMACAP
ZYMALIXIR
ZYMASYRUP
ZYMAVITES
ZYMENOL
ZYMME
GENERIC DRUG NAMES AND CODES
The system adopted to process data on generic drugs was originally
developed
by the National Center for Health Statistics (Koch, 1980) as part of the
National Ambulatory
Care Survey (NAMCS).
50008
50005
50020
50025
50030
50035
50060
50078
50088
50090
50103
50105
50113
50130
50140
50145
50163
50165
50175
50180
50182
50183
ACEBUTOLOL HYDROCHLORIDE
ACETAMINOPHEN
ACETAZOLAMIDE
ACETIC ACID
ACETOHEXAMIDE
ACETONE
ACETYLCYSTEINE
ACYCLOVIR
ALBUTEROL
ALCOHOL
ALLANTOIN
ALLOPURINOL
ALPRAZOLAM
ALUMINUM ACETATE
ALUMINUM CHLORIDE
ALUMINUM HYDROXIDE
ALUMINUM SULFATE
AMANTADINE
AMCINONIDE
AMIKACIN
AMILORIDE
AMINACRINE
50185
50190
50195
50200
50210
50223
50230
50245
50250
50258
50260
50265
50270
50275
50283
50290
50300
50305
50310
50325
50338
50410
50418
50420
50430
50433
50435
50440
50445
50447
50450
50455
50460
50490
50495
50499
50500
50508
50515
50520
50530
50535
50538
50540
50545
50550
50555
50565
50570
50575
50580
50585
50588
50595
AMINO ACIDS
AMINOACETIC ACID
AMINOBENZOIC ACID
AMINOCAPROIC ACID
AMINOPHYLLINE
AMIODARONE HCL
AMITRIPTYLINE
AMMONIUM CHLORIDE
AMOBARBITAL
AMOXAPINE
AMOXICILLIN
AMPHETAMINE
AMPHOTERICIN
AMPICILLIN
AMYLASE
ANISE OIL
ANISOTROPINE
ANTAZOLINE
ANTHRALIN
ANTIPYRINE
ANTIVENIN BEE STING
ASPIRIN
ATENOLOL
ATROPINE
ATTAPULGITE
AURANOFIN
AUROTHIOGLUCOSE
AZATADINE
AZATHIOPRINE
BACAMPICILLIN
BACITRACIN
BACLOFEN
BALSAM
BECLOMETHASONE
BELLADONNA
BENACTYZINE
BENDROFLUMETHIAZIDE
BENTONITE
BENZALKONIUM CHLORIDE
BENZETHONIUM CHLORIDE
BENZOCAINE
BENZOIC & SALICYLIC ACID
BENZOIC ACID
BENZOIN
BENZONATATE
BENZOYL PEROXIDE
BENZPHETAMINE
BENZTROPINE
BENZYL ALCOHOL
BENZYL BENZOATE
BETA-CAROTENE
BETAMETHASONE
BETAXOLOL HCL
BETHANECHOL
50613
50615
50620
50625
50630
50635
50638
50632
50640
50653
50660
50663
50668
50680
50685
50690
50698
50705
50706
50708
50713
50720
50728
50733
50745
50755
50760
50775
50887
50785
50773
50800
50802
50806
50811
50770
50824
50835
50845
50860
50868
50869
50873
50875
50880
50895
50898
50899
50900
50920
50923
50933
50935
50940
BILE SALTS
BIOFLAVONOIDS
BIOTIN
BIPERIDEN
BISACODYL
BISMUTH ANTI-DIARRHEA AGENTS
BISMUTH IODIDE
BISMUTH OXIDE
BISMUTH SALICYLATE
BITOLTEROL MESYLATE
BORIC ACID
BRAN
BRILLIANT BLUE
BROMOCRIPTINE
BROMODIPHENHYDRAMINE
BROMPHENIRAMINE
BUCHU
BUCLIZINE
BUFFERS
BUMETANIDE
BUSPRIONE HCL
BUTABARBITAL
BUTALBITAL
BUTOCONAZOLE NITRATE
CAFFEINE
CALAMINE
CALCITONIN
CALCIUM ACETATE
CALCIUM CARBASPIRIN
CALCIUM CARBONATE
CALCIUM GLYCEROPHOSPHATE
CALCIUM HYDROXIDE
CALCIUM IODIDE
CALCUIM ION
CALCIUM PANTOTHENATE
CALCIUM REPLACEMENT AGENTS
CALJUPUT OIL
CALLICREIN
CAMPHOR
CANTHARIDIN
CAPSICUM
CAPTOPRIL
CARAMIPHEN
CARBACHOL
CARBAMAZEPINE
CARBENICILLIN
CARBETAPENTANE
CARBIDOPA
CARBINOXAMINE
CARISOPRODOL
CARMELLOSE
CASANTHRANOL
CASCARA
CASTOR OIL
50945
50950
50960
50961
50966
50968
50980
50995
51005
51008
51020
51023
51025
51040
51045
51050
51053
51055
51063
51064
51066
51075
51085
51095
51100
51105
51110
51115
51120
51130
51150
51155
51160
51165
51170
51175
51177
51190
51195
51200
51205
51215
51218
51220
51225
51227
51229
51235
51245
51250
51255
51243
51257
51260
CEFACLOR
CEFADROXIL
CEFAZOLIN
CEFONICID SODIUM
CEFTAZIDIME
CELLULASE
CEPHALEXIN
CEPHALOTHIN
CEPHRADINE
CERESIN WAX
CETYL ALCOHOL
CETYLPYRIDINIUM
CHARCOAL
CHLORAL HYDRATE
CHLORAMBUCIL
CHLORAMPHENICOL
CHLORCYCLIZINE
CHLORDIAZEPOXIDE
CHLORHYDROXYQUINOLONE
CHLORIDE ION
CHLORMEZANONE
CHLOROBUTANOL
CHLOROPHYLL
CHLOROQUINE
CHLOROTHIAZIDE
CHLOROTHYMOL
CHLOROTRIANISENE
CHLOROXINE
CHLOROXYLENOL
CHLORPHENIRAMINE
CHLORPROMAZINE
CHLORPROPAMIDE
CHLORPROTHIXENE
CHLORTETRACYCLINE
CHLORTHALIDONE
CHLORZOXAZONE
CHOLECALCIFEROL
CHOLESTYRAMINE
CHOLINE
CHOLINE SALICYLATE
CHORIONIC GONADOTROPIN
CHYMOTRYPSIN
CICLOPIROX
CIMETIDINE
CINNAMON OIL
CINOXACIN
CIPROFLOXACIN HCL
CITRIC ACID
CLEMASTINE
CLIDINIUM
CLINDAMYCIN
CLOBETASOL PROPIONATE
CLOCORTOLONE
CLOFIBRATE
51265
51270
51275
51280
51290
51300
51305
51308
51340
51345
51355
51360
51375
51380
51393
51400
51405
51410
51415
51430
51435
51440
51443
51445
51460
51465
51470
51480
51485
51493
51510
51518
51540
51545
51550
51555
51575
51585
51590
51595
51598
51599
51600
51605
51615
51620
51625
51633
51635
51638
51640
51645
51665
51670
CLOMIPHENE
CLONAZEPAM
CLONIDINE
CLORAZEPATE
CLOTRIMAZOLE
CLOXACILLIN
COAL TAR
COBALAMIN
CODEINE
COLCHICINE
COLESTIPOL
COLISTIN
COLLODION
COMBINATION PRODUCT
COPPER
CORTICOTROPIN
CORTISONE
COSYNTROPIN
COTTONSEED OIL
CROMOLYN SODIUM
CROTAMITON
CRYPTENAMINE
CUBEB
CUPRIC SULFATE
CYCLACILLIN
CYCLANDELATE
CYCLOBENZAPRINE
CYCLOPENTOLATE
CYCLOPHOSPHAMIDE
CYCLOSPORINE
CYPROHEPTADINE
CYSTINE
DANAZOL
DANTHRON
DANTROLENE
DAPSONE
DEFEROXAMINE
DEHYDROCHOLIC ACID
DEMECARIUM
DEMECLOCYCLINE
DEOXYRIBONUCLEASE
DEQUALINIUM ACETATE
DESERPIDINE
DESIPRAMINE
DESMOPRESSIN
DESONIDE
DESOXIMETASONE
DETERGENT
DEXAMETHASONE
DEXBROMPHENIRAMINE
DEXCHLORPHENIRAMINE
DEXPANTHENOL
DEXTROAMPHETAMINE
DEXTROMETHORPHAN
51675
51685
51695
51705
60015
51709
51715
51720
51725
51730
51735
51740
51750
51755
51760
51763
51770
51775
51780
52647
51785
51790
51800
51803
51810
51817
51903
51860
51865
51868
51913
51915
51920
51925
51927
51935
51955
51960
51965
51970
52000
52005
52008
52015
52023
52028
52024
52035
52040
52045
52048
52050
52055
52060
DEXTROSE
DEXTROTHYROXINE
DIAZEPAM
DIBUCAINE
DICHLORALANTIPYRINE
DICHLORODIFLUOROMETHANE
DICHLORPHENAMIDE
DICLOXACILLIN
DICUMAROL
DICYCLOMINE
DIENESTROL
DIETARY SUPPLEMENT
DIETHYLPROPION
DIETHYLSTILBESTROL
DIFLORASONE DIACETATE
DIFUNISAL
DIGITALIS
DIGITOXIN
DIGOXIN
DIHYDROCODEINE
DIHYDROERGOIAMINE
DIHYDROTACHYSTEROL
DIHYDROXYALUMINUM SODIUM CARBONATE
DILTIAZEM
DIMENHYDRINATE
DIMETHICONE
DIPH PERTUSSIS TETANUS VACCINE
DIPHENHYDRAMINE
DIPHENIDOL
DIPHENOXYLATE
DIPIVEFRIN
DIPYRIDAMOLE
DISOPYRAMIDE
DISULFIRAM
DIVALPROEX SODIUM
DOCUSATE
DOXEPIN
DOXORUBICIN
DOXYCYCLINE
DOXYLAMINE
DYPHYLLINE
ECHOTHIOPHATE
ECONAZOLE
EDETATE DISODIUM
ELECTROLYTES
ENALAPRIL
ENCAINIDE HCL
EPHEDRINE
EPINEPHRINE
ERGOCALCIFEROL
ERGOLOID MESYLSTES
ERGONOVINE
ERGOTAMINE
ERYTHRITYL TETRANITRATE
52065
52070
52075
52080
52082
52085
52090
52095
52100
52105
52168
52120
52125
52130
52135
52145
52155
52185
52169
52190
52195
52198
52215
52220
52270
52275
52278
52295
52303
52304
52305
52310
52318
52320
52325
52330
52335
52345
52350
52353
52355
52358
52360
52370
52380
52385
52395
52398
52400
52405
52417
52422
52430
62435
ERYTHROMYCIN
ESTRADIOL
ESTROGENS
ESTRONE
ESTROPIPATE
ETHACRYNIC ACID
ETHAMBUTOL
ETHAVERINE
ETHCHLORVYNOL
ETHER
ETHNODIOL DIACETATE
ETHOHEPTAZINE
ETHOPROPAZINE
ETHOSUXIMIDE
ETHOTOIN
ETHOXZOLAMIDE
ETHYL CHLORIDE
ETIDRONATE DISODIUM
ETRETINATE
EUCALYPTOL
EUGENOL
FAMOTIDINE
FENFLURAMINE
FENOPROFEN
FIBRINOLYSIN
FLAVOXATE
FLECAINIDE ACETATE
FLUDROCORTISONE
FLUMETHIAZIDE
FLUNISOLIDE
FLUOCINOLONE
FLUOCINONIDE
FLUORIDE
FLUOROMETHOLONE
FLUOROURACIL
FLUOXYMESTERONE
FLUPHENAZINE
FLURANDRENOLIDE
FLURAZEPAM
FLURBIPROFEN SODIUM
FOLIC ACID
FOOD SUPPLEMENT
FORMALDEHYDE
FRUCTOSE
FURAZOLIDONE
FUROSEMIDE
GELATIN
GEMFIBROZIL
GENTAMICIN
GENTIAN VIOLET
GLIPIZIDE
GLUCONIC ACID
GLUCOSE ENZYMATIC TEST
GLUTAMIC ACID
52445
52447
52450
52455
52470
52478
52480
52485
52490
52492
52493
52495
52498
52500
52503
52505
52510
52520
52525
52535
52533
52540
52545
52550
52560
52595
52600
52610
52615
52619
52630
52645
52650
52655
52660
52665
52670
52675
52685
52690
52691
52700
52710
52715
52720
52723
52730
52745
52750
52753
52770
52775
52780
52752
GLUTETHIMIDE
GLYBURIDE
GLYCERIN
GLYCOPYRROLATE
GOLD SODIUM THIOMALATE
GRAMICIDIN
GRISEOFULVIN
GUAIACOL
GUAIFENESIN
GUANABENZ
GUANARDEL
GUANETHIDINE
GUANFACINE HCL
GUANIDINE
HALAZEPAM
HALAZONE
HALCINONIDE
HALOPERIDOL
HALOPROGIN
HAMAMELIS WATER
HEMICELLULASE
HEPARIN
HEPATITIS B IMMUNE GLOBULIN
HESPERIDIN
HEXACHLOROPHENE
HEXYLRESORCINOL
HISTAMINE
HISTOPLASMIN
HOMATROPINE
HOREHOUND
HYDRALAZINE
HYDROCHLOROTHIAZIDE
HYDROCODONE
HYDROCORTISONE
HYDROFLUMETHIAZIDE
HYDROGEN PEROXIDE
HYDROMORPHONE
HYDROQUINONE
HYDROXYAMPHETAMINE
HYDROXYCHLOROQUINE
HYDROXYETHYLCELLULOSE
HYDROXYPROPYL METHYLCELLULOSE
HYDROXYUREA
HYDROXYZINE
HYOSCYAMINE
HYOSCYAMUS
IBUPROFEN
IMIPRAMINE
IMMUNE GLOBULIN
INDAPAMIDE
INDOMETHACIN
INFANT FORMULA
INFLUENZA VIRUS VACCINE
INHALER
52785
52790
52791
52795
52800
52825
52830
52820
52845
52847
52850
52855
52870
52883
52890
52885
52895
52900
52908
52915
52920
52925
52927
52930
52935
52943
52945
52948
52950
52955
52972
52978
52973
52979
52975
52980
52985
52986
52995
53003
53004
53010
53020
53035
53043
53050
53055
53065
53070
53090
53095
53105
53110
53115
INOSITOL
INSULIN
INTERFERON ALFA-2A
INULIN
INVERT SUGAR
IODINATED GLYCEROL
IODINE SOLUTIONS
IODINE TOPICAL PREPARATIONS
IODOCHLORHYDROXYQUIN
IODOFORM
IODOQUINOL
IOPANOIC ACID
IPECAC
IPRATROPIUM BROMIDE
IRON BILE SALTS
IRON PREPARATIONS
ISOCARBOXAZID
ISOETHARINE
ISOMETHEPTENE MUCATE
ISONIAZID
ISOPROPAMIDE
ISOPROPYL ALCOHOL
ISOPROPYL PALMITATE
ISOPROTERENOL
ISOSORBIDE
ISOTRENTINOIN
ISOXSUPRINE
JUNIPER
KANAMYCIN
KAOLIN
KETOCONAZOLE
KETOPROFEN
L-TRYPTOPHANE
LABETALOL HCL
LACTASE
LACTIC ACID
LACTOBACILLUS ACIDOPHILUS
LACTOBACILLUS BULGARICUS
LACTULOSE
LANOLIN
LAURETH
LAVENDER OIL
LECITHIN
LEUCOVORIN
LEVOBUNOLOL HCL
LEVODOPA
LEVORPHANOL
LEVOTHYROXINE
LIDOCAINE
LINCOMYCIN
LINDANE
LINSEED OIL
LIOTHYRONINE
LIOTRIX
53118
53120
53125
53135
53140
53145
53148
53150
53160
53170
53175
53195
53190
53180
53220
53248
53250
53260
53275
53277
53280
53285
53290
53295
53298
53300
53320
53325
53328
53330
53335
53340
53350
53355
53365
53370
53385
53435
53438
53450
53460
53470
53475
53485
53500
53510
53515
53520
53525
53530
53535
53540
53550
53560
LIPASE
LITHIUM
LIVER DERIVATIVE
LOMUSTINE
LOPERAMIDE
LORAZEPAM
LOVASTATIN
LOXAPINE
LYSINE
MAGALDRATE
MAGNESIUM ANTACIDS
MAGNESIUM CATHARTICS
MAGNESIUM CHLORIDE
MAGNESIUM GLUCONATE
MAGNESIUM SALICYLATE
MAPROTILINE
MAZINDOL
MEBENDAZOLE
MECLIZINE
MECLOFENAMATE
MEDROXYPROGESTERONE
MEDRYSONE
MEFENAMIC ACID
MEGESTROL
MEGLUMINE
MELPHALAN
MENOTROPINS
MENTHOL
MENTHYL ANTHRANILATE
MEPENZOLATE
MEPERIDINE
MEPHENESIN
MEPHENYTOIN
MEPHOBARBITAL
MEPREDNISONE
MEPROBAMATE
MERCAPTOPURINE
MESORIDAZINE
MESTRANOL
METAPROTERENOL
METAXALONE
METHACYCLINE
METHADONE
METHAMPHETAMINE
METHANTHELINE
METHAQUALONE
METHARBITAL
METHAZOLAMIDE
METHDILAZINE
METHENAMINE
METHICILLIN
METHIMAZOLE
METHIONINE
METHOCARBAMOL
53570
53585
53595
53600
53605
53610
53647
53620
53630
53635
53640
53645
53650
53655
53660
53670
53675
53680
53688
53690
53445
53700
53712
53715
53720
53723
53725
53730
53754
53755
53758
53760
53778
53780
53840
53845
53855
53860
53875
53880
53895
53903
53905
53915
53919
53920
53922
53930
53935
53940
53945
53953
53955
53965
METHOTREXATE
METHOXSALEN
METHOXYPHENAMINE
METHSCOPOLAMINE
METHSUXIMIDE
METHYCLOTHIAZIDE
METHYL NICOTINATE
METHYL SALICYLATE
METHYLCELLULOSE
METHYLDOPA
METHYLENE BLUE
METHYLERGONOVINE
METHYLPARABEN
METHYLPHENIDATE
METHYLPREDNISOLONE
METHYLTESTOSTERONE
METHYPRYLON
METHYSERGIDE
METOCLOPRAMIDE
METOLAZONE
METOPROLOL
METRONIDAZOLE
MEXILETINE HCL
MICONAZOLE
MINERAL OIL
MINERALS
MINOCYCLINE
MINOXIDIL
MOMETASONE FUROATE
MONOBENZONE
MONETHANOLAMINE
MORPHINE
MOXALACTAM
MULTIVITAMINS GENERAL
NADOLOL
NAFCILLIN
NALBUPHINE
NALIDIXIC ACID
NAPHAZOLINE
NAPROXEN
NEOMYCIN
NETILMICIN
NIACIN
NIACINAMIDE
NICOTINE POLACRILEX
NICOTINYL ALCOHOL
NIFEDIPINE
NITROFURANTOIN
NITROFURAZONE
NITROGEN
NITROGLYCERIN
NONIFENSINE MALEATE
NONOXYNOL
NORETHINDRONE
53969
53970
53975
53990
53995
54000
54015
54020
54030
54035
54050
54065
54070
54080
54085
54100
54105
54113
54094
54115
54120
54140
54095
54148
51450
54155
54160
54165
54175
54190
54205
54215
54220
54227
54228
54238
54240
54245
54250
54260
54268
54275
54290
54295
54297
54300
54305
54310
54315
54320
54330
54332
54350
54365
NORFLOXACIN
NORGESTREL
NORTRIPTYLINE
NYLIDRIN
NYSTATIN
OATMEAL
OINTMENT HYDROPHILIC
OLEANDOMYCIN
OLIVE OIL
OPIUM
ORPHENADRINE
OX BILE EXTRACT
OXACILLIN
OXANDROLONE
OXAZEPAM
OXTRIPHYLLINE
OXYBUTYNIN
OXYCHOLESTRIN
OXYCODONE
OXYGEN
OXYMETAZOLINE
OXYPHENBUTAZONE
OXYPHENCYCLIMINE
OXYQUINOLONE
OXYTERACYCLINE
OXYTOCIN
PANCREATIN
PANCRELIPASE
PANTOTHENIC ACID
PAPAVERINE
PARAMETHASONE
PAREGORIC
PARGYLINE
PASSIFLORA EXTRACT
PASSIFLORA EXTRACT
PECTIN
PEMOLINE
PENICILLAMINE
PENICILLIN
PENICILLIN G PROCAINE
PENICILLIN V POTASSIUM
PENTAERYTHRITOL
PENTAZOCINE
PENTOBARBITAL
PENTOXIFYLLINE
PENTYLENETETRAZOL
PEPPERMINT
PEPSIN
PERMETHRIN
PERPHENAZINE
PETROLATUM
PETROLEUM DISTILLATE
PHENACETIN
PHENAZOPYRIDINE
54370
54375
54378
54385
54390
54395
54400
54405
54415
54430
54440
54450
54455
54460
54465
54468
54470
54480
54495
54500
54501
54503
54523
54528
54535
54565
54585
54587
54590
54595
54597
54598
54605
54610
54735
54620
54625
54640
54700
54710
54713
54655
54748
54749
54755
54760
54765
54770
54775
54795
54800
54805
54810
54815
PHENDIMETRAZINE
PHENELZINE
PHENINDAMINE
PHENIRAMINE
PHENMETRAZINE
PHENOBARBITAL
PHENOL
PHENOLPHTHALEIN
PHENOXYBENZAMINE
PHENTERMINE
PHENYL SALICYLATE
PHENYLBUTAZONE
PHENYLEPHRINE
PHENYLMERCURIC NITRATE
PHENYLPROPANOLAMINE
PHENYLTOLOXAMINE
PHENYTOIN
PHOSPHORIC ACID
PHYTONADIONE
PILOCARPINE
PINDOLOL 1
PINE TAR
PIPERONYL
PIROXICAM
PLACEBO
POISON IVY EXTRACT
POLLEN ANTIGEN
POLYCARBOPHIL CALCIUM
POLYETHYLENE GLYCOL
POLYMIXIN B
POLYOXYETHYLENENONYL PHENOL
POLYSORBATE
POLYTHIAZIDE
POLYVINYL ALCOHOL
POTASSIUM ACIDIFYING AGENTS
POTASSIUM ALKALINIZING AGENTS
POTASSIUM AMINOBENZOATE
POTASSIUM BITARTRATE
POTASSIUM GUAIACOL SULFONATE
POTASSIUM IODIDE
POTASSIUM ION
POTASSIUM REPLACEMENT SOLUTIONS
POVIDONE
POVIDONE-IODINE
PRAMOXINE
PRAZEPAM
PRAZOSIN
PREDNISOLONE
PREDNISONE
PRIMIDONE
PROBENECID
PROBUCOL
PROCAINAMIDE
PROCAINE
54825
54830
54835
54845
54850
54860
54870
54890
54865
54895
54905
54910
54920
54923
54950
54960
54965
54975
54980
54983
54985
54990
54995
55000
55030
55035
55040
55045
55050
55060
55061
55064
55070
55075
55080
55085
55105
55108
55110
55117
55135
55140
55150
55160
55165
55180
55185
55195
55200
55210
55213
55225
55235
55240
PROCARBAZINE
PROCHLORPERAZINE
PROCYCLIDINE
PROGESTERONE
PROMAZINE
PROMETHAZINE
PROPANTHELINE
PROPOXYPHENE
PROPRANOLOL
PROPYLENE GLYCOL
PROPYLPARABEN
PROPYLTHIOURACIL
PROTEIN HYDROLYSATE
PROTEINASE
PROTRIPTYLINE
PSEUDOEPHEDRINE
PSYLLIUM
PYRANTEL
PYRAZINAMIDE
PYRETHRINS
PYRIDOSTIGMINE
PYRIDOXINE
PYRILAMINE
PYRIMETHAMINE
QUINACRINE
QUINESTROL
QUINETHAZONE
QUINIDINE
QUININE
RABIES VACCINE
RACEMETHIONINE
RANTIDINE
RAUWOLFIA
RESCINNAMINE
RESERPINE
RESORCINOL
RIBOFLAVIN
RICINOLEIC ACID
RIFAMPIN
RITODRINE
RUTIN
SACCHARIN
SALICYLAMIDE
SALICYLIC ACID
SALSALATE
SCOPOLAMINE
SECOBARBITAL
SELENIUM SULFIDE
SENNA
SESAME OIL
SHARK LIVER OIL
SILVER NITRATE
SILVER SULFADIAZINE
SIMETHICONE
55253
55265
55270
55274
55275
55280
55295
55315
55320
55330
55345
55348
55360
55370
55380
55385
55390
55393
56325
55405
55420
55425
55430
55435
55455
55460
55465
55470
55480
55485
55490
55493
55500
55518
55525
55540
55543
55548
55550
55555
55565
55567
55570
55575
55580
55585
55590
55600
55615
55610
55618
55623
55636
55640
SKIN RESP FACTOR YEAST
SOAP
SODIUM ACETATE
SODIUM AMINOBENZOATE
SODIUM BENZOATE
SODIUM BICARBONATE
SODIUM BORATE
SODIUM CHLORIDE
SODIUM CITRATE
SODIUM FLUORIDE
SODIUM HYPOCHLORITE
SODIUM ION
SODIUM LAURYL SULFATE
SODIUM NITROPRUSSIDE
SODIUM PERBORATE
SODIUM PHOSPHATE
SODIUM POLYSTYRENE SULFONATE
SODIUM PROPIONATE
SODIUM SALICYLATE
SODIUM SULFATE
SODIUM THIOSALICYLATE
SODIUM THIOSULFATE
SOMATROPIN
SORBITOL
SPIDER-BITE ANTIVENIN
SPIRONOLACTONE
STANNOUS FLUORIDE
STANOZOLOL
STARCH
STEARIC ACID
STEARYL ALCOHOL
STOMACH POWDERED
STREPTOMYCIN
SUCRALFATE
SULFACETAMIDE
SULFADIAZINE
SULFAMERAZINE
SULFAMETHAZINE
SULFAMETHIZOLE
SULFAMETHOXAZOLE
SULFANILAMIDE
SULFANILYLBENZAMIDE
SULFAPYRIDINE
SULFASALAZINE
SULFATHIAZOLE
SULFINPYRAZONE
SULFISOXAZOLE
SULFOSALICYLIC ACID
SULINDAC
SULPHUR
SUPROFEN
SURFACTANT
SYRUP
TALBUTAL
55645
55650
55655
55668
56290
55670
55673
55675
55695
55700
55715
55725
55730
55745
55750
55755
55765
55770
55780
55785
55795
55801
55815
55820
55825
55845
55848
55850
55860
55870
55875
55880
55885
55890
55893
55900
55903
55905
55910
55915
55925
55928
55930
55943
55950
55955
55960
55967
55975
55985
55990
56000
55997
56005
TALC
TAMOXIFEN
TANNIC ACID
TEMAZEPAM
TERAZOSIN HCL
TERBUTALINE
TERFENADINE
TERPIN HYDRATE
TESTOSTERONE
TETANUS ANTITOXIN
TETRACAINE
TETRACYCLINE
TETRAHYDROZOLINE
THEOPHYLLINE
THIABENDAZOLE
THIAMINE
THIETHYLPERAZINE
THIMEROSAL
THIOPENTAL
THIORIDAZINE
THIOTHIXENE
THONZONIUM BROMIDE
THYMOL
THYROGLOBULIN
THYROID
TIMOLOL
TITANIUM
TOBRAMYCIN
TOCAINIDE HYDROCHLORIDE
TOLAZAMIDE
TOLAZOLINE
TOLBUTAMIDE
TOLMETIN
TOLNAFTATE
TOLU BALSAM
TRANYLCYPROMINE
TRAZODONE
TRETINOIN
TRIACETIN
TRIAMCINOLONE
TRIAMTERENE
TRIAZOLAM
TRICHLORMETHIAZIDE
TRICHLOROFLUROMETHANE
TRIDIHEXETHYL CHLORIDE
TRIETHANOLAMINE
TRIFLUOPERAZINE
TRIFLURIDINE
TRIHEXYPHENIDYL
TRIMEPRAZINE
TRIMETHADIONE
TRIMETHOBENZAMIDE
TRIMETHOPRIM
TRIMIPRAMINE
56010
56015
56030
56045
56020
56048
56050
56110
50000
56120
56123
56133
56134
56145
56150
56161
56163
56170
56180
56185
56340
56345
56192
56193
56194
56195
56198
56205
56210
56238
56240
56250
56260
56262
56285
56265
56288
56275
TRIOXSALEN
TRIPELENNAMINE
TROLAMINE
TROPICAMIDE
TROPROLIDINE
TRYPSIN
TRYPTOPHAN
UNDECYLENIC ACID
UNDETERMINED
UREA
UROFOLLITROPIN
UROLOGIC SOLUTION-G
UVA URSI
VALPROIC ACID
VANCOMYCIN
VEGETABLE OIL
VERAPAMIL
VIDARABINE
VINCRISTINE
VITAMIN A
VITAMIN B
VITAMIN B COMPLEX
VITAMIN B-12
VITAMIN C
VITAMIN D
VITAMIN E
VITAMIN K
WARFARIN
WATER STERILE
WOOL ALCOHOLS
XYLOMETAZOLINE
YEAST
YOHIMBENE
ZEA
ZINC SULFATE
ZINC TOPICAL AGENTS
ZIRCONIUM
ZOMEPIRAC
T QUESTIONS FROM ROUND 1 OF THE HOUSEHOLD SURVEY
T65.
some
Has (PERSON) ever talked with an insurance agent or found out in
other way what it would cost to buy private health insurance for
(himself/herself)?
Yes...........................1 (T67)
No............................2 (T67)
T66.
out
Has (PARENT/GUARDIAN) ever talked with an insurance agent or found
in some other way what it would cost to buy private health
insurance
for (PERSON)?
Yes...........................1
No............................2
T67.
kind
Has (PERSON) ever been refused health insurance, or limited in the
of health insurance coverage (he/she) could buy, because of poor
health?
Yes...........................1 (NP:BOX T12/T68)
No............................2 (NP:BOX T12/T68)
TECHNICAL SPECIFICATIONS FOR UTILIZATION AND EXPENDITURE VARIABLES
The technical specifications for the construction of the person-level
utilization and expenditure variables has been provided to the user on
this CD-ROM. This will hopefully facilitate a better understanding of the
analytic uses of these variables. The user is provided with the following
variable information: (1) the event source of the variable; (2) the
variable
label found on the file; (3) a generic code which explains how the
variable
was constructed and (4) a conceptual description of the variable.
Key for Abbreviations Used in Section T
DVIS:
a
File 1 of Public Use Tape 14.3, where each record corresponds to
visit to a dental provider , for each eligible and responding
person.
EROM:
a
File 3 of Public Use Tape 14.5, where each record corresponds to
visit to a hospital emergency room, regardless of type of
provider
seen, for each eligible and responding person.
HVIS:
the
File 1 of Public Use Tape 14.2, where each record corresponds to
set of formal home health care services provided during the year
by
each unique type of provider sent by each unique agency, for
each
eligible and responding person.
MEXP:
each
File 2 of Public Use Tape 14.2, where each record corresponds to
unique type of medical item purchased, rented, or otherwise
obtained
per round, for each eligible and responding person.
MVIS:
a
File 1 of Public Use Tape 14.5, where each record corresponds to
visit or telephone call to a physician's office (including HMOs
and
health departments) in settings other than a hospital or at
home,
and to other providers of care (e.g., chiropractors and
psychologists), for each eligible and responding person.
OPAT:
a
File 2 of Public Use tape 15.5, where each record corresponds to
visit to a hospital outpatient department, regardless of type of
provider seen, for each eligible and responding person.
PMED:
each
File 1 of Public Use Tape 14.1, where each record corresponds to
unique medication purchased or otherwise obtained during a
reference
period, for each eligible and responding person.
STAZ:
one
File 1 of Public Use tape 14.4, where each record corresponds to
hospital stay, for each eligible and responding person.
Variable Name:
HOSP
Event Source(s): STAZ
Variable Label:
# OF HOSPITAL ADMISSIONS (SET 1)
Technical Specifications:
Count of STAZ records with NUMNGHTX>=1
Description:
Constructed variable indicating number of hospital admissions
with a stay of 1 or more nights. In Set 1, all newborns have
charges and hospital utilization related to birth (unlike Set 2,
which assigns hospitalization and utilization charges to the
mother, not the newborn).
Variable Name:
HOSPX
Event Source(s): STAZ
Variable Label:
# OF HOSPITAL ADMISSIONS (SET 2)
Technical Specifications:
Count of modified STAZ records w/NUMNGHTX>=1. STAZ records
modified for birth of child (normal delivery), child's charges
set to 0, sum with mother's charges, mother-baby identified by
ODU, PN, MOMPN, EN, and RSNINHOS=4 or 5, BABYNORM=1 and
NORMDELV=1.
Description:
Constructed variable indicating number of hospital admissions
with a stay of 1 or more nights. In Set 2, expenditures and
hospitalization utilization related to birth for newborns are
bundled with the mothers' expenditures and utilization, unless
the delivery was abnormal or if the infant's hospital stay
exceeded that of the mother's.
Variable Name:
HOSPNGT
Event Source(s): STAZ
Variable Label:
# OF NIGHTS IN HOSPITAL (SET 1)
Technical Specifications:
Sum of NUMNGHTX from STAZ records w/NUMNGHTX>=1
Description:
Constructed variable indicating the total number of nights in the
hospital. In Set 1, stays for newborns are counted separately
from mother's stay.
Variable Name:
HOSPNGTX
Event Source(s): STAZ
Variable Label:
# OF NIGHTS IN HOSPITAL (SET 2)
Technical Specifications:
Sum of NUMNGHTX from STAZ records w/NUMNGHTX>=1. STAZ records
modified for birth of child (normal delivery), child's charges
set to 0, sum with mother's charges, mother-baby identified by
ODU, PN, MOMPN, EN, and RSNINHOS =4 or 5, BABYNORM=1 and
NORMDELV=1.
Description:
Constructed variable indicating the total number of nights in
hospital. In Set 2, stays for newborns are not counted
separately from mother's stay unless delivery was abnormal or if
the infant's stay exceeded the mother's.
Variable Name:
HOSMDEXP
Event Source(s): STAZ
Variable Label:
HOSPITAL PHYSICIAN EXPENSE (SET 1) ($)
Technical Specifications:
Sum of EXPDRX from STAZ records with NUMNGHTX>=1
Description:
Constructed variable indicating the hospital physician expense
per stay for physicians billing separately for inpatient
services. In Set 1, stays for newborns are counted separately
from mother's stay.
Variable Name:
HSXMDEXP
Event Source(s): STAZ
Variable Label:
HOSPITAL PHYSICIAN EXPENSE (SET 2) ($)
Technical Specifications:
Sum of EXPDRX from STAZ records with NUMNGHTX>=1. STAZ records
modified for birth of child (normal delivery), child's charges
set to 0, sum with mother's charges, mother-baby identified by
ODU, PN, MOMPN, EN, and RSNINHOS=4 or 5, BABYNORM=1 and
NORMDELV=1.
Description:
Constructed variable indicating the hospital facility expense per
stay for physicians billing separately for inpatient services.
In Set 2, stays for newborns are not counted separately from
mother's stay unless delivery was abnormal or if the infant's
stay exceeded the mother's.
Variable Name:
HOSFCEXP
Event Source(s): STAZ
Variable Label:
HOSPITAL FACILITY EXPENSE (SET 1) ($)
Technical Specifications:
Sum of EXPFACX from STAZ with NUMNGHTX>=1
Description:
Constructed variable indicating the hospital facility expense per
stay. In Set 1, stays for newborns are counted separately from
mother's stay. Expense includes hospital care, room and board,
laboratory charges, x-ray, and services provided by physicians
not billing separately.
Variable Name:
HSXFCEXP
Event Source(s): STAZ
Variable Label:
HOSPITAL FACILITY EXPENSE (SET 2) ($)
Technical Specifications:
Sum of EXPFACX from STAZ records with NUMNGHTX>=1. STAZ records
modified for birth of child (normal delivery), child's charges
set to 0, sum with mother's charges, mother-baby identified by
ODU, PN, MOMPN, EN, and RSNINHOS=4 or 5, BABYNORM=1 and
NORMDELV=1.
Description:
Constructed variable indicating the hospital facility expense per
stay. In Set 2, stays for newborns are not counted separately
from mother's stay unless delivery was abnormal or if the
infant's stay exceeded the mother's. Expense includes hospital
care, room and board, laboratory charges, x-ray, and services
provided by physicians not billing separately.
Variable Name:
EROMHO
Event Source(s): EROM
Variable Label:
# EMERG RM VISITS RSLTNG IN HOSP ADMSS
Technical Specifications:
Count of EROM records w/ADMTHOSX=1
Description:
Number of emergency room visits resulting in hospital admission.
Variable Name:
EROMHEXP
Event Source(s): EROM
Variable Label:
EXP F/EROM VSTS RSLTNG IN HSP ADMISS ($)
Technical Specifications:
Sum of EXPTOTX from EROM records w/ADMTHOSX=1
Description:
Total hospital expense (sum of facility expense and separate
physician expense) for emergency room visits resulting in
hospital admission.
Variable Name:
DRTEL
Event Source(s): MVIS
Variable Label:
# PHONE VSTS W/PHYS, NOT HOSP-BASED
Technical Specifications:
Count of MVIS records w/MVISCLAS=1 & SEETLKMX=1
Description:
Number of telephone calls to physician, not hospital-based.
Variable Name:
DRTELEXP
Event Source(s): MVIS
Variable Label:
EXP F/PHONE VSTS W/PHYS, NOT HOSP-BSD ($)
Technical Specifications:
Sum of EXPTOTX from MVIS records w/MVISCLAS=1 & SEETLKMX=1
Description:
Total expense for telephone calls to physician, not hospitalbased.
Variable Name:
NONDRTEL
Event Source(s): MVIS
Variable Label:
# PHONE VSTS W/NONPHYS, NOT HOSP-BASED
Technical Specifications:
Count of MVIS records w/MVISCLAS=1 & SEETLKMX^=1
Description:
Number of telephone calls to nonphysician, not hospital-based.
Variable Name:
NDRTLEXP
Event Source(s): MVIS
Variable Label:
EXP F/PH VSTS W/NONPHYS, NOT HSP-BSD ($)
Technical Specifications:
Sum of EXPTOTX from MVIS records w/MVISCLAS=1 & SEETLKMX^=1
Description:
Expense for telephone calls to nonphysician, not hospital-based.
Variable Name:
DRVISITS
Event Source(s): MVIS
Variable Label:
# PHYSICIAN VISTS, EXCLUDING HOSP/HOME
Technical Specifications:
Count of MVIS records w/MVISCLAS=2
Description:
Number of visits to physician, not hospital- or home-based.
Variable Name:
DRVISEXP
Event Source(s): MVIS
Variable Label:
EXPENSE F/PHYS VSTS, EXCL HOSP/HOME ($)
Technical Specifications:
Sum of EXPTOTX from MVIS records w/MVISCLAS=2
Description:
Total expense for visits to physician, not hospital- or homebased.
Variable Name:
DENTORTH
Event Source(s): DVIS
Variable Label:
# DENTAL VISITS: ORTHODONTIC
Technical Specifications:
Count of DVIS records w/ORTHDONT=1
Description:
Number of dental visits for orthodontia.
Variable Name:
DENTOEXP
Event Source(s): DVIS
Variable Label:
EXP F/DENTAL VISITS: ORTHODONTIC ($)
Technical Specifications:
Sum of EXPTOTX from DVIS records w/ORTHDONT=1
Description:
Total expense for dental visits for orthodontia.
Variable Name:
DRHOME
Event Source(s): HVIS
Variable Label:
# HOME HEALTH VISITS: PHYSICIAN
Technical Specifications:
Sum of VISTNUMX from HVIS records w/PROVTYPE=7
Description:
Number of home health physician visits.
Variable Name:
Event Source(s):
DRHOMEXP
HVIS
Variable Label:
EXPENSE F/HOME HLTH VSTS: PHYSICIAN ($)
Technical Specifications:
Sum of (VISTNUMX*VISTEXPX) from HVIS records w/PROVTYPE=7
Description:
Total expense for home health physician visits.
Variable Name:
PMEDS
Event Source(s): PMED
Variable Label:
# PRESCRIBED MEDICINES, INCLUDING REFILLS
Technical Specifications:
Sum of PRCHDATX from PMED records
Description:
Number of prescribed medicines, including refills.
Variable Name:
PMEDSEXP
Event Source(s): PMED
Variable Label:
EXP F/PRESCRIBED MEDS, INCL REFILLS ($)
Technical Specifications:
Sum of EXPTOTX from PMED records.
Description:
Total expense for prescribed medicines, including refills.
Variable Name:
MEXP1EXP
Event Source(s): MEXP
Variable Label:
EXPENSE FOR VISION ($)
Technical Specifications:
Sum of EXPTOTX from MEXP records w/CODEITMX=1
Description:
Total expense for glasses and contact lenses.
Variable Name:
MEXP2EXP
Event Source(s): MEXP
Variable Label:
EXPENSE FOR DURABLE GOODS EXCLUDING VISION ($)
Technical Specifications:
Sum of EXPTOTX from MEXP records w/CODEITMX not equal to: 1, 4,
5, 21, 22, 42-44, 62, 79, 91, 92 or 95
Description:
Total expense for durable medical goods, including orthopedic
items, hearing aids/communication items, prostheses, bathing
equipment, home modifications, mattress/pads, beds, furniture,
lifts and hoists, toileting equipment, feeding machines,
dentures, breathing equipment, walkers/crutches, electric and
nonelectric wheelchairs, canes, braces, chairlifts, blood
pressure equipment, heart valves, heart monitors, OT heart items,
testing and monitoring equipment, pumps, warning devices, OT
hearing eqipment stimulators, and heating pads.
Variable Name:
MEXP3EXP
Event Source(s): MEXP
Variable Label:
EXPENSE FOR NON-DURABLE GOODS ($)
Technical Specifications:
Sum of EXPTOTX from MEXP records w/CODEITMX=4, 5, 21, 22, 42-44,
62, 79, 91, 92, or 95
Description:
Total expense for special medical items including diabetic items,
ambulance, clothing, bandages, ostomy supplies, catheters,
diapers, oxygen, OT ambulatory equipment, IV equipment and
supplies, miscellaneous items, and special transportation items.
Variable Name:
TOTALEXP
Event Source(s): STAZ, EROM, MVIS, OPAT, DENT, HVIS, PMED, MEXP
Variable Label:
TOTAL HEALTH CARE EXPENDITURES ($)
Technical Specifications:
HOSMDEXP + HOSFCEXP + EROMSEXP + DRTELEXP + NDRTLEXP + DRVISEXP +
NDRVSEXP + OPDDREXP + OPDNDEXP + DENTEXP + DRHOMEXP + NDMHMEXP +
PMEDSEXP + MEXP1EXP + MEXP2EXP + MEXP3EXP
Description:
Total health care expenditures that include the sum of all
components. (Using Set 1 for hospitalization data.)
Variable Name:
NONDRVIS
Event Source(s): MVIS
Variable Label:
# NONPHYS MED PROV VSTS EXCL HOSP/HOME
Technical Specifications:
Count of MVIS records with MVISCLAS = 3-8
Description:
Number of visits to the following nonphysician medical providers
who are not hospital- or home- based: chiropractor, podiatrist,
optometrist, psychologist, and other medical provider (both those
who do and do not work for physicians).
Variable Name:
NDRVSEXP
Event Source(s): MVIS
Variable Label:
EXPENSE F/NONPHYS VSTS EXCL HSP/HME ($)
Technical Specifications:
Sum of EXPTOTX from MVIS records with MVISCLAS = 3-8
Description:
Total expense for nonphysician medical providers, not hospitalor home-based.
Variable Name:
OPDDR
Event Source(s): STAZ, OPAT
Variable Label:
# HOSP OUTPAT PHYS VSTS & O-NGHT ADMISS
Technical Specifications:
(Count of STAZ records w/NUMNGHTX=0) + (Count of OPAT records
w/SEEDOCX < 1)
Description:
Number of outpatient physician visits including hospital
admissions with no overnight stay.
Variable Name:
OPDDREXP
Event Source(s): STAZ, OPAT
Variable Label:
EXP F/HSP OP PHYS VSTS HOSP OUTPAT VST & 0-NGT ADMSS
Technical Specifications:
(Sum of EXPTOTX from STAZ records w/NUMNGHTX=0) + (Sum of EXPTOTX
from OPAT records w/SEEDOCX < 1)
Description:
Total expense for outpatient physician visits and hospital
admission with no overnight stay.
Variable Name:
OPDNONDR
Event Source(s): OPAT
Variable Label:
# HOSP OUTPT NONPHYSICIAN VISITS
Technical Specifications:
Count of OPAT records w/SEEDOCX > 1
Description:
Number of nonphysician outpatient visits (i.e., chiropractors,
nurses, technologists, optometrists, podiatrists, physician's
�WPCD
assistants, psychologists, social workers, and other medical
providers).
Variable Name:
OPDNDEXP
Event Source(s): OPAT
Variable Label:
EXP F/HOSP OPAT NONPHYSICIAN VSTS ($)
Technical Specifications:
Sum of EXPTOTX from OPAT records w/SEEDOCX > 1
Description:
Total expense for nonphysician outpatient visits (i.e.,
chiropractors, nurses, technologists, optometrists, podiatrists,
physician's assistants, psychologists, social workers, and other
medical providers).
Variable Name:
Event Source(s):
EROMS
EROM
Variable Label:
TOTAL # EMERGENCY ROOM VISITS
Technical Specifications:
EROMHO + (Count of EROM records w/ADMTHOSX=2
Description:
Total number of emergency room visits (including those that did
and did not result in a hospital admission).
Variable Name:
EROMSEXP
Event Source(s): EROM
Variable Label:
EXPENSE FOR EMERGENCY ROOM VISITS ($)
Technical Specifications:
EROMHEXP + (Sum of EXPTOTX from EROM records w/ADMTHOSX=2)
Description:
Total expense for all emergency room visits.
Variable Name:
NONDRMHM
Event Source(s): HVIS
Variable Label:
# NONPHYSICIAN HOME HEALTH VSTS
Technical Specifications:
Count of HVIS records w/PROVTYPE NE 7
Description:
Total number of non-physician home health visits (i.e., nurse/
practitioners, LPNs, physical therapists, other therapists,
social workers, other nonphysician medical providers, home health
aides and homemakers).
Variable Name:
NDMHMEXP
Event Source(s): HVIS�
EXP F/NONPHYSICIAN HOME HEALTH VSTS ($)
Technical Specifications:
Sum of (VISTNUMX* VISTEXPX) from HVIS records w/PROVTYPE NE 7
Description:
Total expense for nonphysician home health visits.
Variable Name:
DENT
Event Source(s): DVIS
Variable Label:
TOTAL # DENTAL VISITS
Technical Specifications:
DENTORTH + (Count of DENT records w/ORTHDONT NE 1)
Description:
Number of dental visits (orthodontic and nonorthodontic).
Variable Name:
Event Source(s):
Variable Label:
DENTEXP
DVIS
EXPENSE FOR DENTAL VISITS ($)
Technical Specifications:
DENTOEXP + (Sum of EXPTOTX from DENT records w/ORTHDONT NE 1)
Description:
Total expense for dental visits (orthodontic and nonorthodontic).
NOTE:
These estimates were made using a SAS data file and may
differ slightly from estimates made using the Tape 18
EBCDIC data file or a SAS file created from the Tape 18
EBCDIC data file.
COMPARISON OF ESTIMATES OF NMES HEALTH CARE UTILIZATION USING NMES PUBLIC
USE
TAPES 13, 14, AND 18
NOTE:
to
This table was originally
formatted as a nine column table. Due
space restrictions, the first four colums appear together followed
by
the remaining five columns.
For NMES PUBLIC USE TAPES
13, 14, and 18
Variable
DRVISITS
DRTEL
NONDRVIS
NONDRTEL
EROMS
EROMHO
HOSP
HOSPNGT
DRHOME
NONDRMHM
PMEDS
DENT
DENTORTH
OPDDR
OPDNONDR
Unwt. #SP with
Use and with
Positive Weight
(INCALPER)
22,828
3,208
7,171
970
5,728
1,183
3,719
3,719
172
968
20,000
13,439
937
4,747
2,771
Wt. Est. of #SP
with Use and with
Positive Weight
(INCALPER)
161,080,390
23,506,119
52,072,475
7,162,368
37,702,370
7,017,536
24,169,932
24,169,932
969,169
5,227,676
138,958,096
101,563,130
7,490,088
30,966,001
19,330,734
NMES Public Use Tape 14
NMES PUBLIC USE TAPE 13
Total
Mean
Utilization �
741,869,278
39,801,274
320,275,683
10,085,806
53,424,204
8,181,324
31,225,348
204,950,141
3,841,755
254,560,170
1,231,005,708
291,766,756
39,153,609
N/A
N/A
4.61
1.69
6.15
1.41
1.42
1.17
1.29
8.48
3.96
48.69
8.86
2.87
5.23
N/A
N/A
NMES Public Use Tape 18
VARIABLE
Total
Utilization
DRVISITS
DRTEL
NONDRVIS
NONDRTEL
EROMS
EROMHO
HOSP
HOSPNGT
DRHOME
NONDRMHM
PMEDS
DENT
DENTORTH
OPDDR
OPDNONDR
741,869,278
39,801,274
320,275,683
10,085,806
53,424,204
8,181,324
31,225,348
204,950,141
3,841,755
254,560,170
1,231,005,708
291,766,756
39,153,609
81,458,388
53,659,174
Mean
Utilization
Tape
Series#
4.61
1.69
6.15
1.41
1.42
1.17
1.29
8.48
3.96
48.69
8.86
2.87
5.23
2.63
2.78
14.5
14.5
14.5
14.5
14.5
14.5
14.4
14.4
14.2
14.2
14.1
14.3
14.3
14.5
14.5
Total
Mean
Utilization Utilization
741,869,278
39,801,274
320,275,683
10,085,806
53,424,204
8,181,324
31,225,348
204,950,141
3,841,755
254,560,170
1,231,005,708
291,766,756
39,153,609
81,458,388
53,659,174
4.61
�
6.15
1.41
1.42
1.17
1.29
8.48
3.96
48.69
8.86
2.87
5.23
2.63
2.78
National Medical Expenditure Survey, Household Survey, 1987. Agency for
Health Care Policy and Research.
NOTES:
(1) For each of these utilization variables, the total utilization and
mean
utilization include only sample persons (SP) with a positive value
for
that utilization variable and with a positive value for the fullyear
person-level weight (INCALPER).
(2)
All of these estimates were made using SAS data files and may differ
slightly from estimates made using the Tape 13, 14, or 18 EBCDIC
data
files or SAS files created from the Tape 13, 14, or 18 EBCDIC data
files.
(The weighted estimates of #SP with use and with positive weight
(INCALPER) were made using a SAS version of the Public Use Tape 18
data
(3)
file.)�
The variables from Tape 18 summarizing use of outpatient services
(i.e., OPDDR, OPDNONDR) have no analogous variables on Tape 13. See
Section 1.6.5 of this documentation for additional details on the
construction of these variables.
COMPARISON OF ESTIMATES OF NMES HEALTH CARE EXPENDITURES USING NMES
PUBLIC USE
TAPES 14 AND 18
For NMES Public Use
NMES Public Use Tape
14
Tapes 14 and 18
Variable
Tape
Unwt. #SP with
Wt. Est. of #SP
Exp and with
with Exp and with
Total
Expenditure
Mean
Expenditure
Series
Positive Weight
Positive Weight
#
(INCALPER)
(INCALPER)
DRVISEXP
14.5
22,257
157,110,773
40,124,560,016
255.39
DRTELEXP
14.5
547
3,719,705
362,471,072
97.45
NDRVSEXP
14.5
6,023
43,954,235
11,907,090,471
270.90
NDRTLEXP
14.5
170
1,212,246
71,413,612
58.91
EROMSEXP
14.5
�
4,858
32,508,850
8,855,387,184
272.40
HOSMDEXP
14.4
2,742
17,358,746
33,642,586,023
1,938.08
HOSFCEXP
14.4
3,719
24,169,932
153,881,290,216 6,366.64
DRHOMEXP
14.2
172
969,169
158,077,912
NDMHMEXP
14.2
968
5,227,676
11,406,512,846
2,181.95
PMEDSEXP
14.1
19,725
137,106,664
22,233,377,225
162.16
DENTEXP
14.3
13,439
101,563,130
29,995,670,778
295.34
163.11
DENTOEXP
14.3
937
7,490,088
7,175,349,701
957.98
MEXP1EXP
14.2
5,085
37,015,099
4,660,313,533
125.90
MEXP2EXP
14.2
1,524
9,870,875
2,267,329,594
229.70
MEXP3EXP
14.2
1,674
10,035,894
1,686,084,959
168.01
OPDDREXP
14.5
4,657
30,390,719
31,278,799,318
1,029.22
OPDNDEXP
14.5
2,721
18,978,481
11,550,006,928
608.58
TOTALEXP
14.1-5
28,704
202,169,978
364,080,971,685 1,800.87
NMES Public Use
Tape 18
Variable
Total
Expenditure
Mean
Expenditure
DRVISEXP
DRTELEXP
NDRVSEXP
NDRTLEXP
EROMSEXP
HOSMDEXP
HOSFCEXP
DRHOMEXP
NDMHMEXP
PMEDSEXP
DENTEXP
DENTOEXP
MEXP1EXP
MEXP2EXP
MEXP3EXP
OPDDREXP
OPDNDEXP
TOTALEXP
40,124,560,016
362,471,072
11,907,090,471
71,413,612
8,855,387,184
3,642,586,002
153,881,290,290
158,077,912
11,406,512,846
22,233,374,790
29,995,670,778
7,175,349,701
4,660,313,533
2,267,329,594
1,686,084,959
31,278,801,751
11,550,005,636
364,080,970,446
255.39
97.45
270.90
58.91
272.40�
1,938.08
6,366.64
163.11
2,181.95
162.16
295.34
957.98
125.90
229.70
168.01
1,029.22
608.58
1,800.87
National Medical Expenditure Survey, Household Survey, 1987. Agency for
Health Care Policy and Research.
NOTES:
(1)
For each of these expenditure variables, the total expenditure and
mean
expenditure include only sample persons (SP) with a positive value
for
that expenditure variable and with a positive value for the fullyear
person-level weight (INCALPER).
(2)
All of these estimates were made using SAS data files and may
differ
slightly from estimates made using the Tape 14 or 18 EBCDIC data
files
or SAS files created from the Tape 14 or 18 EBCDIC data files.
(The weighted estimates of #SP with expenditures and with positive
weight (INCALPER) were made using a SAS version of the Public Use
Tape 18 data file.)
(3)
The variable TOTALEXP is the sum of the following PUF 18
expenditure
variables: DRVISEXP, DRTELEXP, NDRVSEXP, NDRTLEXP, EROMSEXP,
HOSMDEXP,
HOSFCEXP, DRHOMEXP, NDMHMEXP, PMEDSEXP, DENTEXP, MEXP1EXP,
MEXP2EXP,
MEXP3EXP, OPDDREXP and OPDNDEXP.